DISEASE/TRAIT	MAPPED_TRAIT	STUDY ACCESSION	Other	Background
Cannabis use (age at onset)	Cannabis use|| age at onset	GCST006386	Cannabis use|| age at onset	
Cannabis use (age at onset)	Cannabis use|| age at onset	GCST002917	Cannabis use|| age at onset	
Schizophrenia (age at onset)	schizophrenia|| age at onset	GCST001115	schizophrenia|| age at onset	
Parkinson's disease in GBA mutation carriers (age at onset)	Parkinson's disease|| GBA carrier status|| age at onset	GCST003060	age at onset|| Parkinson's disease	GBA carrier status
Bipolar disorder (age of onset and psychotic symptoms)	age at onset|| psychotic symptoms|| bipolar disorder	GCST000969	age at onset|| psychotic symptoms|| bipolar disorder	
Curve progression in adolescent idiopathic scoliosis	adolescent idiopathic scoliosis|| disease progression measurement	GCST004981	adolescent idiopathic scoliosis|| disease progression measurement	
Severe progression in rheumatoid arthritis	rheumatoid arthritis|| disease progression measurement	GCST004998	rheumatoid arthritis|| disease progression measurement	
Liver transplant-free survival in primary sclerosing cholangitis (time to event)	event free survival time|| sclerosing cholangitis	GCST005859	event free survival time|| sclerosing cholangitis	
Cholangiocarcinoma in primary sclerosing cholangitis (time to event)	event free survival time|| cholangiocarcinoma|| sclerosing cholangitis	GCST005860	event free survival time|| cholangiocarcinoma|| sclerosing cholangitis	
Event free survival in diffuse large B-cell lymphoma treated with immunochemotherapy	diffuse large B-cell lymphoma|| event free survival time|| response to immunochemotherapy	GCST003178	diffuse large B-cell lymphoma|| event free survival time|| response to immunochemotherapy	
Breast cancer (survival)	event free survival time|| survival time|| breast carcinoma	GCST001373	event free survival time|| survival time|| breast carcinoma	
Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)	event free survival time|| type I diabetes mellitus|| carrier status|| autoantibody measurement	GCST006197	event free survival time|| type I diabetes mellitus|| autoantibody measurement	carrier status
Overall survival in osteosarcoma	osteosarcoma|| overall survival	GCST005158	osteosarcoma|| overall survival	
Progression free survival in metastatic colorectal cancer (CAPOX-B vs CAPOX-B plus cetuximab)	progression free survival|| metastatic colorectal cancer|| response to cetuximab|| response to CAPOX-B	GCST003058	progression free survival|| metastatic colorectal cancer|| response to cetuximab|| response to CAPOX-B	
Progression free survival in metastatic colorectal cancer (chemotherapy interaction)	progression free survival|| metastatic colorectal cancer|| response to cetuximab|| response to CAPOX-B	GCST003057	progression free survival|| metastatic colorectal cancer|| response to cetuximab|| response to CAPOX-B	
Breast cancer (survival)	survival time|| breast carcinoma	GCST005106	survival time|| breast carcinoma	
Breast cancer (survival)	survival time|| breast carcinoma	GCST002727	survival time|| breast carcinoma	
Breast cancer (survival)	estrogen-receptor negative breast cancer|| survival time|| estrogen-receptor positive breast cancer|| breast carcinoma	GCST002861	survival time|| estrogen-receptor negative breast cancer|| estrogen-receptor positive breast cancer|| breast carcinoma	
Survival in breast cancer (estrogen-receptor positive)	event free survival time|| estrogen-receptor positive breast cancer	GCST005901	event free survival time|| estrogen-receptor positive breast cancer	
Survival in endocrine treated breast cancer (estrogen-receptor positive)	event free survival time|| estrogen-receptor positive breast cancer|| response to endocrine therapy	GCST005900	event free survival time|| estrogen-receptor positive breast cancer|| response to endocrine therapy	
Survival in colorectal cancer (distant metastatic)	metastasis measurement|| colorectal cancer|| survival time	GCST003230	metastasis measurement|| colorectal cancer|| survival time	
Survival in colorectal cancer (non-distant metastatic)	metastasis measurement|| colorectal cancer|| survival time	GCST003231	metastasis measurement|| colorectal cancer|| survival time	
Survival in breast cancer (TP53 expression interaction)	overall survival|| breast carcinoma|| TP53 mutation status	GCST004229	overall survival|| breast carcinoma|| TP53 mutation status	
Survival in TP53 positive breast cancer	overall survival|| TP53 Positive Breast Carcinoma	GCST004228	overall survival|| TP53 Positive Breast Carcinoma	
Survival in pancreatic cancer	overall survival|| pancreatic carcinoma	GCST004485	overall survival|| pancreatic carcinoma	
Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin	overall survival|| ovarian carcinoma|| response to cisplatin|| response to paclitaxel	GCST004896	overall survival|| ovarian carcinoma|| response to cisplatin|| response to paclitaxel	
Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	progression free survival|| response to carboplatin|| ovarian carcinoma|| response to paclitaxel	GCST003328	progression free survival|| response to carboplatin|| ovarian carcinoma|| response to paclitaxel	
Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	progression free survival|| ovarian carcinoma|| response to cisplatin|| response to paclitaxel	GCST004897	progression free survival|| ovarian carcinoma|| response to cisplatin|| response to paclitaxel	
Progression free survival in EGFR-mutation-positive never-smoking lung adenocarcinoma treated with gefitinib or erlotinib	progression free survival|| response to gefitinib|| response to erlotinib|| lung adenocarcinoma	GCST003794	progression free survival|| response to gefitinib|| response to erlotinib|| lung adenocarcinoma	
Survival in colorectal cancer	colorectal cancer|| survival time	GCST003229	colorectal cancer|| survival time	
Survival in breast cancer (estrogen-receptor negative)	estrogen-receptor negative breast cancer|| survival time|| breast carcinoma	GCST002902	estrogen-receptor negative breast cancer|| survival time|| breast carcinoma	
Survival in breast cancer (estrogen-receptor positive)	survival time|| estrogen-receptor positive breast cancer|| breast carcinoma	GCST002903	survival time|| estrogen-receptor positive breast cancer|| breast carcinoma	
Survival in head and neck cancer	head and neck malignant neoplasia|| survival time	GCST003541	head and neck malignant neoplasia|| survival time	
Sepsis from pneumonia (survival)	survival time|| pneumonia|| septic shock|| sepsis	GCST002725	survival time|| pneumonia|| septic shock|| sepsis	
Survival in sporadic amyotrophic lateral sclerosis	sporadic amyotrophic lateral sclerosis|| survival time	GCST003632	sporadic amyotrophic lateral sclerosis|| survival time	
Survival in endocrine treated breast cancer (estrogen-receptor positive)	survival time|| estrogen-receptor positive breast cancer|| breast carcinoma|| response to endocrine therapy	GCST002901	survival time|| estrogen-receptor positive breast cancer|| breast carcinoma|| response to endocrine therapy	
Age-related cataracts (age at onset)	age at onset|| age-related cataract	GCST002618	age at onset|| age-related cataract	
Alcohol dependence (age at onset)	age at onset|| alcohol dependence	GCST002477	age at onset|| alcohol dependence	
Alzheimer disease and age of onset	Alzheimer's disease|| age at onset	GCST003427	Alzheimer's disease|| age at onset	
Alzheimer's disease (age of onset)	Alzheimer's disease|| age at onset	GCST006120	Alzheimer's disease|| age at onset	
Alzheimer's disease (age of onset)	Alzheimer's disease|| age at onset	GCST001280	Alzheimer's disease|| age at onset	
Alzheimer's disease (survival time)	Alzheimer's disease|| survival time	GCST002775	Alzheimer's disease|| survival time	
Amyotrophic lateral sclerosis (age of onset)	amyotrophic lateral sclerosis|| age at onset	GCST001663	amyotrophic lateral sclerosis|| age at onset	
Bipolar disorder (age of onset <21) or attention deficit hyperactivity disorder	attention deficit hyperactivity disorder|| bipolar disorder	GCST004002	attention deficit hyperactivity disorder|| bipolar disorder	
Frontotemporal dementia (age at onset)	age at onset|| Frontotemporal dementia	GCST006147	age at onset|| Frontotemporal dementia	
Frontotemporal dementia (age at onset)	age at onset|| Frontotemporal dementia	GCST004096	age at onset|| Frontotemporal dementia	
Frontotemporal dementia with GRN mutation (age at onset)	age at onset|| Frontotemporal dementia	GCST006149	age at onset|| Frontotemporal dementia	
Multiple myeloma (survival)	overall survival|| multiple myeloma	GCST003051	overall survival|| multiple myeloma	
Multiple sclerosis (age of onset)	multiple sclerosis|| age at onset	GCST000267	multiple sclerosis|| age at onset	
Myopia (age of diagnosis)	age at onset|| Myopia	GCST006290	age at onset|| Myopia	
Narcolepsy (age of onset)	narcolepsy with cataplexy|| age at onset	GCST002261	narcolepsy with cataplexy|| age at onset	
Non-small cell lung cancer (survival)	survival time|| non-small cell lung carcinoma	GCST002577	survival time|| non-small cell lung carcinoma	
Non-small cell lung cancer (survival)	survival time|| non-small cell lung carcinoma	GCST002032	survival time|| non-small cell lung carcinoma	
Non-small cell lung cancer (survival)	survival time|| non-small cell lung carcinoma	GCST000871	survival time|| non-small cell lung carcinoma	
Parkinson's disease (age of onset)	Parkinson's disease|| age at onset	GCST003653	Parkinson's disease|| age at onset	
Parkinson's disease (age of onset)	Parkinson's disease|| age at onset	GCST000490	Parkinson's disease|| age at onset	
"Parkinson's disease (familial, age at onset)"	Parkinson's disease|| age at onset	GCST003652	Parkinson's disease|| age at onset	
"Parkinson's disease (non-familial, age at onset)"	Parkinson's disease|| age at onset	GCST003651	Parkinson's disease|| age at onset	
Prostate cancer (survival)	survival time|| prostate carcinoma	GCST003100	survival time|| prostate carcinoma	
Spherical equivalent or myopia (age of diagnosis)	age at onset|| Myopia|| refractive error measurement	GCST006291	age at onset|| Myopia|| refractive error measurement	
Restricted and repetitive behaviours in autism spectrum disorder	autism spectrum disorder|| behavior or behavioral disorder measurement	GCST004377	 behavior or behavioral disorder measurement	autism spectrum disorder
Serum metabolite concentrations in chronic kidney disease	chronic kidney disease|| serum metabolite measurement	GCST005648	 serum metabolite measurement	chronic kidney disease
Serum metabolite ratios in chronic kidney disease	chronic kidney disease|| serum metabolite measurement	GCST005650	 serum metabolite measurement	chronic kidney disease
3-hydroxy-1-methylpropylmercapturic acid levels in smokers	smoking behavior|| 3-hydroxy-1-methylpropylmercapturic acid measurement	GCST002957	3-hydroxy-1-methylpropylmercapturic acid measurement	smoking behavior
3-hydroxypropylmercapturic acid levels in smokers	smoking behavior|| 3-hydroxypropylmercapturic acid measurement	GCST002956	3-hydroxypropylmercapturic acid measurement	smoking behavior
Change in HbA1c levels in response to metformin treatment in type 2 diabetes	A1C measurement|| type II diabetes mellitus|| response to metformin	GCST005753	A1C measurement|| response to metformin	type II diabetes mellitus
Paneth cell defects in Crohn's disease	abnormal paneth cell measurement|| Crohn's disease	GCST004251	abnormal paneth cell measurement	Crohn's disease
Acute kidney injury in critical illness	Acute kidney injury|| illness severity status	GCST003656	Acute kidney injury	illness severity status
Acute kidney injury in coronary artery bypass surgery (creatinine rise)	coronary artery bypass|| Acute kidney injury|| serum creatinine measurement	GCST002982	Acute kidney injury|| serum creatinine measurement	coronary artery bypass
Acute-on-chronic liver failure in hepatitis B	acute-on-chronic liver failure|| hepatitis B infection	GCST004165	acute-on-chronic liver failure	hepatitis B infection
Adult onset asthma in ever-smokers	smoking behavior|| adult onset asthma	GCST004222	adult onset asthma	smoking behavior
Cannabis-related aggression	Cannabis use|| aggressive behavior	GCST006175	aggressive behaviour	Cannabis use
Aggressiveness in attention deficit hyperactivity disorder	attention deficit hyperactivity disorder|| aggressive behaviour measurement|| childhood aggressive behaviour measurement	GCST003473	aggressive behaviour measurement|| childhood aggressive behaviour measurement	attention deficit hyperactivity disorder
Airway responsiveness in chronic obstructive pulmonary disease	airway responsiveness measurement|| chronic obstructive pulmonary disease	GCST002724	airway responsiveness measurement	chronic obstructive pulmonary disease
Problematic alcohol use in trauma-exposed individuals	response to trauma exposure|| alcohol dependence measurement	GCST005236	alcohol dependence measurement|| response to trauma exposure	
Allergic rhinitis in asthma	allergic rhinitis|| asthma	GCST002552	allergic rhinitis	asthma
Alloimmunization response to red blood cell transfusion in sickle cell anemia	Sickle cell anemia|| alloimmunization|| response to red blood cell transfusion	GCST002691	alloimmunization|| response to red blood cell transfusion	Sickle cell anemia
Thiopurine-induced alopecia in inflammatory bowel disease	Alopecia|| response to thiopurine|| inflammatory bowel disease	GCST006206	Alopecia|| response to thiopurine	inflammatory bowel disease
Thiopurine-induced alopecia in inflammatory bowel disease (conditioned on rs116855232)	Alopecia|| response to thiopurine|| inflammatory bowel disease	GCST006214	Alopecia|| response to thiopurine	inflammatory bowel disease
Thiopurine-induced severe alopecia in inflammatory bowel disease	Alopecia|| response to thiopurine|| inflammatory bowel disease	GCST006207	Alopecia|| response to thiopurine	inflammatory bowel disease
Thiopurine-induced severe alopecia in inflammatory bowel disease (conditioned on rs116855232)	Alopecia|| response to thiopurine|| inflammatory bowel disease	GCST006199	Alopecia|| response to thiopurine	inflammatory bowel disease
Amygdala volume in trauma-exposed individuals	response to trauma exposure|| amygdala volume	GCST005239	amygdala volume|| response to trauma exposure	
Plasma androstenedione levels in resected early stage-receptor positive breast cancer	androstenedione measurement|| estrogen-receptor positive breast cancer	GCST004363	androstenedione measurement	estrogen-receptor positive breast cancer
Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer	androstenedione measurement|| estrogen-receptor positive breast cancer|| estrone measurement	GCST004361	androstenedione measurement|| estrone measurement	estrogen-receptor positive breast cancer
Anthropometric traits in newborns	anthropometric measurement|| neonate	GCST001964	anthropometric measurement	neonate
Antibody status in Tripanosoma cruzi seropositivity	antibody measurement|| Trypanosoma cruzi seropositivity	GCST002280	antibody measurement	Trypanosoma cruzi seropositivity
Antipsychotic drug-induced weight gain in schizophrenia	schizophrenia|| antipsychotic drug related weight gain	GCST003579	antipsychotic drug related weight gain	schizophrenia
antipsychotic drug dosage in schizophrenia or schizoaffective disorder	schizophrenia|| antipsychotic drug use measurement|| schizoaffective disorder	GCST003341	antipsychotic drug use measurement	schizophrenia|| schizoaffective disorder
Anti-saccade error rate in psychotic disorders	antisaccade response measurement|| schizophrenia|| bipolar disorder|| schizoaffective disorder	GCST005027	antisaccade response measurement	schizophrenia|| bipolar disorder|| schizoaffective disorder
Anxiety in major depressive disorder	unipolar depression|| anxiety	GCST002202	anxiety	unipolar depression
AR-C124910XX levels in individuals with acute coronary syndromes treated with ticagrelor	AR-C124910XX measurement|| acute coronary syndrome	GCST002883	AR-C124910XX measurement	acute coronary syndrome
Asparaginase hypersensitivity in acute lymphoblastic leukemia	asparaginase hypersensitivity|| acute lymphoblastic leukemia	GCST002915	asparaginase hypersensitivity	acute lymphoblastic leukemia
Asparaginase-induced acute pancreatitis in acute lymphoblastic leukemia	asparaginase-induced acute pancreatitis|| acute lymphoblastic leukemia	GCST003500	asparaginase-induced acute pancreatitis	acute lymphoblastic leukemia
Asparaginase-induced acute pancreatitis in acute lymphoblastic leukemia (onset time)	asparaginase-induced acute pancreatitis|| acute lymphoblastic leukemia	GCST003501	asparaginase-induced acute pancreatitis	acute lymphoblastic leukemia
Postoperative atrial fibrillation in coronary artery bypass grafting surgery	coronary artery bypass|| atrial fibrillation	GCST002975	atrial fibrillation	coronary artery bypass
Atrioventricular septal defects in Down syndrome	Atrioventricular canal defect|| Down syndrome	GCST003047	Atrioventricular canal defect	Down syndrome
Suicide attempts in bipolar disorder	bipolar disorder|| attempted suicide	GCST001015	attempted suicide	bipolar disorder
Suicide attempts in major depressive disorder	unipolar depression|| attempted suicide	GCST002972	attempted suicide	unipolar depression
Suicide attempts in depression or bipolar disorder	unipolar depression|| bipolar disorder|| attempted suicide	GCST002503	attempted suicide	unipolar depression|| bipolar disorder
Attention function in attention deficit hyperactive disorder	attention deficit hyperactivity disorder|| attention function measurement	GCST003025	attention function measurement	attention deficit hyperactivity disorder
Gastric parietal cell autoantibody levels in type 1 diabetes	type I diabetes mellitus|| autoantibody measurement	GCST004382	autoantibody measurement	type I diabetes mellitus
Glutamate decarboxylase autoantibody levels in type 1 diabetes	type I diabetes mellitus|| autoantibody measurement	GCST004380	autoantibody measurement	type I diabetes mellitus
Insulinoma-associated antigen 2 autoantibody levels in type 1 diabetes	type I diabetes mellitus|| autoantibody measurement	GCST004381	autoantibody measurement	type I diabetes mellitus
Autoimmune hepatitis in primary sclerosing cholangitis	Autoimmune Hepatitis|| sclerosing cholangitis	GCST005853	Autoimmune Hepatitis	sclerosing cholangitis
Infective endocarditis in Staphylococcus aureus infection	bacterial endocarditis|| Staphylococcus aureus infection	GCST006805	bacterial endocarditis	Staphylococcus aureus infection
Behavioural changes in frontotemporal lobe dementia	Frontotemporal dementia|| behavior	GCST006146	behavior	Frontotemporal dementia
Temperament (bipolar disorder)	behavior or behavioral disorder measurement|| personality trait|| bipolar disorder	GCST001419	behavior or behavioral disorder measurement|| personality trait	bipolar disorder
Behavioral disturbance or psychiatric symptoms in prion disease	behavioral abnormality|| prion disease	GCST002863	behavioral abnormality	prion disease
Cerebrospinal AB1-42 levels in Alzheimer's disease dementia	Alzheimer's disease|| beta-amyloid 1-42 measurement	GCST002531	beta-amyloid 1-42 measurement	Alzheimer's disease
Total bilirubin levels in HIV-1 infection	HIV-1 infection|| bilirubin measurement	GCST002745	bilirubin measurement	HIV-1 infection
Bilirubin levels in extreme obesity	bilirubin measurement|| obesity	GCST002628	bilirubin measurement	obesity
Bilirubin levels in tenofovir-treated HIV infection	bilirubin measurement|| response to tenofovir|| HIV infection	GCST006074	bilirubin measurement|| response to tenofovir	HIV infection
Binge eating behaviour in bipolar disorder	binge eating|| bipolar disorder	GCST005387	binge eating	bipolar disorder
Binge eating behaviour in bipolar disorder	binge eating|| bipolar disorder	GCST002420	binge eating	bipolar disorder
Bone mineral density x blood lead interaction in current smokers (1df test)	smoking behavior|| blood lead measurement|| bone density	GCST006132	blood lead measurement|| bone density	smoking behavior
Bone mineral density x blood lead interaction in current smokers (2df test)	smoking behavior|| blood lead measurement|| bone density	GCST006133	blood lead measurement|| bone density	smoking behavior
Waist circumference adjusted for BMI in active individuals	BMI-adjusted waist circumference|| physical activity measurement	GCST004564	BMI-adjusted waist circumference	physical activity measurement
Waist circumference adjusted for BMI in inactive individuals	BMI-adjusted waist circumference|| physical activity measurement	GCST004565	BMI-adjusted waist circumference	physical activity measurement
Waist circumference adjusted for BMI in smokers	smoking behavior|| BMI-adjusted waist circumference	GCST004503	BMI-adjusted waist circumference	smoking behavior
Waist-to-hip ratio adjusted for BMI in active individuals	BMI-adjusted waist-hip ratio|| physical activity measurement	GCST004578	BMI-adjusted waist-hip ratio	physical activity measurement
Waist-to-hip ratio adjusted for BMI in inactive individuals	BMI-adjusted waist-hip ratio|| physical activity measurement	GCST004577	BMI-adjusted waist-hip ratio	physical activity measurement
Waist-to-hip ratio adjusted for BMI in smokers	smoking behavior|| BMI-adjusted waist-hip ratio	GCST004509	BMI-adjusted waist-hip ratio	smoking behavior
Fat distribution (HIV)	HIV-1 infection|| body fat distribution	GCST001343	body fat distribution	HIV-1 infection
Body mass index in asthmatics	body mass index|| asthma	GCST001945	body mass index	asthma
Body mass in chronic obstructive pulmonary disease	chronic obstructive pulmonary disease|| body mass index	GCST000850	body mass index	chronic obstructive pulmonary disease
Body mass index in physically active individuals	physical activity measurement|| body mass index	GCST004559	body mass index	physical activity measurement
Body mass index in physically inactive individuals	physical activity measurement|| body mass index	GCST004560	body mass index	physical activity measurement
BMI in smokers	smoking behavior|| body mass index	GCST004498	body mass index	smoking behavior
Weight loss (gastric bypass surgery)	gastric bypass|| body weight loss	GCST001991	body weight loss	gastric bypass
Weight loss (gastric bypass surgery)	gastric bypass|| body weight loss	GCST001985	body weight loss	gastric bypass
Bone fracture in osteoporosis	bone fracture|| osteoporosis	GCST004403	bone fracture	osteoporosis
Bone mineral accretion in asthma (oral corticosteroid dose interaction)	bone mineral accretion measurement|| response to corticosteroid|| asthma	GCST002926	bone mineral accretion measurement|| response to corticosteroid	asthma
Breast Cancer in BRCA1 mutation carriers	carrier status|| breast carcinoma	GCST005075	breast carcinoma	carrier status
Breast cancer in childhood cancer survivors	breast carcinoma|| childhood cancer	GCST005111	breast carcinoma	childhood cancer
Breast cancer in childhood cancer survivors treated with less than 10 gray radiotherapy	breast carcinoma|| childhood cancer	GCST005110	breast carcinoma	childhood cancer
Breslow thickness in cutaneous melanoma	cutaneous melanoma|| Breslow thickness	GCST003639	Breslow thickness	cutaneous melanoma
Bronchopulmonary dysplasia in preterm infants	Bronchopulmonary dysplasia|| premature birth	GCST006460	Bronchopulmonary dysplasia	premature birth
C-peptide levels in type I diabetes	C-peptide measurement|| type I diabetes mellitus	GCST005436	C-peptide measurement	type I diabetes mellitus
Fasting C-peptide levels in type I diabetes	C-peptide measurement|| type I diabetes mellitus	GCST005438	C-peptide measurement	type I diabetes mellitus
Random C-peptide levels in type I diabetes	C-peptide measurement|| type I diabetes mellitus	GCST005437	C-peptide measurement	type I diabetes mellitus
Stimulated C-peptide levels in type I diabetes	C-peptide measurement|| type I diabetes mellitus	GCST005435	C-peptide measurement	type I diabetes mellitus
C-reactive protein levels in ischemic stroke	Ischemic stroke|| C-reactive protein measurement	GCST003211	C-reactive protein measurement	Ischemic stroke
Exhaled carbon monoxide levels in smokers with chronic obstructive pulmonary disease	smoking status measurement|| chronic obstructive pulmonary disease|| carbon monoxide exhalation measurement	GCST005919	carbon monoxide exhalation measurement	smoking status measurement|| chronic obstructive pulmonary disease
Cardiomyopathy in childhood cancer survivors	childhood cancer|| cardiomyopathy	GCST003299	cardiomyopathy	childhood cancer
Anthracycline-induced cardiotoxicity in childhood cancer	childhood cancer|| cardiotoxicity|| response to anthracycline-based chemotherapy	GCST003062	cardiotoxicity|| response to anthracycline-based chemotherapy	childhood cancer
Cardiovascular heart disease in diabetics	cardiovascular disease|| type II diabetes mellitus	GCST002153	cardiovascular disease	type II diabetes mellitus
Cardiovascular disease in hypertension (ACE inhibitor interaction)	hypertension|| cardiovascular disease|| response to angiotensin-converting enzyme inhibitor	GCST003186	cardiovascular disease|| response to angiotensin-converting enzyme inhibitor	hypertension
Cardiovascular disease in hypertension (calcium channel blocker interaction)	hypertension|| cardiovascular disease|| response to calcium channel blocker	GCST003205	cardiovascular disease|| response to calcium channel blocker	hypertension
Major coronary event in cardiovascular disease (time to event) (darapladib treatment interaction)	response to darapladib|| acute coronary syndrome|| coronary heart disease|| cardiovascular event measurement	GCST004958	cardiovascular event measurement|| response to darapladib	acute coronary syndrome|| coronary heart disease
Major coronary event in placebo-treated cardiovascular disease (time to event)	acute coronary syndrome|| coronary heart disease|| cardiovascular event measurement|| response to placebo	GCST004961	cardiovascular event measurement|| response to placebo	acute coronary syndrome|| coronary heart disease
Cataracts in type 2 diabetes	cataract|| type II diabetes mellitus	GCST001736	cataract	type II diabetes mellitus
Caudate volume in trauma-exposed individuals	response to trauma exposure|| caudate nucleus volume	GCST005240	caudate nucleus volume|| response to trauma exposure	
Cerebral amyloid deposition in APOEe4 carriers (PET imaging)	APOE carrier status|| cerebral amyloid deposition measurement	GCST003076	cerebral amyloid deposition measurement	APOE carrier status
Cerebrospinal fluid clusterin levels in APOEe4+ carriers	APOE carrier status|| cerebrospinal fluid clusterin measurement	GCST003131	cerebrospinal fluid clusterin measurement	APOE carrier status
Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	Chagas cardiomyopathy|| Trypanosoma cruzi seropositivity	GCST002285	Chagas cardiomyopathy	Trypanosoma cruzi seropositivity
Cholangiocarcinoma in primary sclerosing cholangitis	cholangiocarcinoma|| sclerosing cholangitis	GCST005855	cholangiocarcinoma	sclerosing cholangitis
Cholelithiasis-related traits in sickle cell anemia	Sickle cell anemia|| cholelithiasis|| bilirubin measurement	GCST001497	cholelithiasis|| bilirubin measurement	Sickle cell anemia
Chronic bronchitis in chronic obstructive pulmonary disease	chronic obstructive pulmonary disease|| chronic bronchitis	GCST002621	chronic bronchitis	chronic obstructive pulmonary disease
End stage renal disease in APOL1 risk genotype-negative individuals	chronic kidney disease|| APOL1 risk genotype carrier status	GCST006815	chronic kidney disease	APOL1 risk genotype carrier status
End stage renal disease in APOL1 risk genotype-positive individuals	chronic kidney disease|| APOL1 risk genotype carrier status	GCST006816	chronic kidney disease	APOL1 risk genotype carrier status
Chronic kidney disease in diabetes	chronic kidney disease|| diabetes mellitus	GCST005880	chronic kidney disease	diabetes mellitus
End-stage renal disease in diabetes	chronic kidney disease|| diabetes mellitus	GCST005886	chronic kidney disease	diabetes mellitus
End stage renal failure in renal transplantation (recipient effect)	renal transplant outcome measurement|| chronic kidney disease	GCST005427	chronic kidney disease	renal transplant outcome measurement
End-stage renal disease in Type 1 diabetics	type I diabetes mellitus|| chronic kidney disease	GCST002182	chronic kidney disease	type I diabetes mellitus
Chronic kidney disease in type 2 diabetes	chronic kidney disease|| type II diabetes mellitus	GCST005882	chronic kidney disease	type II diabetes mellitus
End-stage renal disease in type 2 diabetes	chronic kidney disease|| type II diabetes mellitus	GCST005885	chronic kidney disease	type II diabetes mellitus
Chronic kidney disease and diabetic kidney disease in diabetes	chronic kidney disease|| diabetes mellitus|| diabetic nephropathy	GCST005884	chronic kidney disease|| diabetic nephropathy	diabetes mellitus
End-stage renal disease or diabetic nephropathy in type 1 diabetes	type I diabetes mellitus|| chronic kidney disease|| diabetic nephropathy	GCST002464	chronic kidney disease|| diabetic nephropathy	type I diabetes mellitus
Chronic kidney disease and diabetic kidney disease in type 2 diabetes	chronic kidney disease|| diabetic nephropathy|| type II diabetes mellitus	GCST005883	chronic kidney disease|| diabetic nephropathy	type II diabetes mellitus
Chronic mucus hypersecretion in chronic obstructive pulmonary disease	chronic obstructive pulmonary disease|| chronic mucus hypersecretion	GCST002612	chronic mucus hypersecretion	chronic obstructive pulmonary disease
Clostridium difficile infection in multiple myeloma	clostridium difficile infection|| multiple myeloma	GCST005686	clostridium difficile infection	multiple myeloma
Response to cognitive-behavioural therapy in anxiety disorder	anxiety disorder|| cognitive behavioural therapy	GCST003469	cognitive behavioural therapy	anxiety disorder
Cognitive decline rate in late mild cognitive impairment	cognitive impairment|| cognitive decline measurement	GCST003075	cognitive decline measurement	cognitive impairment
Rate of cognitive decline in mild cognitive impairment (time interaction)	cognitive impairment|| cognitive decline measurement|| disease progression measurement	GCST004371	cognitive decline measurement|| disease progression measurement	cognitive impairment
Neurocognitive impairment in HIV-1 infection (continuous)	HIV-1 infection|| cognitive impairment measurement	GCST004406	cognitive impairment measurement	HIV-1 infection
Neurocognitive impairment in HIV-1 infection (dichotomous)	HIV-1 infection|| cognitive impairment measurement	GCST004407	cognitive impairment measurement	HIV-1 infection
Executive inhibition (Stroop WIT and CIT) in attention deficit hyperactivity disorder	attention deficit hyperactivity disorder|| cognitive inhibition measurement	GCST004336	cognitive inhibition measurement	attention deficit hyperactivity disorder
Colorectal carcinoma in primary sclerosing cholangitis	colorectal cancer|| sclerosing cholangitis	GCST005856	colorectal cancer	sclerosing cholangitis
Mucinous adenocarcinoma in colorectal cancer	colorectal cancer|| colorectal mucinous adenocarcinoma	GCST006411	colorectal mucinous adenocarcinoma	colorectal cancer
Common carotid intima-media thickness in HIV infection	common carotid intimal medial thickness|| HIV infection	GCST005184	common carotid intimal medial thickness	HIV infection
Carotid atherosclerosis in HIV infection	HIV-1 infection|| common carotid intimal medial thickness|| internal carotid intimal medial thickness|| carotid artery disease	GCST000555	common carotid intimal medial thickness|| internal carotid intimal medial thickness|| carotid artery disease	HIV-1 infection
Pharmacokinetics of antiepileptic drugs in severe mental disorder (concentration drug ratio)	unipolar depression|| schizophrenia|| bipolar disorder|| concentration dose ratio|| response to anticonvulsant	GCST002887	concentration dose ratio|| response to anticonvulsant	unipolar depression|| schizophrenia|| bipolar disorder
Pharmacokinetics of antidepressant drugs in severe mental disorder (concentration dose ratio)	unipolar depression|| schizophrenia|| bipolar disorder|| concentration dose ratio|| response to antidepressant	GCST002891	concentration dose ratio|| response to antidepressant	unipolar depression|| schizophrenia|| bipolar disorder
Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio)	unipolar depression|| schizophrenia|| bipolar disorder|| concentration dose ratio|| response to antipsychotic drug	GCST002888	concentration dose ratio|| response to antipsychotic drug	unipolar depression|| schizophrenia|| bipolar disorder
Coronary arterial lesions in patients with Kawasaki disease	mucocutaneous lymph node syndrome|| coronary aneurysm	GCST002026	coronary aneurysm	mucocutaneous lymph node syndrome
Coronary arterial lesions in patients with Kawasaki disease	mucocutaneous lymph node syndrome|| coronary aneurysm	GCST001878	coronary aneurysm	mucocutaneous lymph node syndrome
Coronary artery aneurysm in Kawasaki disease	mucocutaneous lymph node syndrome|| coronary aneurysm	GCST003560	coronary aneurysm	mucocutaneous lymph node syndrome
Coronary artery aneurysm in Kawasaki disease	mucocutaneous lymph node syndrome|| coronary aneurysm	GCST003192	coronary aneurysm	mucocutaneous lymph node syndrome
Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes	coronary artery calcification|| type II diabetes mellitus	GCST005173	coronary artery calcification	type II diabetes mellitus
Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes	coronary artery calcification|| type II diabetes mellitus	GCST005175	coronary artery calcification	type II diabetes mellitus
Coronary artery calcified atherosclerotic plaque score in type 2 diabetes	coronary artery calcification|| type II diabetes mellitus	GCST005174	coronary artery calcification	type II diabetes mellitus
Coronary artery disease in diabetes	diabetes mellitus|| coronary artery disease	GCST006405	coronary artery disease	diabetes mellitus
Coronary artery disease in type 1 diabetes	type I diabetes mellitus|| coronary artery disease	GCST006281	coronary artery disease	type I diabetes mellitus
Coronary heart disease in familial hypercholesterolemia	familial hypercholesterolemia|| coronary heart disease	GCST002478	coronary heart disease	familial hypercholesterolemia
Baseline cortisol levels in response to low dose short synacthen test in corticosteroid treated asthma	childhood onset asthma|| cortisol measurement|| response to corticosteroid|| response to synacthen	GCST005925	cortisol measurement|| response to corticosteroid|| response to synacthen	childhood onset asthma
Cotinine levels in smokers with chronic obstructive pulmonary disease	smoking status measurement|| cotinine measurement|| chronic obstructive pulmonary disease	GCST005916	cotinine measurement	smoking status measurement|| chronic obstructive pulmonary disease
Creatine kinase in statin users	response to statin|| creatine kinase measurement	GCST002603	creatine kinase measurement|| response to statin	
Mixed cryoglobulinemia vasculitis in chronic hepatitis C infection	cryoglobulinemia|| Chronic Hepatitis C infection	GCST002534	cryoglobulinemia	Chronic Hepatitis C infection
Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)	cumulative dose response to bevacizumab|| chemotherapy-induced hypertension|| breast carcinoma	GCST002566	cumulative dose response to bevacizumab	breast carcinoma|| chemotherapy-induced hypertension
Response to paclitaxel in ovarian cancer (MTT IC50)	ovarian carcinoma|| cytotoxicity measurement|| response to paclitaxel	GCST003441	cytotoxicity measurement|| response to paclitaxel	ovarian carcinoma
Depressive episodes in bipolar disorder	depressive episode measurement|| bipolar disorder	GCST003091	depressive episode measurement	bipolar disorder
Depression in response to interferon-based therapy in chronic hepatitis C	Chronic Hepatitis C infection|| response to interferon|| depressive symptom measurement	GCST003824	depressive symptom measurement|| response to interferon	Chronic Hepatitis C infection
Diabetes in response to antihypertensive drug treatment (treatment strategy interaction)	response to antihypertensive drug|| diabetes mellitus|| hypertension|| response to beta blocker|| response to calcium channel blocker	GCST003797	diabetes mellitus|| response to antihypertensive drug|| response to beta blocker|| response to calcium channel blocker	hypertension
Foot ulcer in diabetes and neuropathy	type I diabetes mellitus|| diabetic foot|| type II diabetes mellitus|| neuropathy	GCST004724	diabetic foot	type I diabetes mellitus|| type II diabetes mellitus|| neuropathy
Foot ulcer and neuropathy in diabetes	type I diabetes mellitus|| diabetic foot|| type II diabetes mellitus|| neuropathy	GCST004725	diabetic foot|| neuropathy	type I diabetes mellitus|| type II diabetes mellitus
Diabetic macular edema in type 2 diabetes	diabetic macular edema|| type II diabetes mellitus	GCST006282	diabetic macular edema	type II diabetes mellitus
Diabetic kidney disease in diabetes	diabetes mellitus|| diabetic nephropathy	GCST005881	diabetic nephropathy	diabetes mellitus
Diabetic kidney disease in diabetes (ESRD vs. no ESRD)	diabetes mellitus|| diabetic nephropathy	GCST005894	diabetic nephropathy	diabetes mellitus
Early diabetic kidney disease in diabetes	diabetes mellitus|| diabetic nephropathy	GCST005890	diabetic nephropathy	diabetes mellitus
Late diabetic kidney disease in diabetes	diabetes mellitus|| diabetic nephropathy	GCST005888	diabetic nephropathy	diabetes mellitus
Diabetic kidney disease in type 2 diabetes	diabetic nephropathy|| type II diabetes mellitus	GCST005895	diabetic nephropathy	type II diabetes mellitus
Early diabetic kidney disease in type 2 diabetes	diabetic nephropathy|| type II diabetes mellitus	GCST005889	diabetic nephropathy	type II diabetes mellitus
Late diabetic kidney disease in type 2 diabetes	diabetic nephropathy|| type II diabetes mellitus	GCST005887	diabetic nephropathy	type II diabetes mellitus
Sight-threatening diabetic retinopathy in type 2 diabetes	diabetic retinopathy|| type II diabetes mellitus	GCST003042	diabetic retinopathy	 type II diabetes mellitus
Diabetic retinopathy in type 2 diabetes	diabetic retinopathy|| type II diabetes mellitus	GCST002684	diabetic retinopathy	type II diabetes mellitus
Severe diabetic retinopathy in type 2 diabetes	diabetic retinopathy|| type II diabetes mellitus	GCST006424	diabetic retinopathy	type II diabetes mellitus
Diarrhoea in darapladib-treated cardiovascular disease (time to event)	response to darapladib|| diarrhea|| acute coronary syndrome|| coronary heart disease	GCST004962	diarrhea|| response to darapladib	acute coronary syndrome|| coronary heart disease
Moderate or severe diarrhoea in darapladib-treated cardiovascular disease (time to event)	response to darapladib|| diarrhea|| acute coronary syndrome|| coronary heart disease	GCST004967	diarrhea|| response to darapladib	acute coronary syndrome|| coronary heart disease
Diastolic blood pressure night-to-day ratio in hypertension	diastolic blood pressure change measurement|| hypertension	GCST006273	diastolic blood pressure change measurement	hypertension
Diastolic blood pressure response to hydrochlorothiazide in hypertension	response to hydrochlorothiazide|| diastolic blood pressure change measurement|| hypertension	GCST003805	diastolic blood pressure change measurement|| response to hydrochlorothiazide	hypertension
Thiopurine-induced digestive symptoms in inflammatory bowel disease	digestive system disease|| response to thiopurine|| inflammatory bowel disease	GCST006210	digestive system disease|| response to thiopurine	inflammatory bowel disease
Type 1 diabetes in high risk HLA genotype individuals (time to event)	disease free survival|| type I diabetes mellitus|| carrier status	GCST006196	disease free survival|| type I diabetes mellitus	carrier status
Poor prognosis in Crohn's disease	Crohn's disease|| disease prognosis measurement	GCST004053	disease prognosis measurement	Crohn's disease
Relapse in multiple sclerosis	multiple sclerosis|| disease recurrence	GCST004752	disease recurrence	multiple sclerosis
Breast cancer-free interval (treatment with aromatase inhibitor)	disease recurrence|| response to aromatase inhibitor|| breast carcinoma	GCST003816	disease recurrence|| response to aromatase inhibitor	breast carcinoma
Clozapine-induced agranulocytosis/granulocytopenia in treatment-resistant schizophrenia	drug-induced agranulocytosis|| treatment refractory schizophrenia|| response to clozapine	GCST003628	drug-induced agranulocytosis|| response to clozapine	treatment refractory schizophrenia
Clozapine-induced agranulocytosis/granulocytopenia in treatment-resistant schizophrenia	drug-induced agranulocytosis|| treatment refractory schizophrenia|| response to clozapine	GCST003450	drug-induced agranulocytosis|| response to clozapine	treatment refractory schizophrenia
Thionamide-induced agranulocytosis in Graves' disease	drug-induced agranulocytosis|| response to thioamide|| Graves disease	GCST003018	drug-induced agranulocytosis|| response to thioamide	Graves disease
Liver injury in anti-retroviral drug treated HIV	response to efavirenz|| HIV infection|| drug-induced liver injury	GCST004261	drug-induced liver injury|| response to efavirenz	HIV infection
Drug-induced liver injury in interferon-beta-treated multiple sclerosis	multiple sclerosis|| response to interferon beta|| drug-induced liver injury	GCST006270	drug-induced liver injury|| response to interferon beta	multiple sclerosis
Liver injury in anti-tuberculosis drug treatment	response to rifampicin|| Tuberculosis|| drug-induced liver injury	GCST003792	drug-induced liver injury|| response to rifampicin	Tuberculosis
Liver injury in combined anti-retroviral and anti-tuberculosis drug-treated HIV with tuberculosis	response to rifampicin|| Tuberculosis|| response to efavirenz|| HIV infection|| drug-induced liver injury	GCST004262	drug-induced liver injury|| response to rifampicin|| response to efavirenz	HIV infection|| Tuberculosis
Eating disorder in bipolar disorder	eating disorder|| bipolar disorder	GCST003132	eating disorder	bipolar disorder
Ejection fraction in Tripanosoma cruzi seropositivity	Trypanosoma cruzi seropositivity|| ejection fraction measurement	GCST002281	ejection fraction measurement	Trypanosoma cruzi seropositivity
Emphysema distribution in smoking	smoking behavior|| emphysema pattern measurement	GCST003761	emphysema pattern measurement	smoking behavior
Erectile dysfunction in type 1 diabetes	type I diabetes mellitus|| erectile dysfunction	GCST001572	erectile dysfunction	type I diabetes mellitus
Erythema nodosum in inflammatory bowel disease	erythema nodosum|| inflammatory bowel disease	GCST002380	erythema nodosum	inflammatory bowel disease
Estrogen receptor status in breast cancer	estrogen-receptor negative breast cancer|| estrogen-receptor positive breast cancer|| breast carcinoma	GCST003821	estrogen-receptor negative breast cancer|| estrogen-receptor positive breast cancer	breast carcinoma
Plasma estrone conjugates levels in resected early stage estrogen-receptor positive breast cancer	estrone conjugate measurement|| estrogen-receptor positive breast cancer	GCST004359	estrone conjugate measurement	estrogen-receptor positive breast cancer
Estrone conjugates/estrone ratio in resected early stage estrogen-receptor positive breast cancer	estrone conjugate measurement|| estrogen-receptor positive breast cancer|| estrone measurement	GCST004360	estrone conjugate measurement|| estrone measurement	estrogen-receptor positive breast cancer
Plasma estrone levels in resected estrogen-receptor positive breast cancer	estrogen-receptor positive breast cancer|| estrone measurement	GCST004362	estrone measurement	estrogen-receptor positive breast cancer
Executive function in ADHD	attention deficit hyperactivity disorder|| executive function measurement	GCST006219	executive function measurement	attention deficit hyperactivity disorder
Eye movement in schizophrenia (horizontal position gain)	eye movement measurement|| schizophrenia	GCST006448	eye movement measurement	schizophrenia
Eye movement in schizophrenia (integrated eye movement score)	eye movement measurement|| schizophrenia	GCST006451	eye movement measurement	schizophrenia
Eye movement in schizophrenia (scanpath length)	eye movement measurement|| schizophrenia	GCST006459	eye movement measurement	schizophrenia
Family history of upper gastrointestinal cancer in esophageal squamous cell carcinoma	esophageal squamous cell carcinoma|| family history of upper gastrointestinal cancer	GCST004799	family history of upper gastrointestinal cancer	esophageal squamous cell carcinoma
Bone mineral density (femoral neck) in inflammatory bowel disease	inflammatory bowel disease|| femoral neck bone mineral density	GCST005784	femoral neck bone mineral density	inflammatory bowel disease
Fetal hemoglobin levels in sickle cell anemia	fetal hemoglobin measurement|| Sickle cell anemia	GCST002687	fetal hemoglobin measurement	Sickle cell anemia
High fetal hemoglobin in sickle cell disease	fetal hemoglobin measurement|| Sickle cell disease and related diseases	GCST006251	fetal hemoglobin measurement	Sickle cell disease and related diseases
Response to bronchodilator in chronic obstructive pulmonary disease (change in FEV1)	FEV change measurement|| response to bronchodilator|| chronic obstructive pulmonary disease	GCST003830	FEV change measurement|| response to bronchodilator	chronic obstructive pulmonary disease
Response to inhaled glucocorticoid treatment in asthma (change in FEV1)	FEV change measurement|| response to glucocorticoid|| asthma	GCST002754	FEV change measurement|| response to glucocorticoid	asthma
Response to montelukast in asthma (change in FEV1)	FEV change measurement|| response to montelukast|| asthma	GCST002979	FEV change measurement|| response to montelukast	asthma
Response to zileuton treatment in asthma (FEV1 change interaction)	FEV change measurement|| response to zileuton|| asthma	GCST002951	FEV change measurement|| response to zileuton	asthma
Post bronchodilator FEV1/FVC ratio in smoking	smoking behavior|| FEV/FEC ratio	GCST006310	FEV/FEC ratio	smoking behavior
Pre bronchodilator FEV1/FVC ratio in never-smokers	smoking status measurement|| FEV/FEC ratio	GCST003826	FEV/FEC ratio	smoking status measurement
Lung function (FEV1/FVC) in asthma (dust mite allergen exposure interaction)	allergen exposure measurement|| asthma|| FEV/FEC ratio	GCST004108	FEV/FEC ratio|| allergen exposure measurement	asthma
Thiopurine-induced fever in inflammatory bowel disease	fever|| response to thiopurine|| inflammatory bowel disease	GCST006209	fever|| response to thiopurine	inflammatory bowel disease
Fibrinogen levels in ischemic stroke	Ischemic stroke|| fibrinogen measurement	GCST003212	fibrinogen measurement	Ischemic stroke
Follicule stimulating hormone levels in polycystic ovary syndrome	polycystic ovary syndrome|| follicle stimulating hormone measurement	GCST005270	follicle stimulating hormone measurement	polycystic ovary syndrome
Post bronchodilator percent predicted FEV1 in smoking	smoking behavior|| forced expiratory volume	GCST006309	forced expiratory volume	smoking behavior
Lung function (FEV1) in asthma (dust mite allergen exposure interaction)	forced expiratory volume|| allergen exposure measurement|| asthma	GCST004107	forced expiratory volume|| allergen exposure measurement	asthma
Post bronchodilator FEV1 in COPD	forced expiratory volume|| response to bronchodilator|| chronic obstructive pulmonary disease	GCST003263	forced expiratory volume|| response to bronchodilator	chronic obstructive pulmonary disease
Electroencephalographic traits in alcoholism	frontal theta oscillation measurement|| alcohol dependence	GCST001503	frontal theta oscillation measurement	alcohol dependence
Moderate functional decline in sporadic amyotrophic lateral sclerosis	functional decline measurement|| sporadic amyotrophic lateral sclerosis	GCST003333	functional decline measurement	sporadic amyotrophic lateral sclerosis
Rapid functional decline in sporadic amyotrophic lateral sclerosis	functional decline measurement|| sporadic amyotrophic lateral sclerosis	GCST003332	functional decline measurement	sporadic amyotrophic lateral sclerosis
"Functional impairment in major depressive disorder, bipolar disorder and schizophrenia"	unipolar depression|| schizophrenia|| bipolar disorder|| functional impairment measurement	GCST002188	functional impairment measurement	unipolar depression|| schizophrenia|| bipolar disorder
Relative hand skill in reading disability	functional laterality|| dyslexia	GCST002183	functional laterality	dyslexia
Gallbladder carcinoma in primary sclerosing cholangitis	gallbladder neoplasm|| sclerosing cholangitis	GCST005857	gallbladder neoplasm	sclerosing cholangitis
Disturbances of the gamma-frequency band of electroencephalography measures in schizophrenia	schizophrenia|| gamma wave measurement	GCST004953	gamma wave measurement	schizophrenia
MGMT methylation in smokers	smoking behavior|| gene methylation measurement	GCST003031	gene methylation measurement	smoking behavior
Glomerular filtration rate change in heart transplantation	response to transplant|| GFR change measurement	GCST006496	GFR change measurement|| response to transplant	
Glomerular filtration rate in chronic kidney disease	glomerular filtration rate|| chronic kidney disease	GCST003139	glomerular filtration rate	chronic kidney disease
Glomerular filtration rate in diabetes	glomerular filtration rate|| diabetes mellitus	GCST005891	glomerular filtration rate	diabetes mellitus
Glomerular filtration rate in type 2 diabetes	glomerular filtration rate|| type II diabetes mellitus	GCST005892	glomerular filtration rate	type II diabetes mellitus
Glomerular filtration rate in diabetics (creatinine)	glomerular filtration rate|| diabetes mellitus|| serum creatinine measurement	GCST003373	glomerular filtration rate|| serum creatinine measurement	diabetes mellitus
Change in glucose in response to thiazide diuretic treatment in hypertension	response to thiazide|| hypertension|| glucose measurement	GCST005577	glucose measurement|| response to thiazide	hypertension
Gout in chronic kidney disease	gout|| chronic kidney disease	GCST006425	gout	chronic kidney disease
Thyroid-associated orbitopathy in graves' disease	Graves disease|| Graves ophthalmopathy	GCST003640	Graves ophthalmopathy	Graves disease
Plasma haptoglobin levels in type 2 diabetes	haptoglobin measurement|| type II diabetes mellitus	GCST005808	haptoglobin measurement	type II diabetes mellitus
Urinary haptoglobin levels in type 2 diabetes	haptoglobin measurement|| type II diabetes mellitus	GCST005807	haptoglobin measurement	type II diabetes mellitus
Hemoglobin A2 levels in sickle cell anemia	Sickle cell anemia|| hemoglobin A2 measurement	GCST002536	hemoglobin A2 measurement	Sickle cell anemia
Liver fibrosis severity in HIV/hepatitis C co-infection	HIV-1 infection|| Hepatic fibrosis|| hepatitis C infection	GCST003606	Hepatic fibrosis	HIV-1 infection|| hepatitis C infection
Liver fibrosis in pediatric non-alcoholic fatty acid liver disease	non-alcoholic fatty liver disease|| Hepatic fibrosis	GCST004938	Hepatic fibrosis	non-alcoholic fatty liver disease
Hepatic lipid content in extreme obesity	hepatic lipid content measurement|| obesity	GCST002632	hepatic lipid content measurement	obesity
Hepatitis B surface antigen seroclearance in chronic hepatitis B infection	Hepatitis B virus surface antigen seropositivity|| chronic hepatitis B infection	GCST006364	Hepatitis B virus surface antigen seropositivity	chronic hepatitis B infection
Familial hepatitis B virus-related hepatocellular carcinoma	hepatocellular carcinoma|| hepatitis B infection	GCST004736	hepatocellular carcinoma	hepatitis B infection
Hepatocellular carcinoma in hepatitis B infection	hepatocellular carcinoma|| hepatitis B infection	GCST005746	hepatocellular carcinoma	hepatitis B infection
Hepatocellular carcinoma in hepatitis B infection	hepatocellular carcinoma|| hepatitis B infection	GCST003189	hepatocellular carcinoma	hepatitis B infection
Hepatocellular carcinoma in hepatitis C infection	hepatocellular carcinoma|| hepatitis C infection	GCST006037	hepatocellular carcinoma	hepatitis C infection
Hepatocellular carcinoma in primary sclerosing cholangitis	hepatocellular carcinoma|| sclerosing cholangitis	GCST005858	hepatocellular carcinoma	sclerosing cholangitis
HER2 status in breast cancer	HER2 status|| breast carcinoma	GCST004528	HER2 status	breast carcinoma
HDL Cholesterol in HIV-infection	HIV-1 infection|| high density lipoprotein cholesterol measurement	GCST002744	high density lipoprotein cholesterol measurement	HIV-1 infection
Hippocampal volume in schizophrenia	schizophrenia|| hippocampal volume	GCST002076	hippocampal volume	schizophrenia
Setpoint viral load in HIV-1 infection	HIV-1 infection|| HIV viral set point measurement	GCST003183	HIV-1 infection	HIV viral set point measurement
Hypertension risk in short sleep duration	hypertension|| short sleep	GCST001405	hypertension	short sleep
Immunoglobulin G index levels in multiple sclerosis	multiple sclerosis|| IgG index	GCST002757	IgG index	multiple sclerosis
Inflammatory biomarkers in Kawasaki disease	mucocutaneous lymph node syndrome|| inflammatory biomarker measurement|| C-reactive protein measurement	GCST002640	inflammatory biomarker measurement|| C-reactive protein measurement	mucocutaneous lymph node syndrome
Initial pursuit acceleration in psychotic disorders	schizophrenia|| initial pursuit acceleration|| bipolar disorder|| schizoaffective disorder	GCST005026	initial pursuit acceleration	schizophrenia|| bipolar disorder|| schizoaffective disorder
Interferon alpha levels in systemic lupus erythematosus	interferon alpha measurement|| systemic lupus erythematosus	GCST002666	interferon alpha measurement	systemic lupus erythematosus
Plasma kynurenine levels in major depressive disorder	unipolar depression|| kynurenine measurement	GCST005342	kynurenine measurement	unipolar depression
Plasma kynurenine to tryptophan ratio in major depressive disorder	unipolar depression|| kynurenine:tryptophan ratio	GCST005343	kynurenine:tryptophan ratio	unipolar depression
Language impairment in frontotemporal lobe dementia	language impairment|| Frontotemporal dementia	GCST006152	language impairment	Frontotemporal dementia
Laterality in neovascular age-related macular degeneration	laterality measurement|| wet macular degeneration	GCST004813	laterality measurement	wet macular degeneration
Thiopurine-induced acute severe leukopenia in inflammatory bowel disease	leukopenia|| response to thiopurine|| inflammatory bowel disease	GCST006205	leukopenia|| response to thiopurine	inflammatory bowel disease
Thiopurine-induced acute severe leukopenia in inflammatory bowel disease (conditioned on rs116855232)	leukopenia|| response to thiopurine|| inflammatory bowel disease	GCST006215	leukopenia|| response to thiopurine	inflammatory bowel disease
Thiopurine-induced leukopenia in inflammatory bowel disease	leukopenia|| response to thiopurine|| inflammatory bowel disease	GCST006201	leukopenia|| response to thiopurine	inflammatory bowel disease
Thiopurine-induced leukopenia in inflammatory bowel disease	leukopenia|| response to thiopurine|| inflammatory bowel disease	GCST003603	leukopenia|| response to thiopurine	inflammatory bowel disease
Thiopurine-induced leukopenia in inflammatory bowel disease (conditioned on rs116855232)	leukopenia|| response to thiopurine|| inflammatory bowel disease	GCST006202	leukopenia|| response to thiopurine	inflammatory bowel disease
Thiopurine-induced severe leukopenia in inflammatory bowel disease	leukopenia|| response to thiopurine|| inflammatory bowel disease	GCST006204	leukopenia|| response to thiopurine	inflammatory bowel disease
Thiopurine-induced severe leukopenia in inflammatory bowel disease (conditioned on rs116855232)	leukopenia|| response to thiopurine|| inflammatory bowel disease	GCST006200	leukopenia|| response to thiopurine	inflammatory bowel disease
Lichen planus in hepatitis C	lichen planus|| hepatitis C infection	GCST004090	lichen planus	hepatitis C infection
Lipoprotein-associated phospholipase A2 activity change in response to darapladib treatment in cardiovascular disease	response to darapladib|| acute coronary syndrome|| lipoprotein-associated phospholipase A(2) change measurement|| coronary heart disease	GCST004966	lipoprotein-associated phospholipase A(2) change measurement|| response to darapladib	acute coronary syndrome|| coronary heart disease
Lipoprotein-associated phospholipase A2 activity change in response to darapladib treatment in cardiovascular disease (adjusted for baseline)	response to darapladib|| acute coronary syndrome|| lipoprotein-associated phospholipase A(2) change measurement|| coronary heart disease	GCST004968	lipoprotein-associated phospholipase A(2) change measurement|| response to darapladib	acute coronary syndrome|| coronary heart disease
Lipoprotein phospholipase A2 activity in cardiovascular disease	lipoprotein-associated phospholipase A(2) measurement|| acute coronary syndrome|| coronary heart disease	GCST004963	lipoprotein-associated phospholipase A(2) measurement	acute coronary syndrome|| coronary heart disease
Liver disease severity in Alagille syndrome	Alagille syndrome|| liver disease	GCST003616	liver disease	Alagille syndrome
Liver disease in chronic hepatitis B virus infection	liver disease|| chronic hepatitis B infection	GCST002204	liver disease	chronic hepatitis B infection
Body mass index (change over time) in cancer	cancer|| longitudinal BMI measurement	GCST004106	longitudinal BMI measurement	cancer
Body mass index (change over time) in cancer or chronic obstructive pulmonary disease	cancer|| longitudinal BMI measurement|| chronic obstructive pulmonary disease	GCST004103	longitudinal BMI measurement	cancer|| chronic obstructive pulmonary disease
Body mass index (change over time) in chronic obstructive pulmonary disease	longitudinal BMI measurement|| chronic obstructive pulmonary disease	GCST004105	longitudinal BMI measurement	chronic obstructive pulmonary disease
Body mass index (change over time) in gastrointestinal cancer	longitudinal BMI measurement|| Digestive System Carcinoma	GCST004101	longitudinal BMI measurement	Digestive System Carcinoma
Body mass index (change over time) in gastrointestinal cancer or chronic obstructive pulmonary disease	longitudinal BMI measurement|| Digestive System Carcinoma|| chronic obstructive pulmonary disease	GCST004100	longitudinal BMI measurement	Digestive System Carcinoma|| chronic obstructive pulmonary disease
Body mass index (change over time) in lung cancer	lung carcinoma|| longitudinal BMI measurement	GCST004104	longitudinal BMI measurement	lung carcinoma
Body mass index (change over time) in lung cancer or chronic obstructive pulmonary disease	lung carcinoma|| longitudinal BMI measurement|| chronic obstructive pulmonary disease	GCST004102	longitudinal BMI measurement	lung carcinoma|| chronic obstructive pulmonary disease
Lipid levels in hepatitis C treatment	Chronic Hepatitis C infection|| low density lipoprotein cholesterol measurement	GCST001418	low density lipoprotein cholesterol measurement	Chronic Hepatitis C infection
Lung cancer in ever smokers	smoking status measurement|| lung carcinoma	GCST006400	lung carcinoma	smoking status measurement
Lung cancer in ever smokers	smoking status measurement|| lung carcinoma	GCST004749	lung carcinoma	smoking status measurement
Lung cancer in never smokers	smoking status measurement|| lung carcinoma	GCST004747	lung carcinoma	smoking status measurement
Lung disease severity in cystic fibrosis	Cystic fibrosis|| lung disease severity measurement	GCST003143	lung disease severity measurement	Cystic fibrosis
Lupus nephritis in systemic lupus erythematosus	systemic lupus erythematosus|| lupus nephritis	GCST002479	lupus nephritis	systemic lupus erythematosus
Luteinizing hormone levels in polycystic ovary syndrome	luteinizing hormone measurement|| polycystic ovary syndrome	GCST005269	luteinizing hormone measurement	polycystic ovary syndrome
Hypersomnia during a major depressive episode in bipolar disorder	major depressive episode|| bipolar disorder|| hypersomnia	GCST003016	major depressive episode|| hypersomnia	bipolar disorder
Depressive and manic episodes in bipolar disorder	manic episode measurement|| depressive episode measurement|| bipolar disorder	GCST003090	manic episode measurement|| depressive episode measurement	bipolar disorder
Manic episodes in bipolar disorder	manic or hypomanic episode|| bipolar disorder	GCST003089	manic or hypomanic episode	bipolar disorder
Mean corpuscular hemoglobin concentration in sickle cell disease	Sickle cell anemia|| mean corpuscular hemoglobin concentration	GCST004378	mean corpuscular hemoglobin concentration	Sickle cell anemia
Total mean fractional anisotropy measurement in first episode schizophrenia	schizophrenia|| mean fractional anisotropy measurement|| white matter microstructure measurement	GCST004996	mean fractional anisotropy measurement|| white matter microstructure measurement	schizophrenia
Medication adherence in chronic diseases	diabetes mellitus|| hypertension|| medication adherence behavior	GCST002637	medication adherence behavior	diabetes mellitus|| hypertension
Memory dysfunction in frontotemporal lobe dementia	memory impairment|| Frontotemporal dementia	GCST006151	memory impairment	Frontotemporal dementia
Metastasis at diagnosis in osteosarcoma	metastasis measurement|| date of diagnosis|| osteosarcoma	GCST002978	metastasis measurement|| date of diagnosis	osteosarcoma
Methadone dose in opioid dependence	opioid dependence|| methadone dose measurement	GCST006856	methadone dose measurement	opioid dependence
Methadone dose in opioid dependence	opioid dependence|| methadone dose measurement	GCST004136	methadone dose measurement	opioid dependence
Migraine in bipolar disorder	bipolar disorder|| migraine disorder	GCST002656	migraine disorder	bipolar disorder
Migraine in psychiatric disorder	bipolar disorder|| migraine disorder	GCST000695	migraine disorder	bipolar disorder
Mood disorder in prion disease	prion disease|| mood disorder	GCST002864	mood disorder	prion disease 
Mortality in heart failure	heart failure|| mortality	GCST003539	mortality	heart failure
Mortality in heart failure	heart failure|| mortality	GCST000661	mortality	heart failure
Mortality in sepsis	sepsis|| mortality	GCST003817	mortality	sepsis
Platinum-induced myelosuppression in non-small cell lung cancer	myelosuppression|| response to platinum based chemotherapy|| non-small cell lung carcinoma	GCST002833	myelosuppression|| response to platinum based chemotherapy	non-small cell lung carcinoma
Myocardial infarction in placebo-treated cardiovascular disease (time to event)	acute coronary syndrome|| coronary heart disease|| myocardial infarction|| response to placebo	GCST004965	myocardial infarction|| response to placebo	acute coronary syndrome|| coronary heart disease
Perioperative myocardial infarction in coronary artery bypass surgery	coronary artery bypass|| myocardial infarction	GCST002892	myocardial infarction	coronary artery bypass
Myocardial infarction in coronary artery disease	coronary heart disease|| myocardial infarction	GCST000946	myocardial infarction	coronary heart disease
Myocardial infarction in cardiovascular disease (time to event) (darapladib treatment interaction)	response to darapladib|| acute coronary syndrome|| coronary heart disease|| myocardial infarction	GCST004959	myocardial infarction|| response to darapladib	acute coronary syndrome|| coronary heart disease
Myocardial infarction in darapladib-treated cardiovascular disease (time to event)	response to darapladib|| acute coronary syndrome|| coronary heart disease|| myocardial infarction	GCST004964	myocardial infarction|| response to darapladib	acute coronary syndrome|| coronary heart disease
Surgical necrotising enterocolitis in extremely premature birth	necrotizing enterocolitis|| premature birth	GCST005800	necrotizing enterocolitis	premature birth
Neuropathic pain in head and neck cancer	head and neck malignant neoplasia|| neuropathic pain	GCST005934	neuropathic pain	head and neck malignant neoplasia
Possible neuropathic pain in post total joint replacement surgery for osteoarthritis	neuropathic pain|| osteoarthritis	GCST003963	neuropathic pain	osteoarthritis
Neuropathic pain in type 2 diabetes	neuropathic pain|| type II diabetes mellitus	GCST003063	neuropathic pain	type II diabetes mellitus
Neuropathic pain in type 2 diabetes	neuropathic pain|| type II diabetes mellitus	GCST002507	neuropathic pain	type II diabetes mellitus
Neutrophil count in HIV-infection	neutrophil count|| HIV-1 infection	GCST002743	neutrophil count	HIV-1 infection
nicotine metabolite ratio in current smokers	smoking behavior|| nicotine metabolite ratio	GCST003629	nicotine metabolite ratio	smoking behavior
nicotine metabolite ratio in current smokers	smoking behavior|| nicotine metabolite ratio	GCST004976	nicotine metabolite ratio	smoking behavior
Non-small cell lung cancer in heavy smokers	smoking behavior|| non-small cell lung carcinoma	GCST005747	non-small cell lung carcinoma	smoking behavior
Obesity in adult survivors of childhood cancer not exposed to cranial radiation	childhood cancer|| obesity	GCST002904	obesity	childhood cancer
Oligoclonal band status in multiple sclerosis	multiple sclerosis|| oligoclonal band measurement	GCST002758	oligoclonal band measurement	multiple sclerosis
Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder	attention deficit hyperactivity disorder|| oppositional defiant disorder measurement	GCST003472	oppositional defiant disorder measurement	attention deficit hyperactivity disorder
Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder	attention deficit hyperactivity disorder|| oppositional defiant disorder measurement	GCST003030	oppositional defiant disorder measurement	attention deficit hyperactivity disorder
Ovarian cancer in BRCA1 mutation carriers	carrier status|| ovarian carcinoma	GCST004414	ovarian carcinoma	carrier status
Ovarian cancer in BRCA2 mutation carriers	carrier status|| ovarian carcinoma	GCST004416	ovarian carcinoma	carrier status
Pre-treatment pain in head and neck squamous cell carcinoma	pain|| head and neck squamous cell carcinoma	GCST003760	pain	head and neck squamous cell carcinoma
Pallidum volume in trauma-exposed individuals	pallidum volume|| response to trauma exposure	GCST005242	pallidum volume|| response to trauma exposure	
Thiopurine-induced pancreatitis in inflammatory bowel disease	pancreatitis|| response to thiopurine|| inflammatory bowel disease	GCST006208	pancreatitis|| response to thiopurine	inflammatory bowel disease
Parasitemia in Tripanosoma cruzi seropositivity	parasitemia measurement|| Trypanosoma cruzi seropositivity	GCST002282	parasitemia measurement	Trypanosoma cruzi seropositivity
Abnormal white matter microstructure in first episode schizophrenia (multivariate analysis)	parietal cortex measurement|| schizophrenia|| white matter microstructure measurement|| cingulate cortex measurement	GCST004997	parietal cortex measurement|| white matter microstructure measurement|| cingulate cortex measurement	schizophrenia
Parkinsonism in frontotemporal lobe dementia	Parkinson's disease|| Frontotemporal dementia	GCST006153	Parkinson's disease	Frontotemporal dementia
Response to anthracycline-based chemotherapy in breast cancer (pathologic complete response)	pathologic complete response measurement|| breast carcinoma|| response to anthracycline-based chemotherapy	GCST003224	pathologic complete response measurement|| response to anthracycline-based chemotherapy	breast carcinoma
Bortezomib-induced peripheral neuropathy in multiple myeloma	peripheral neuropathy|| multiple myeloma|| response to bortezomib	GCST003964	peripheral neuropathy|| response to bortezomib	multiple myeloma
Bortezomib-induced peripheral neuropathy in multiple myeloma	peripheral neuropathy|| multiple myeloma|| response to bortezomib	GCST003438	peripheral neuropathy|| response to bortezomib	multiple myeloma
Docetaxel-induced peripheral neuropathy in metastatic castrate-resistant prostate cancer	peripheral neuropathy|| response to docetaxel|| metastatic prostate cancer	GCST003672	peripheral neuropathy|| response to docetaxel	metastatic prostate cancer
Neuropathy in taxane-treated breast cancer	peripheral neuropathy|| response to docetaxel|| breast carcinoma|| response to paclitaxel	GCST003627	peripheral neuropathy|| response to docetaxel|| response to paclitaxel	breast carcinoma
Taxane-induced peripheral neuropathy in breast cancer	peripheral neuropathy|| breast carcinoma|| response to taxane	GCST005804	peripheral neuropathy|| response to taxane	breast carcinoma
Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia	peripheral neuropathy|| acute lymphoblastic leukemia|| response to vincristine	GCST002792	peripheral neuropathy|| response to vincristine	acute lymphoblastic leukemia
Personality traits in bipolar disorder	personality trait|| bipolar disorder	GCST000995	personality trait	bipolar disorder
Betaine levels in individuals undergoing cardiac evaluation	plasma betaine measurement|| angiographic measurement	GCST003358	plasma betaine measurement	angiographic measurement
Response to clopidogrel therapy in coronary heart disease	platelet reactivity measurement|| response to clopidogrel|| coronary heart disease	GCST003899	platelet reactivity measurement|| response to clopidogrel	coronary heart disease
Pneumoconiosis in silica exposure	pneumoconiosis|| response to silica exposure	GCST002515	pneumoconiosis|| response to silica exposure	
Post traumatic stress disorder symptom count in trauma-exposed individuals	response to trauma exposure|| post-traumatic stress disorder symptom measurement	GCST005550	post-traumatic stress disorder symptom measurement|| response to trauma exposure	
PR interval in Tripanosoma cruzi seropositivity	PR interval|| Trypanosoma cruzi seropositivity	GCST002279	PR interval	Trypanosoma cruzi seropositivity
Proliferative diabetic retinopathy in type 2 diabetes	proliferative diabetic retinopathy|| type II diabetes mellitus	GCST006283	proliferative diabetic retinopathy	type II diabetes mellitus
Proteinuria in chronic kidney disease	chronic kidney disease|| Proteinuria	GCST003142	Proteinuria	chronic kidney disease
Prothrombin fragments F1+2 levels in ischemic stroke	Ischemic stroke|| prothrombin fragments F1+2 measurement	GCST003235	prothrombin fragments F1+2 measurement	Ischemic stroke
Psychosis in Alzheimer's disease	Alzheimer's disease|| psychotic symptoms	GCST001282	psychotic symptoms	Alzheimer's disease
Psychotic symptoms in prion disease	prion disease|| psychotic symptoms	GCST002867	psychotic symptoms	prion disease
Pulmonary artery enlargement in chronic obstructive pulmonary disease	pulmonary artery enlargement|| chronic obstructive pulmonary disease	GCST002797	pulmonary artery enlargement	chronic obstructive pulmonary disease
Post-bronchodilator lung function in asthma (FEV1)	pulmonary function measurement|| forced expiratory volume|| response to bronchodilator|| asthma	GCST003110	pulmonary function measurement|| forced expiratory volume|| response to bronchodilator	asthma
Post-bronchodilator lung function in asthma (FEV1/FVC)	pulmonary function measurement|| response to bronchodilator|| asthma|| FEV/FEC ratio	GCST003107	pulmonary function measurement|| response to bronchodilator|| FEV/FEC ratio	asthma
Pulse pressure in young-onset hypertension	pulse pressure measurement|| early onset hypertension	GCST002470	pulse pressure measurement	early onset hypertension
Pursuit maintenance gain in psychotic disorders	schizophrenia|| pursuit maintenance gain measurement|| bipolar disorder|| schizoaffective disorder	GCST005028	pursuit maintenance gain measurement	schizophrenia|| bipolar disorder|| schizoaffective disorder
Putamen volume in trauma-exposed individuals	response to trauma exposure|| putamen volume	GCST005244	putamen volume|| response to trauma exposure	
Pyoderma gangrenosum in inflammatory bowel disease	pyoderma gangrenosum|| inflammatory bowel disease	GCST002379	pyoderma gangrenosum	inflammatory bowel disease
QRS duration in Tripanosoma cruzi seropositivity	QRS duration|| Trypanosoma cruzi seropositivity	GCST002284	QRS duration||	Trypanosoma cruzi seropositivity
QT interval in Tripanosoma cruzi seropositivity	QT interval|| Trypanosoma cruzi seropositivity	GCST002278	QT interval	Trypanosoma cruzi seropositivity
Red blood cell density in sickle cell anemia	Sickle cell anemia|| red blood cell density measurement	GCST004379	red blood cell density measurement	Sickle cell anemia
Renal elimination rate in vancomycin therapy	renal elimination rate measurement|| response to vancomycin	GCST002947	renal elimination rate measurement|| response to vancomycin	
Serum uric acid levels in response to allopurinol in gout	response to allopurinol|| gout|| uric acid measurement	GCST004751	response to allopurinol|| uric acid measurement	gout
Myocardial infarction in hypertension (ACE inhibitor interaction)	hypertension|| response to angiotensin-converting enzyme inhibitor|| myocardial infarction	GCST003187	response to angiotensin-converting enzyme inhibitor|| myocardial infarction	hypertension
Cardiomyopathy in childhood cancer survivors (anthracycline treatment interaction)	childhood cancer|| response to anthracycline-based chemotherapy|| cardiomyopathy	GCST003300	response to anthracycline-based chemotherapy|| cardiomyopathy	childhood cancer
Adverse response to antithyroid drugs in Graves disease	Graves disease|| response to anti-thyroid drug	GCST006278	response to anti-thyroid drug	Graves disease
Remission after antidepressant treatment in major depression	unipolar depression|| response to antidepressant	GCST006818	response to antidepressant	unipolar depression
Response to antidepressants in depression	unipolar depression|| response to antidepressant	GCST006817	response to antidepressant	unipolar depression
Response to antipsychotic treatment in schizophrenia	schizophrenia|| response to antipsychotic drug	GCST006292	response to antipsychotic drug	schizophrenia
Response to lurasidone in schizophrenia	schizophrenia|| response to antipsychotic drug	GCST006248	response to antipsychotic drug	schizophrenia
Cardiovascular disease in hypertension (beta blocker interaction)	hypertension|| response to beta blocker|| cardiovascular disease	GCST003203	response to beta blocker|| cardiovascular disease	hypertension
Myocardial infarction in hypertension (beta blocker interaction)	hypertension|| response to beta blocker|| myocardial infarction	GCST003201	response to beta blocker|| myocardial infarction	hypertension
Response to chemotherapy in breast cancer (hypertension) (bevacizumab)	response to bevacizumab|| breast carcinoma|| chemotherapy-induced hypertension	GCST002567	response to bevacizumab|| chemotherapy-induced hypertension	breast carcinoma
Adverse response to chemotherapy (congestive heart failure) in breast cancer	response to bevacizumab|| congestive heart failure|| breast carcinoma|| response to anthracycline-based chemotherapy	GCST003939	response to bevacizumab|| congestive heart failure|| response to anthracycline-based chemotherapy	breast carcinoma
Asthma (bronchodilator response)	response to bronchodilator|| asthma	GCST002154	response to bronchodilator	asthma
Asthma (bronchodilator response)	response to bronchodilator|| asthma	GCST001911	response to bronchodilator	asthma
Asthma (bronchodilator response)	response to bronchodilator|| asthma	GCST001597	response to bronchodilator	asthma
Bronchodilator response in asthma	response to bronchodilator|| asthma	GCST002796	response to bronchodilator	asthma
Post bronchodilator FEV1/FVC ratio in COPD	response to bronchodilator|| chronic obstructive pulmonary disease|| FEV/FEC ratio	GCST003265	response to bronchodilator|| FEV/FEC ratio	chronic obstructive pulmonary disease
Myocardial infarction in hypertension (calcium channel blocker interaction)	hypertension|| response to calcium channel blocker|| myocardial infarction	GCST003206	response to calcium channel blocker|| myocardial infarction	hypertension
Carboplatin disposition in epthelial ovarian cancer	Malignant epithelial tumor of ovary|| response to carboplatin	GCST005351	response to carboplatin	Malignant epithelial tumor of ovary
Response to cholinesterase inhibitors in Alzheimer's disease	response to cholinesterase inhibitor|| Alzheimer's disease	GCST001835	response to cholinesterase inhibitor	Alzheimer's disease
Response to inhaled corticosteroid treatment in asthma (change in FEV1)	FEV change measurement|| response to corticosteroid|| asthma	GCST003567	response to corticosteroid|| FEV change measurement	asthma
Response to inhaled corticosteroid treatment in asthma (change in FEV1)	FEV change measurement|| response to corticosteroid|| asthma	GCST002432	response to corticosteroid|| FEV change measurement	asthma
Response to cyclophosphamide in systemic lupus erythematosus with lupus nephritis	response to cyclophosphamide|| systemic lupus erythematosus|| lupus nephritis	GCST003445	response to cyclophosphamide	systemic lupus erythematosus|| lupus nephritis
Response to Dalcetrapib treatment in acute coronary syndrome	response to dalcetrapib|| acute coronary syndrome|| cardiovascular event measurement	GCST002747	response to dalcetrapib|| cardiovascular event measurement	acute coronary syndrome
Response to dendritic cell-based immunotherapy in HIV infection	response to dendritic cell-based immunotherapy|| HIV infection	GCST003852	response to dendritic cell-based immunotherapy	HIV infection
Myocardial infarction in hypertension (diuretic interaction)	response to diruetic|| hypertension|| myocardial infarction	GCST003202	response to diruetic|| myocardial infarction	hypertension
Cardiovascular disease in hypertension (diuretic interaction)	response to diruetic|| hypertension|| cardiovascular disease	GCST003204	response to diuretic|| cardiovascular disease	hypertension
Response to tocilizumab in rheumatoid arthritis	rheumatoid arthritis|| response to drug	GCST001476	response to drug	rheumatoid arthritis
Duloxetine response in major depressive disorder (% change in symptom score)	unipolar depression|| response to duloxetine	GCST004738	response to duloxetine	unipolar depression
Duloxetine response in major depressive disorder (remitter/non-remitter status)	unipolar depression|| response to duloxetine	GCST004740	response to duloxetine	unipolar depression
Duloxetine response in major depressive disorder (responder/non-responder status)	unipolar depression|| response to duloxetine	GCST004741	response to duloxetine	unipolar depression
Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)	HIV-1 infection|| response to efavirenz|| virologic response measurement	GCST002771	response to efavirenz|| virologic response measurement	HIV-1 infection
Response to gemcitabine in pancreatic cancer	response to gemcitabine|| pancreatic carcinoma	GCST001390	response to gemcitabine	pancreatic carcinoma
Response to gemcitabine in pancreatic cancer	response to gemcitabine|| pancreatic carcinoma	GCST001346	response to gemcitabine	pancreatic carcinoma
Response to haloperidol in psychosis	psychosis|| response to haloperidol	GCST002465	response to haloperidol	psychosis
Response to haloperidol in schizophrenia	schizophrenia|| response to haloperidol	GCST006298	response to haloperidol	schizophrenia
Response to chemotherapy in multiple myeloma (oral mucositis) (high-dose melphalan)	multiple myeloma|| response to high-dose melphalan|| chemotherapy-induced oral mucositis	GCST002605	response to high-dose melphalan|| chemotherapy-induced oral mucositis	multiple myeloma
Response to interferon beta in multiple sclerosis	multiple sclerosis|| response to interferon beta	GCST003193	response to interferon beta	multiple sclerosis
Response to interferon beta in multiple sclerosis	multiple sclerosis|| response to interferon beta	GCST002910	response to interferon beta	multiple sclerosis
Neutralising antibody response to interferon beta therapy in multiple sclerosis (area under the curve for the first two years)	multiple sclerosis|| response to interferon beta|| antibody measurement	GCST005708	response to interferon beta|| antibody measurement	multiple sclerosis
Neutralising antibody response to interferon beta therapy in multiple sclerosis (maximum antibody levels)	multiple sclerosis|| response to interferon beta|| antibody measurement	GCST005709	response to interferon beta|| antibody measurement	multiple sclerosis
Neutralising antibody response to interferon beta therapy in multiple sclerosis (mean antibody levels)	multiple sclerosis|| response to interferon beta|| antibody measurement	GCST005707	response to interferon beta|| antibody measurement	multiple sclerosis
Neutralising antibody response to interferon beta therapy in multiple sclerosis (presence of antibodies)	multiple sclerosis|| response to interferon beta|| antibody measurement	GCST005706	response to interferon beta|| antibody measurement	multiple sclerosis
Neutralising antibody response to interferon beta therapy in multiple sclerosis (time to production)	multiple sclerosis|| response to interferon beta|| antibody measurement	GCST005710	response to interferon beta|| antibody measurement	multiple sclerosis
Response to irinotecan in non-small-cell lung cancer	response to irinotecan|| non-small cell lung carcinoma	GCST001558	response to irinotecan	non-small cell lung carcinoma
Response to ketogenic dietary therapies in epilepsy	response to ketogenic diet|| epilepsy	GCST006567	response to ketogenic diet||	epilepsy
Objective response to lithium treatment in bipolar disorder	bipolar disorder|| response to lithium ion	GCST003161	response to lithium ion	bipolar disorder
Response to lithium treatment in bipolar disorder	bipolar disorder|| response to lithium ion	GCST003378	response to lithium ion	bipolar disorder
Subjective response to lithium treatment in bipolar disorder	bipolar disorder|| response to lithium ion	GCST003160	response to lithium ion	bipolar disorder
Response to mepolizumab in severe asthma	response to mepolizumab|| asthma	GCST005115	response to mepolizumab	asthma
Response to metformin in type 2 diabetes (HbA1c reduction)	A1C measurement|| type II diabetes mellitus|| response to metformin	GCST004522	response to metformin|| A1C measurement	 type II diabetes mellitus
Methotrexate-induced interstitial lung disease in rheumatoid arthritis	response to methotrexate|| rheumatoid arthritis|| interstitial lung disease	GCST004358	response to methotrexate|| interstitial lung disease	rheumatoid arthritis
Response to methylphenidate treatment in attention-deficit/hyperactivity disorder	attention deficit hyperactivity disorder|| response to methylphenidate	GCST005318	response to methylphenidate	attention deficit hyperactivity disorder
Response to olanzapine in schizophrenia	schizophrenia|| response to olanzapine	GCST006293	response to olanzapine	schizophrenia
Pharmacokinetics of olanzapine in severe mental disorder (concentration dose ratio)	unipolar depression|| schizophrenia|| bipolar disorder|| response to olanzapine|| concentration dose ratio	GCST002885	response to olanzapine|| concentration dose ratio	unipolar depression|| schizophrenia|| bipolar disorder
Paclitaxel disposition in epithelial ovarian cancer	Malignant epithelial tumor of ovary|| response to paclitaxel	GCST005352	response to paclitaxel	Malignant epithelial tumor of ovary
Response to paliperidone in schizophrenia (CGI-S score)	schizophrenia|| response to paliperidone|| schizophrenia symptom severity measurement	GCST004039	response to paliperidone|| schizophrenia symptom severity measurement	schizophrenia
Response to paliperidone in schizophrenia (Multivariate)	schizophrenia|| response to paliperidone|| schizophrenia symptom severity measurement	GCST004043	response to paliperidone|| schizophrenia symptom severity measurement	schizophrenia
Response to paliperidone in schizophrenia (negative Marder score)	schizophrenia|| response to paliperidone|| schizophrenia symptom severity measurement	GCST004041	response to paliperidone|| schizophrenia symptom severity measurement	schizophrenia
Response to paliperidone in schizophrenia (PANSS score)	schizophrenia|| response to paliperidone|| schizophrenia symptom severity measurement	GCST004042	response to paliperidone|| schizophrenia symptom severity measurement	schizophrenia
Response to paliperidone in schizophrenia (positive Marder score)	schizophrenia|| response to paliperidone|| schizophrenia symptom severity measurement	GCST004040	response to paliperidone|| schizophrenia symptom severity measurement	schizophrenia
Response to Pazopanib in cancer (hepatotoxicity)	cancer|| response to pazopanib|| serum alanine aminotransferase measurement	GCST003232	response to pazopanib|| serum alanine aminotransferase measurement	cancer
Response to perphenazine in schizophrenia	schizophrenia|| response to perphenazine	GCST006297	response to perphenazine	schizophrenia
Placebo response in major depressive disorder (% change in symptom score)	unipolar depression|| response to placebo	GCST004739	response to placebo	unipolar depression
Placebo response in major depressive disorder (remitter/non-remitter status)	unipolar depression|| response to placebo	GCST004742	response to placebo	unipolar depression
Placebo response in major depressive disorder (responder/non-responder status)	unipolar depression|| response to placebo	GCST004743	response to placebo	unipolar depression
Response to platinum-based chemotherapy in non-small-cell lung cancer	response to platinum based chemotherapy|| non-small cell lung carcinoma	GCST001629	response to platinum based chemotherapy	non-small cell lung carcinoma
Response to platinum-based chemotherapy in non-small-cell lung cancer	response to platinum based chemotherapy|| non-small cell lung carcinoma	GCST001035	response to platinum based chemotherapy	non-small cell lung carcinoma
Response to carboplatin and paclitaxel in ovarian cancer (Caspase 3/7 EC50)	response to platinum based chemotherapy|| ovarian carcinoma|| cytotoxicity measurement|| response to paclitaxel	GCST003443	response to platinum based chemotherapy||  cytotoxicity measurement|| response to paclitaxel	ovarian carcinoma
Response to carboplatin and paclitaxel in ovarian cancer (MTT IC50)	response to platinum based chemotherapy|| ovarian carcinoma|| cytotoxicity measurement|| response to paclitaxel	GCST003444	response to platinum based chemotherapy||  cytotoxicity measurement|| response to paclitaxel	ovarian carcinoma
Response to carboplatin in ovarian cancer (Caspase 3/7 EC50)	response to platinum based chemotherapy|| ovarian carcinoma|| cytotoxicity measurement	GCST003442	response to platinum based chemotherapy|| cytotoxicity measurement	ovarian carcinoma
Response to carboplatin in ovarian cancer (MTT IC50)	response to platinum based chemotherapy|| ovarian carcinoma|| cytotoxicity measurement	GCST003440	response to platinum based chemotherapy|| cytotoxicity measurement	ovarian carcinoma
Response to paclitaxel in ovarian cancer (Caspase 3/7 EC50)	response to platinum based chemotherapy|| ovarian carcinoma|| cytotoxicity measurement	GCST003439	response to platinum based chemotherapy|| cytotoxicity measurement	ovarian carcinoma
Platinum-induced hepatotoxicity in non-small cell lung cancer	response to platinum based chemotherapy|| non-small cell lung carcinoma|| drug-induced liver injury	GCST002993	response to platinum based chemotherapy|| drug-induced liver injury	non-small cell lung carcinoma
Response to platinum-based neoadjuvant chemotherapy in cervical cancer	cervical carcinoma|| response to platinum-based neoadjuvant chemotherapy	GCST004097	response to platinum-based neoadjuvant chemotherapy	cervical carcinoma
Response to quetiapine in schizophrenia	schizophrenia|| response to quetiapine	GCST006295	response to quetiapine	schizophrenia
Response to radiotherapy in prostate cancer (overall toxicity)	response to radiation|| prostate carcinoma	GCST003583	response to radiation	prostate carcinoma
"Response to radiotherapy in prostate cancer (toxicity, decreased urine stream)"	response to radiation|| prostate carcinoma	GCST003581	response to radiation	prostate carcinoma
"Response to radiotherapy in prostate cancer (toxicity, rectal bleeding)"	response to radiation|| prostate carcinoma	GCST003584	response to radiation	prostate carcinoma
"Response to radiotherapy in prostate cancer (toxicity, urinary frequency)"	response to radiation|| prostate carcinoma	GCST003582	response to radiation	prostate carcinoma
Response to radiotherapy in prostate cancer (toxicity)	response to radiation|| prostate carcinoma	GCST002511	response to radiation	prostate carcinoma
Breast cancer in childhood cancer survivors treated with more than 10 gray radiotherapy	response to radiation|| breast carcinoma|| childhood cancer	GCST005112	response to radiation|| breast carcinoma	childhood cancer
Obesity in adult survivors of childhood cancer exposed to cranial radiation	response to radiation|| childhood cancer|| obesity	GCST002900	response to radiation|| obesity	childhood cancer
Response to ranibizumab in age-related macular degeneration (exudative)	response to ranibizumab|| wet macular degeneration	GCST006277	response to ranibizumab	wet macular degeneration
Response to ranibizumab in age-related macular degeneration (dry maculae)	response to ranibizumab|| age-related macular degeneration|| macula measurement	GCST004802	response to ranibizumab|| macula measurement	age-related macular degeneration
Response to ranibizumab in age-related macular degeneration (additional treatment requirement)	response to ranibizumab|| age-related macular degeneration|| treatment outcome measurement	GCST004803	response to ranibizumab|| treatment outcome measurement	age-related macular degeneration
Response to rate control therapy in atrial fibrillation	response to rate control therapy|| atrial fibrillation	GCST002473	response to rate control therapy	atrial fibrillation
Nevirapine-induced hypersensitivity in HIV (hypersensitivity syndrome)	response to reverse transcriptase inhibitor|| drug hypersensitivity syndrome|| HIV infection	GCST004116	response to reverse transcriptase inhibitor|| drug hypersensitivity syndrome	HIV infection
Nevirapine-induced hypersensitivity in HIV (drug-induced liver injury)	response to reverse transcriptase inhibitor|| HIV infection|| drug-induced liver injury	GCST004114	response to reverse transcriptase inhibitor|| drug-induced liver injury	HIV infection
Nevirapine-induced hypersensitivity in HIV	response to reverse transcriptase inhibitor|| hypersensitivity reaction disease|| HIV infection	GCST004118	response to reverse transcriptase inhibitor|| hypersensitivity reaction disease	HIV infection
Nevirapine-induced hypersensitivity in HIV (rash)	response to reverse transcriptase inhibitor|| maculopapular eruption|| HIV infection	GCST004117	response to reverse transcriptase inhibitor|| maculopapular eruption	HIV infection
Nevirapine-induced hypersensitivity in HIV (Stevens-Johnson syndrome or toxic epidermal necrosis)	response to reverse transcriptase inhibitor|| Stevens-Johnson syndrome|| toxic epidermal necrolysis|| HIV infection	GCST004115	response to reverse transcriptase inhibitor|| Stevens-Johnson syndrome|| toxic epidermal necrolysis	HIV infection
Response to risperidone in schizophrenia	schizophrenia|| response to risperidone	GCST006294	response to risperidone	schizophrenia
Remission after SSRI treatment in major depression	unipolar depression|| response to selective serotonin reuptake inhibitor	GCST006266	response to selective serotonin reuptake inhibitor	unipolar depression
Response to selective serotonin reuptake inhibitors in depression	unipolar depression|| response to selective serotonin reuptake inhibitor	GCST006267	response to selective serotonin reuptake inhibitor	unipolar depression
Response to serotonin reuptake inhibitors in major depressive disorder	unipolar depression|| response to selective serotonin reuptake inhibitor	GCST002868	response to selective serotonin reuptake inhibitor	unipolar depression
Response to serotonin reuptake inhibitors in non-psychotic unipolar depression	unipolar depression|| response to selective serotonin reuptake inhibitor	GCST003118	response to selective serotonin reuptake inhibitor	unipolar depression
Response to stavudine in HIV (lipoatrophy)	HIV-1 infection|| response to stavudine|| Lipoatrophy	GCST002968	response to stavudine|| Lipoatrophy	HIV-1 infection
Response to tamoxifen in oestrogen receptor positive/HER2 negative breast cancer	response to tamoxifen|| HER2 status|| estrogen-receptor positive breast cancer	GCST006615	response to tamoxifen	HER2 status|| estrogen-receptor positive breast cancer
Tenofovir clearance in HIV infection	response to tenofovir|| HIV infection	GCST006073	response to tenofovir	HIV infection
Tenofovir clearance in HIV infection (concomitant antiretroviral treatment interaction)	response to tenofovir|| HIV infection	GCST006071	response to tenofovir	HIV infection
6-month creatinine clearance change response to tenofovir treatment in HIV infection (concomitant antiretroviral treatment interaction)	response to tenofovir|| HIV infection|| creatinine clearance measurement	GCST006070	response to tenofovir|| creatinine clearance measurement	HIV infection
6-month creatinine clearance change response to tenofovir treatment in HIV infection (treatment arm interaction)	response to tenofovir|| HIV infection|| creatinine clearance measurement	GCST006072	response to tenofovir|| creatinine clearance measurement	HIV infection
Time-dependent creatinine clearance change response to tenofovir treatment in HIV infection (time and treatment arm interaction)	response to tenofovir|| HIV infection|| creatinine clearance measurement	GCST006069	response to tenofovir|| creatinine clearance measurement	HIV infection
Thiopurine-induced liver dysfunction in inflammatory bowel disease	response to thiopurine|| inflammatory bowel disease|| liver disease	GCST006212	response to thiopurine|| liver disease	inflammatory bowel disease
Thiopurine-induced infection in inflammatory bowel disease	response to thiopurine|| inflammatory bowel disease|| susceptibility to infectious disease measurement	GCST006211	response to thiopurine|| susceptibility to infectious disease measurement	inflammatory bowel disease
Response to thiopurine immunosuppressants in inflammatory bowel disease (pancreatitis) (azathioprine and mercaptopurine)	response to thiopurine|| thiopurine immunosuppressant-induced pancreatitis|| inflammatory bowel disease	GCST002607	response to thiopurine|| thiopurine immunosuppressant-induced pancreatitis	inflammatory bowel disease
Response to anti-TNF therapy in rheumatoid arthritis	rheumatoid arthritis|| response to TNF antagonist	GCST003329	response to TNF antagonist	rheumatoid arthritis
Response to anti-TNF therapy in rheumatoid arthritis	rheumatoid arthritis|| response to TNF antagonist	GCST001927	response to TNF antagonist	rheumatoid arthritis
"Response to anti-TNF treatment (adalimumab, etanercept or infliximab) in rheumatoid arthritis"	rheumatoid arthritis|| response to TNF antagonist	GCST002869	response to TNF antagonist	rheumatoid arthritis
Response to TNF-alpha inhibitors in rheumatoid arthritis	rheumatoid arthritis|| response to TNF antagonist	GCST001772	response to TNF antagonist	rheumatoid arthritis
Response to TNF-alpha inhibitors in rheumatoid arthritis	rheumatoid arthritis|| response to TNF antagonist	GCST001510	response to TNF antagonist	rheumatoid arthritis
Response to TNF inhibitor in rheumatoid arthritis (change in disease activity score)	rheumatoid arthritis|| response to TNF antagonist|| arthritis disease activity score measurement	GCST006610	response to TNF antagonist|| arthritis disease activity score measurement	rheumatoid arthritis
Response to TNF inhibitor in rheumatoid arthritis (erythrocyte sedimentation rate)	rheumatoid arthritis|| response to TNF antagonist|| blood sedimentation	GCST006607	response to TNF antagonist|| blood sedimentation	rheumatoid arthritis
Response to TNF inhibitor in rheumatoid arthritis (change in swollen 28-joint count)	rheumatoid arthritis|| response to TNF antagonist|| joint damage measurement	GCST006606	response to TNF antagonist|| joint damage measurement	rheumatoid arthritis
Response to TNF inhibitor in rheumatoid arthritis (change in tender 28-joint count)	rheumatoid arthritis|| response to TNF antagonist|| joint damage measurement	GCST006609	response to TNF antagonist|| joint damage measurement	rheumatoid arthritis
Response to TNF inhibitor in rheumatoid arthritis (change in patient global heath assessment score)	rheumatoid arthritis|| self rated health|| response to TNF antagonist	GCST006608	response to TNF antagonist||self rated health	rheumatoid arthritis
Adverse response to dabrafenib or dabrafenib-trametinib treatment in melanoma (pyrexia)	response to trametinib|| fever|| melanoma|| response to dabrafenib	GCST003456	response to trametinib|| fever|| response to dabrafenib	melanoma
Venlafaxine response in generalised anxiety disorder (HAMA-A score reduction after 12 weeks)	response to venlafaxine|| generalized anxiety disorder	GCST004272	response to venlafaxine	generalized anxiety disorder
Venlafaxine response in generalised anxiety disorder (HAMA-A score reduction after 24 weeks)	response to venlafaxine|| generalized anxiety disorder	GCST004271	response to venlafaxine	generalized anxiety disorder
Venlafaxine response in generalised anxiety disorder (remitters vs non-remitters after 12 weeks)	response to venlafaxine|| generalized anxiety disorder	GCST004274	response to venlafaxine	generalized anxiety disorder
Venlafaxine response in generalised anxiety disorder (remitters vs non-remitters after 24 weeks)	response to venlafaxine|| generalized anxiety disorder	GCST004273	response to venlafaxine	generalized anxiety disorder
Venlafaxine response in generalised anxiety disorder (responders vs non-responders after 12 weeks)	response to venlafaxine|| generalized anxiety disorder	GCST004270	response to venlafaxine	generalized anxiety disorder
Venlafaxine response in generalised anxiety disorder (responders vs non-responders after 24 weeks)	response to venlafaxine|| generalized anxiety disorder	GCST004275	response to venlafaxine	generalized anxiety disorder
Response to ziprazidone in schizophrenia	schizophrenia|| response to ziprasidone	GCST006296	response to ziprasidone	schizophrenia
Risky sexual behaviors in alcohol dependence	alcohol dependence|| risky sexual behaviour measurement	GCST004955	risky sexual behaviour measurement	alcohol dependence
Lachrymal/Salivary gland lesion in type 1 autoimmune pancreatitis	salivary gland lesion|| autoimmune pancreatitis type 1|| lachrymal gland lesion	GCST002913	salivary gland lesion|| lachrymal gland lesion	autoimmune pancreatitis type 1
Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)	serum alanine aminotransferase measurement|| response to combination chemotherapy|| acute lymphoblastic leukemia	GCST004250	serum alanine aminotransferase measurement|| response to combination chemotherapy	acute lymphoblastic leukemia
Creatinine levels in ischemic stroke	Ischemic stroke|| serum creatinine measurement	GCST003213	serum creatinine measurement	Ischemic stroke
Peak creatinine levels in vancomycin therapy	response to vancomycin|| serum creatinine measurement	GCST002948	serum creatinine measurement|| response to vancomycin	
IgE levels in asthmatics	serum IgE measurement|| asthma	GCST002122	serum IgE measurement	asthma
IgE levels in asthmatics (D.f. specific)	serum IgE measurement|| asthma	GCST002125	serum IgE measurement	asthma
IgE levels in asthmatics (D.p. specific)	serum IgE measurement|| asthma	GCST002124	serum IgE measurement	asthma
Sex hormone-binding globulin levels in polycystic ovary syndrome	polycystic ovary syndrome|| sex hormone-binding globulin measurement	GCST005271	sex hormone-binding globulin measurement	polycystic ovary syndrome
Sexual dimorphism in anthropometric traits	anthropometric measurement|| sexual dimorphism	GCST002063	sexual dimorphism	anthropometric measurement
Sex difference in attention deficit hyperactivity disorder	attention deficit hyperactivity disorder|| sexual dimorphism	GCST005363	sexual dimorphism	attention deficit hyperactivity disorder
Thiopurine-induced skin symptoms in inflammatory bowel disease	skin disease|| response to thiopurine|| inflammatory bowel disease	GCST006213	skin disease|| response to thiopurine	inflammatory bowel disease
Skin fluorescence in type 1 diabetes	skin fluorescence measurement|| type I diabetes mellitus	GCST003418	skin fluorescence measurement	type I diabetes mellitus
Current cigarettes per day in chronic obstructive pulmonary disease	chronic obstructive pulmonary disease|| smoking behaviour measurement	GCST006042	smoking behaviour measurement	chronic obstructive pulmonary disease
Current cigarettes per day in chronic obstructive pulmonary disease	chronic obstructive pulmonary disease|| cigarettes per day measurement	GCST005917	smoking behaviour measurement	chronic obstructive pulmonary disease
Current cigarettes per day in chronic obstructive pulmonary disease	chronic obstructive pulmonary disease|| smoking behaviour measurement	GCST001111	smoking behaviour measurement	chronic obstructive pulmonary disease
Lifetime average cigarettes per day in chronic obstructive pulmonary disease	chronic obstructive pulmonary disease|| smoking behaviour measurement	GCST001112	smoking behaviour measurement	chronic obstructive pulmonary disease
Smoking cessation in chronic obstructive pulmonary disease	chronic obstructive pulmonary disease|| smoking cessation	GCST005918	smoking cessation	chronic obstructive pulmonary disease
Smoking cessation in chronic obstructive pulmonary disease	chronic obstructive pulmonary disease|| smoking cessation	GCST001108	smoking cessation	chronic obstructive pulmonary disease
Bone mineral density (lumbar spine) in inflammatory bowel disease	inflammatory bowel disease|| spine bone mineral density	GCST005783	spine bone mineral density	inflammatory bowel disease
Bone mineral density change response to combined chemotherapy in acute lymphoblastic leukemia	spine bone mineral density change measurement|| response to combination chemotherapy|| acute lymphoblastic leukemia	GCST005214	spine bone mineral density change measurement|| response to combination chemotherapy	acute lymphoblastic leukemia
Suicidal ideation in depression or bipolar disorder	unipolar depression|| suicidal ideation|| bipolar disorder	GCST002505	suicidal ideation	unipolar depression|| bipolar disorder
Suicide in bipolar disorder	suicide behaviour measurement|| bipolar disorder|| attempted suicide	GCST002699	suicide behaviour measurement|| attempted suicide	bipolar disorder
Suicide ideation score in major depressive disorder	suicide ideation measurement|| unipolar depression	GCST002974	suicide ideation measurement	unipolar depression
Systolic blood pressure in sickle cell anemia	Sickle cell anemia|| systolic blood pressure	GCST002187	systolic blood pressure	Sickle cell anemia
Systolic blood pressure night-to-day ratio in hypertension	hypertension|| systolic blood pressure change measurement	GCST006274	systolic blood pressure change measurement	hypertension
Systolic blood pressure response to hydrochlorothiazide in hypertension	response to hydrochlorothiazide|| hypertension|| systolic blood pressure change measurement	GCST003807	response to hydrochlorothiazide||  systolic blood pressure change measurement	hypertension
Blood pressure response to hydrochlorothiazide in hypertension	response to hydrochlorothiazide|| diastolic blood pressure change measurement|| hypertension|| systolic blood pressure change measurement	GCST002784	systolic blood pressure change measurement|| response to hydrochlorothiazide|| diastolic blood pressure change measurement	hypertension
Testosterone levels in polycystic ovary syndrome	polycystic ovary syndrome|| testosterone measurement	GCST005272	testosterone measurement	polycystic ovary syndrome
Thalamus volume in trauma-exposed individuals	response to trauma exposure|| thalamus volume	GCST005245	thalamus volume|| response to trauma exposure	
Thiopurine methyltransferase activity in acute lymphoblastic leukemia patients treated with mercaptopurines	thiopurine methyltransferase activity measurement|| response to mercaptopurine|| acute lymphoblastic leukemia	GCST003609	response to mercaptopurine|| thiopurine methyltransferase activity measurement	acute lymphoblastic leukemia
Thrombin-antithrombin complex levels in ischemic stroke	Ischemic stroke|| thrombin-antithrombin complex measurement	GCST003233	thrombin-antithrombin complex measurement	Ischemic stroke
Thrombocytopenia in coronary artery bypass surgery	coronary artery bypass|| thrombocytopenia	GCST006435	thrombocytopenia	coronary artery bypass 
Thrombomodulin levels in ischemic stroke	Ischemic stroke|| thrombomodulin measurement	GCST003234	thrombomodulin measurement	Ischemic stroke
Thyroid peroxidase autoantibody levels in type 1 diabetes	type I diabetes mellitus|| thyroid peroxidase antibody measurement	GCST004383	thyroid peroxidase antibody measurement	type I diabetes mellitus
Ticagrelor levels in individuals with acute coronary syndromes treated with ticagrelor	ticagrelor measurement|| acute coronary syndrome	GCST002882	ticagrelor measurement	acute coronary syndrome
Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	response to simvastatin|| type II diabetes mellitus|| total cholesterol change measurement|| response to fenofibrate	GCST004765	response to simvastatin|| total cholesterol change measurement|| response to fenofibrate	type II diabetes mellitus
Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes	triglyceride change measurement|| response to simvastatin|| type II diabetes mellitus|| response to fenofibrate	GCST004766	response to simvastatin|| triglyceride change measurement|| response to fenofibrate	type II diabetes mellitus
Triglyceride levels in chylomicrons and largest VLDL	chylomicron measurement|| triglyceride measurement|| very low density lipoprotein cholesterol measurement	GCST005512	triglyceride measurement	chylomicron measurement|| very low density lipoprotein cholesterol measurement
Triglyceride levels in small HDL	triglyceride measurement|| high density lipoprotein cholesterol measurement	GCST005509	triglyceride measurement	high density lipoprotein cholesterol measurement
Triglyceride levels in very large HDL	triglyceride measurement|| high density lipoprotein cholesterol measurement	GCST005498	triglyceride measurement	high density lipoprotein cholesterol measurement
Triglyceride levels in IDL	triglyceride measurement|| intermediate density lipoprotein measurement	GCST005480	triglyceride measurement	intermediate density lipoprotein measurement
Triglyceride levels in large VLDL	triglyceride measurement|| very low density lipoprotein cholesterol measurement	GCST005460	triglyceride measurement	very low density lipoprotein cholesterol measurement
Triglyceride levels in medium VLDL	triglyceride measurement|| very low density lipoprotein cholesterol measurement	GCST005467	triglyceride measurement	very low density lipoprotein cholesterol measurement
Triglyceride levels in small VLDL	triglyceride measurement|| very low density lipoprotein cholesterol measurement	GCST005472	triglyceride measurement	very low density lipoprotein cholesterol measurement
Triglyceride levels in very large VLDL	triglyceride measurement|| very low density lipoprotein cholesterol measurement	GCST005452	triglyceride measurement	very low density lipoprotein cholesterol measurement
Triglyceride levels in very small VLDL	triglyceride measurement|| very low density lipoprotein cholesterol measurement	GCST005475	triglyceride measurement	very low density lipoprotein cholesterol measurement
CSF tryptophan concentration in tuberculous meningitis	tryptophan measurement|| meningeal tuberculosis	GCST005331	tryptophan measurement	meningeal tuberculosis
Depression in smokers	smoking behavior|| unipolar depression	GCST006427	unipolar depression	smoking behavior
Serum urate levels in chronic kidney disease	urate measurement|| chronic kidney disease	GCST006426	urate measurement	chronic kidney disease
Urate levels in obese individuals	obese body mass index status|| urate measurement	GCST002828	urate measurement	obese body mass index status
Urate levels in overweight individuals	urate measurement|| overweight body mass index status	GCST002829	urate measurement	overweight body mass index status
Urate levels in lean individuals	urate measurement|| underweight body mass index status	GCST002830	urate measurement	underweight body mass index status
Change in serum uric acid levels in response to thiazide diuretic treatment (hydrochlorothiazide) in hypertension	response to hydrochlorothiazide|| hypertension|| uric acid measurement	GCST005646	uric acid measurement|| response to hydrochlorothiazide	hypertension
"Urinary 1,3-butadiene metabolite levels in smokers"	"smoking status measurement|| urinary 1,3-butadiene measurement"	GCST004254	"urinary 1,3-butadiene measurement"	smoking status measurement
Urinary albumin-to-creatinine ratio in diabetes	diabetes mellitus|| urinary albumin to creatinine ratio	GCST003250	urinary albumin to creatinine ratio	diabetes mellitus
Fractional excretion of metabolites in chronic kidney disease	chronic kidney disease|| urinary metabolite measurement	GCST005666	urinary metabolite measurement	chronic kidney disease
Urinary metabolite concentrations in chronic kidney disease	chronic kidney disease|| urinary metabolite measurement	GCST005651	urinary metabolite measurement	chronic kidney disease
Urinary metabolite ratios in chronic kidney disease	chronic kidney disease|| urinary metabolite measurement	GCST005649	urinary metabolite measurement	chronic kidney disease
S-phenylmercapturic acid levels in smokers	smoking behavior|| urinary S-phenylmercapturic acid measurement	GCST003483	urinary S-phenylmercapturic acid measurement	smoking behavior
Uveitis in juvenile idiopathic arthritis	chronic childhood arthritis|| uveitis	GCST006126	uveitis	chronic childhood arthritis
Vancomycin trough in vancomycin therapy	vancomycin trough measurement|| response to vancomycin	GCST002946	vancomycin trough measurement|| response to vancomycin	
Vaso-occlusive pain in sickle-cell anemia	Sickle cell anemia|| vaso-occlusive pain measurement	GCST004644	vaso-occlusive pain measurement	Sickle cell anemia
Vein graft stenosis in coronary artery bypass grafting	coronary artery bypass|| vein graft stenosis	GCST002793	vein graft stenosis	coronary artery bypass
Response to abacavir-containing treatment in HIV-1 infection (virologic failure)	HIV-1 infection|| virologic response measurement|| response to abacavir	GCST002769	virologic response measurement|| response to abacavir	HIV-1 infection
Vision loss in proton beam irradiation treatment of choroidal melanoma	response to radiation|| choroidal melanoma|| visual acuity measurement	GCST005589	visual acuity measurement|| response to radiation 	choroidal melanoma
Response to ranibizumab in age-related macular degeneration (visual acuity)	visual acuity measurement|| response to ranibizumab|| age-related macular degeneration	GCST004801	visual acuity measurement|| response to ranibizumab	age-related macular degeneration
Vitamin B levels in ischemic stroke	stroke|| vitamin B measurement	GCST002559	vitamin B measurement	stroke
vWF levels in ischaemic stroke and hyperhomocysteinaemia	Ischemic stroke|| von Willebrand factor measurement|| homocysteine measurement	GCST004598	von Willebrand factor measurement	Ischemic stroke|| homocysteine measurement
White matter hyperintensities in ischemic stroke	Ischemic stroke|| white matter hyperintensity measurement	GCST003245	white matter hyperintensity measurement	Ischemic stroke
White matter microstructure in first episode schizophrenia (left anterior cingulate cortex)	schizophrenia|| white matter microstructure measurement|| cingulate cortex measurement	GCST004994	white matter microstructure measurement|| cingulate cortex measurement	schizophrenia
White matter microstructure in first episode schizophrenia (left posterior cingulate cortex)	schizophrenia|| white matter microstructure measurement|| cingulate cortex measurement	GCST004995	white matter microstructure measurement|| cingulate cortex measurement	schizophrenia
White matter microstructure in first episode schizophrenia (right anterior cingulate cortex)	schizophrenia|| white matter microstructure measurement|| cingulate cortex measurement	GCST004993	white matter microstructure measurement|| cingulate cortex measurement	schizophrenia
White matter microstructure in first episode schizophrenia (right posterior cingulate cortex)	schizophrenia|| white matter microstructure measurement|| cingulate cortex measurement	GCST004992	white matter microstructure measurement|| cingulate cortex measurement	schizophrenia
White matter microstructure in first episode schizophrenia (left inferior parietal cortex)	parietal cortex measurement|| schizophrenia|| white matter microstructure measurement	GCST004991	white matter microstructure measurement|| parietal cortex measurement	schizophrenia
Yu-Zhi constitution type in type 2 diabetes	Yu-Zhi constitution type|| type II diabetes mellitus	GCST003026	Yu-Zhi constitution type	type II diabetes mellitus
Acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation	response to allogeneic hematopoietic stem cell transplant|| acute graft vs. host disease	GCST002958	response to allogeneic hematopoietic stem cell transplant|| acute graft vs. host disease	
Acute graft versus host disease in bone marrow transplantation (donor effect)	acute graft vs. host disease|| donor genotype effect measurement	GCST003942	acute graft vs. host disease|| donor genotype effect measurement	
Subjective response to lithium treatment	bipolar disorder|| response to lithium ion	GCST003158	bipolar disorder|| response to lithium ion	
Uncontrolled blood pressure in combination therapy (beta blocker and thiazide diuretic)	blood pressure|| response to thiazide|| response to beta blocker	GCST005039	blood pressure|| response to thiazide|| response to beta blocker	
Odor events in darapladib-treated cardiovascular disease (time to event)	response to darapladib|| body odor measurement|| acute coronary syndrome|| coronary heart disease	GCST004960	body odor measurement|| response to darapladib	acute coronary syndrome|| coronary heart disease
Bronchopulmonary dysplasia in preterm infants	infant|| Bronchopulmonary dysplasia	GCST004783	Bronchopulmonary dysplasia	infant
Major coronary event in darapladib-treated cardiovascular disease (time to event)	response to darapladib|| acute coronary syndrome|| coronary heart disease|| cardiovascular event measurement	GCST004957	cardiovascular event measurement|| response to darapladib	acute coronary syndrome|| coronary heart disease
Cerebrospinal fluid clusterin levels in APOEe4- carriers	Alzheimer's disease|| cerebrospinal fluid clusterin measurement	GCST003137	cerebrospinal fluid clusterin measurement	Alzheimer's disease
Adverse response to chemotherapy in breast cancer (alopecia) (anti-microtubule)	chemotherapy-induced alopecia|| response to antimicrotubule agent	GCST002177	chemotherapy-induced alopecia|| response to antimicrotubule agent	
Adverse response to chemotherapy in breast cancer (alopecia) (docetaxel)	chemotherapy-induced alopecia|| response to docetaxel	GCST002180	chemotherapy-induced alopecia|| response to docetaxel	
Adverse response to chemotherapy in breast cancer (alopecia) (paclitaxel)	chemotherapy-induced alopecia|| response to paclitaxel	GCST002179	chemotherapy-induced alopecia|| response to paclitaxel	
Resistance to antipsychotic treatment in schizophrenia (childhood trauma interaction)	childhood trauma measurement|| response to antipsychotic drug|| treatment refractory schizophrenia	GCST004374	childhood trauma measurement|| response to antipsychotic drug	treatment refractory schizophrenia
Diabetic kidney disease in type 2 diabetes (ESRD vs. no ESRD)	chronic kidney disease|| diabetic nephropathy	GCST005893	chronic kidney disease|| diabetic nephropathy	
Chronic kidney disease (chronic kidney disease vs normal or mildly reduced eGFR) in type 1 diabetes	type 1 diabetes nephropathy|| chronic kidney disease	GCST003867	chronic kidney disease|| type 1 diabetes nephropathy	
Chronic kidney disease (severe chronic kidney disease vs normal kidney function) in type 1 diabetes	type 1 diabetes nephropathy|| chronic kidney disease	GCST003863	chronic kidney disease|| type 1 diabetes nephropathy	
Kidney disease (early and late stages) in type 1 diabetes	type 1 diabetes nephropathy|| chronic kidney disease	GCST003864	chronic kidney disease|| type 1 diabetes nephropathy	
Kidney disease (early stage) in type 1 diabetes	type 1 diabetes nephropathy|| chronic kidney disease	GCST003865	chronic kidney disease|| type 1 diabetes nephropathy	
Kidney disease (end stage renal disease vs non-end stage renal disease) in type 1 diabetes	type 1 diabetes nephropathy|| chronic kidney disease	GCST003862	chronic kidney disease|| type 1 diabetes nephropathy	
Kidney disease (end stage renal disease vs normoalbuminuria) in type 1 diabetes	type 1 diabetes nephropathy|| chronic kidney disease	GCST003861	chronic kidney disease|| type 1 diabetes nephropathy	
Kidney disease (late stage) in type 1 diabetes	type 1 diabetes nephropathy|| chronic kidney disease	GCST003866	chronic kidney disease|| type 1 diabetes nephropathy	
Phospholipid levels in chylomicrons and largest VLDL	chylomicron measurement|| very low density lipoprotein cholesterol measurement|| phospholipid measurement	GCST005511	chylomicron measurement|| very low density lipoprotein cholesterol measurement|| phospholipid measurement	
Peak cortisol response to low dose short synacthen test in corticosteroid treated asthma	childhood onset asthma|| cortisol measurement|| response to corticosteroid|| response to synacthen	GCST005926	cortisol measurement|| response to corticosteroid|| response to synacthen	childhood onset asthma
Cough in response to angiotensin-converting enzyme inhibitor drugs	response to angiotensin-converting enzyme inhibitor|| Cough	GCST004049	Cough|| response to angiotensin-converting enzyme inhibitor	
Cough in response to angiotensin-converting enzyme inhibitor drugs	response to angiotensin-converting enzyme inhibitor|| Cough	GCST003027	Cough|| response to angiotensin-converting enzyme inhibitor	
Diabetic nephropathy in type 1 diabetes	type I diabetes mellitus|| diabetic retinopathy	GCST002716	diabetic nephropathy	type I diabetes mellitus
Diastolic blood pressure in combination therapy (beta blocker and thiazide diuretic)	diastolic blood pressure|| response to thiazide|| response to beta blocker	GCST005041	diastolic blood pressure|| response to thiazide|| response to beta blocker	
Disease-free survival in breast cancer	disease free survival|| breast carcinoma	GCST002847	disease free survival|| breast carcinoma	
Survival in colon cancer	disease free survival|| colonic neoplasm|| overall survival	GCST002822	disease free survival|| colonic neoplasm|| overall survival	
Survival in microsatellite instability low/stable colorectal cancer	disease free survival|| colorectal cancer|| microsatellite instability measurement|| overall survival	GCST002820	disease free survival|| colorectal cancer|| microsatellite instability measurement|| overall survival	
Survival in rectal cancer	disease free survival|| rectum cancer|| overall survival	GCST002821	disease free survival|| rectum cancer|| overall survival	
Disease progression in age-related macular degeneration	age-related macular degeneration|| disease progression measurement	GCST005359	age-related macular degeneration|| disease progression measurement	
Disease progression to geographic atrophy form in age-related macular degeneration	atrophic macular degeneration|| disease progression measurement	GCST005360	atrophic macular degeneration|| disease progression measurement	
Age at loss of ambulation in Duchenne muscular dystrophy	Duchenne muscular dystrophy|| disease progression measurement	GCST006286	Duchenne muscular dystrophy|| disease progression measurement	
Huntington's disease progression	Huntington disease|| disease progression measurement	GCST004691	Huntington disease|| disease progression measurement	
Disease progression to choroidal neovascularization form in age-related macular degeneration	disease progression measurement|| wet macular degeneration	GCST005358	disease progression measurement|| wet macular degeneration	
Depression (age of onset)	mental or behavioural disorder|| age at onset	GCST001643	age at onset	mental or behavioural disorder 
Schizophrenia (age at onset) (sex interaction)	schizophrenia|| age at onset	GCST001114		
Brain imaging in schizophrenia (dorsolateral prefrontal cortex interaction)	schizophrenia|| dorsolateral prefrontal cortex functional measurement	GCST000271	dorsolateral prefrontal cortex functional measurement|| schizophrenia	
Cholesterol ester levels in medium HDL	esterified cholesterol measurement|| high density lipoprotein cholesterol measurement	GCST005506	esterified cholesterol measurement|| high density lipoprotein cholesterol measurement	
Cholesterol ester levels in very large HDL	esterified cholesterol measurement|| high density lipoprotein cholesterol measurement	GCST005501	esterified cholesterol measurement|| high density lipoprotein cholesterol measurement	
Cholesterol ester levels in very large HDL	esterified cholesterol measurement|| high density lipoprotein cholesterol measurement	GCST005495	esterified cholesterol measurement|| high density lipoprotein cholesterol measurement	
Cholesterol ester levels in large LDL	esterified cholesterol measurement|| low density lipoprotein cholesterol measurement	GCST005484	esterified cholesterol measurement|| low density lipoprotein cholesterol measurement	
Cholesterol ester levels in medium LDL	esterified cholesterol measurement|| low density lipoprotein cholesterol measurement	GCST005489	esterified cholesterol measurement|| low density lipoprotein cholesterol measurement	
Estrogen receptor status in HER2 positive breast cancer	estrogen-receptor negative breast cancer|| HER2 status|| estrogen-receptor positive breast cancer|| breast carcinoma	GCST003822	estrogen receptor status	HER2 status|| breast carcinoma
F-cell distribution in sickle cell anaemia	fetal hemoglobin measurement|| Sickle cell anemia	GCST000982	fetal hemoglobin measurement	Sickle cell anemia
Pulmonary function in asthmatics	pulmonary function measurement|| asthma	GCST002608	pulmonary function measurement	asthma
Gestational age at birth in labor-initiated deliveries (child effect)	gestational age|| birth measurement	GCST003687	gestational age	birth measurement
Gestational age at birth in labor-initiated deliveries (maternal effect)	gestational age|| birth measurement	GCST003684	gestational age	birth measurement
Gestational age at birth in premature rupture of membrane-initiated deliveries (child effect)	gestational age|| birth measurement	GCST003689	gestational age	birth measurement
Gestational age at birth in premature rupture of membrane-initiated deliveries (maternal effect)	gestational age|| birth measurement	GCST003685	gestational age	birth measurement
Glomerular filtration rate in non diabetics (creatinine)	glomerular filtration rate|| serum creatinine measurement	GCST003401	glomerular filtration rate|| serum creatinine measurement	
Decline in glucose metabolism in posterior cingulate cortex	glucose metabolism decline measurement|| cingulate cortex measurement	GCST006632	glucose metabolism decline measurement|| cingulate cortex measurement	
HDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	HDL cholesterol change measurement|| response to simvastatin|| type II diabetes mellitus|| response to fenofibrate	GCST004763	HDL cholesterol change measurement|| response to fenofibrate|| response to simvastatin	type II diabetes mellitus
Antipsychotic drug-induced QTc interval change in schizophrenia	heart rate variability measurement|| response to antipsychotic drug	GCST004987	heart rate variability measurement|| response to antipsychotic drug	schizophrenia
Estrogen receptor status in HER2 negative breast cancer	estrogen-receptor negative breast cancer|| HER2 status|| estrogen-receptor positive breast cancer|| breast carcinoma	GCST003823	estrogen receptor status	breast carcinoma|| HER2 status
Hippocampal volume in trauma-exposed individuals	response to trauma exposure|| hippocampal volume	GCST005243	hippocampal volume||response to trauma exposure	
HIV-1 viral setpoint	HIV-1 infection|| HIV viral set point measurement	GCST002976	HIV viral set point measurement	HIV-1 infection
Change in intraocular pressure in response to steroid treatment (triamcinolone acetonide)	response to triamcinolone acetonide|| intraocular pressure change measurement	GCST002837	intraocular pressure change measurement|| response to triamcinolone acetonide	
Joint damage progression in ACPA-positive rheumatoid arthritis	ACPA-positive rheumatoid arthritis|| joint damage measurement	GCST002139	joint damage measurement	ACPA-positive rheumatoid arthritis
Joint damage progression in ACPA-negative rheumatoid arthritis	ACPA-negative rheumatoid arthritis|| joint damage measurement	GCST003256	joint damage measurement	ACPA-negative rheumatoid arthritis
LDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	LDL cholesterol change measurement|| response to simvastatin|| type II diabetes mellitus|| response to fenofibrate	GCST004764	LDL cholesterol change measurement|| response to fenofibrate|| response to simvastatin	type II diabetes mellitus
Change in LVEF in response to paclitaxel in HER2+ breast cancer	left ventricular diastolic function measurement|| response to paclitaxel	GCST004789	left ventricular diastolic function measurement|| response to paclitaxel	
Change in LVEF in response to paclitaxel and in response to paclitaxel and trastuzumab in HER+ breast cancer	response to trastuzumab|| left ventricular diastolic function measurement|| response to paclitaxel	GCST004788	left ventricular diastolic function measurement|| response to trastuzumab|| response to paclitaxel	
Change in LVEF in response to paclitaxel and trastuzumab in HER2+ breast cancer	response to trastuzumab|| left ventricular diastolic function measurement|| response to paclitaxel	GCST004790	left ventricular diastolic function measurement|| response to trastuzumab|| response to paclitaxel	
Phospholipid levels in large LDL	low density lipoprotein cholesterol measurement|| phospholipid measurement	GCST005482	low density lipoprotein cholesterol measurement|| phospholipid measurement	
Phospholipid levels in medium LDL	low density lipoprotein cholesterol measurement|| phospholipid measurement	GCST005487	low density lipoprotein cholesterol measurement|| phospholipid measurement	
Brain activation in response to working memory task	memory performance|| functional brain measurement|| short-term memory	GCST003698	memory performance|| functional brain measurement|| short-term memory	
Remission after SSRI treatment in MDD or neuroticism	unipolar depression|| neuroticism measurement|| response to selective serotonin reuptake inhibitor	GCST005835	neuroticism measurement|| response to selective serotonin reuptake inhibitor	unipolar depression
Cisplatin-induced hearing loss in brain tumor patients	ototoxicity|| hearing loss|| response to cisplatin	GCST002780	ototoxicity|| hearing loss|| response to cisplatin	
Phospholipid levels in large HDL	phospholipid measurement|| high density lipoprotein cholesterol measurement	GCST005499	phospholipid measurement|| high density lipoprotein cholesterol measurement	
Phospholipid levels in medium HDL	phospholipid measurement|| high density lipoprotein cholesterol measurement	GCST005504	phospholipid measurement|| high density lipoprotein cholesterol measurement	
Phospholipid levels in very large HDL	phospholipid measurement|| high density lipoprotein cholesterol measurement	GCST005493	phospholipid measurement|| high density lipoprotein cholesterol measurement	
Phospholipid levels in IDL	phospholipid measurement|| intermediate density lipoprotein measurement	GCST005477	phospholipid measurement|| intermediate density lipoprotein measurement	
Acute graft rejection in renal transplantation (donor effect)	renal transplant outcome measurement|| donor genotype effect measurement	GCST005432	renal transplant outcome measurement|| donor genotype effect measurement	
Acute graft rejection in renal transplantation (donor-recipient interaction)	renal transplant outcome measurement|| donor genotype effect measurement	GCST005433	renal transplant outcome measurement|| donor genotype effect measurement	
Angioedema in response to angiotensin-converting enzyme inhibitor	response to angiotensin-converting enzyme inhibitor|| angioedema	GCST002091	response to angiotensin-converting enzyme inhibitor|| angioedema	
Response to antidepressants in depression	unipolar depression|| mood disorder|| response to antidepressant	GCST003803	response to antidepressant	unipolar depression|| mood disorder
Response to aripiprazole in schizophrenia	schizophrenia|| response to aripiprazole|| response to antipsychotic drug	GCST006285	response to aripiprazole|| response to antipsychotic drug	schizophrenia
Bronchodilator response in asthma (inhaled corticosteroid treatment interaction)	response to bronchodilator|| asthma	GCST002291	response to bronchodilator|| response to corticosteroid	asthma
Response to bupropion in depression	unipolar depression|| response to bupropion|| mood disorder	GCST003800	response to bupropion	unipolar depression|| mood disorder
Response to angiotensin II receptor blocker therapy	response to candesartan|| hypertension	GCST001520	response to candesartan	hypertension
Response to angiotensin II receptor blocker therapy (opposite direction w/ diuretic therapy)	response to candesartan|| hypertension	GCST001518	response to candesartan	hypertension
Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU)	response to cyclophosphamide|| chemotherapy-induced alopecia|| response to 5' fluorouracil|| response to doxorubicin	GCST002178	response to cyclophosphamide|| chemotherapy-induced alopecia|| response to 5' fluorouracil|| response to doxorubicin	
Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+epirubicin+/-5FU)	response to epirubicin|| response to cyclophosphamide|| chemotherapy-induced alopecia|| response to 5' fluorouracil	GCST002176	response to epirubicin|| response to cyclophosphamide|| chemotherapy-induced alopecia|| response to 5' fluorouracil	
Response to citalopram or escitalopram in depression	unipolar depression|| response to escitalopram|| response to citalopram|| mood disorder	GCST003802	response to escitalopram|| response to citalopram	unipolar depression|| mood disorder
Thiazide-induced adverse metabolic effects in hypertensive patients	response to hydrochlorothiazide|| triglyceride measurement|| fasting blood glucose measurement	GCST001859	response to hydrochlorothiazide|| triglyceride measurement|| fasting blood glucose measurement	
Hepatocellular carcinoma in post hepatitis C eradication by interferon therapy	response to interferon|| hepatocellular carcinoma|| virologic response measurement	GCST004160	response to interferon|| hepatocellular carcinoma	virologic response measurement
Response to irinotecan and platinum-based chemotherapy in non-small-cell lung cancer	response to irinotecan|| non-small cell lung carcinoma	GCST001901	response to irinotecan	non-small cell lung carcinoma
Response to long-chain n-3 polyunsaturated fatty acid supplementation (change in triglyceride levels)	triglyceride change measurement|| response to long-chain n-3 PUFA dietary supplementation	GCST006055	response to long-chain n-3 PUFA dietary supplementation|| triglyceride change measurement	
Urinary symptoms in response to radiotherapy in prostate cancer	response to radiation|| prostate carcinoma|| lower urinary tract symptom	GCST001847	response to radiation|| lower urinary tract symptom	prostate carcinoma
Response to SSRI in MDD or conscientiouness	conscientiousness measurement|| unipolar depression|| response to selective serotonin reuptake inhibitor	GCST005836	conscientiousness measurement|| response to selective serotonin reuptake inhibitor	unipolar depression
Response to selective serotonin reuptake inhibitors in depression	unipolar depression|| response to selective serotonin reuptake inhibitor|| mood disorder	GCST003801	response to selective serotonin reuptake inhibitor	unipolar depression|| mood disorder
Response to SSRI in MDD or openness	unipolar depression|| response to selective serotonin reuptake inhibitor|| openness measurement	GCST005834	response to selective serotonin reuptake inhibitor|| openness measurement	unipolar depression
Remission after SSRI treatment in MDD or openness	unipolar depression|| response to selective serotonin reuptake inhibitor|| openness measurement	GCST005833	response to selective serotonin reuptake inhibitor|| openness measurement	unipolar depression
Nucleus accumbens volume in trauma-exposed individuals	response to trauma exposure|| nucleus accumbens volume	GCST005241	response to trauma exposure|| nucleus accumbens volume	
Rheumatoid factor seropositivity in rheumatoid arthritis	rheumatoid arthritis|| rheumatoid factor seropositivity measurement|| rheumatoid factor measurement	GCST003330	rheumatoid factor seropositivity measurement|| rheumatoid factor measurement	rheumatoid arthritis
Age at smoking initiation in chronic obstructive pulmonary disease	chronic obstructive pulmonary disease|| smoking initiation	GCST001113	smoking initiation	chronic obstructive pulmonary disease
Response to angiotensin II receptor blocker treatment (losartan) (change in systolic blood pressure levels)	systolic blood pressure|| blood pressure|| response to losartan	GCST002583	systolic blood pressure|| blood pressure|| response to losartan	
Systolic blood pressure in combination therapy (beta blocker and thiazide diuretic)	systolic blood pressure|| response to thiazide|| response to beta blocker	GCST005040	systolic blood pressure|| response to thiazide|| response to beta blocker	
Tacrolimus trough concentration in kidney transplant patients	tacrolimus measurement|| renal transplant outcome measurement	GCST005144	tacrolimus measurement	renal transplant outcome measurement
Resistance to Mycobacterium tuberculosis in HIV-positive individuals measured by a negative tuberculin skin test (continuous)	tuberculin skin test reactivity measurement|| decreased susceptibility to bacterial infection	GCST004689	tuberculin skin test reactivity measurement|| decreased susceptibility to bacterial infection	
Resistance to Mycobacterium tuberculosis in HIV-positive individuals measured by a negative tuberculin skin test (dichotomous)	tuberculin skin test reactivity measurement|| decreased susceptibility to bacterial infection	GCST004690	tuberculin skin test reactivity measurement|| decreased susceptibility to bacterial infection	
Cholesterol ester levels in large VLDL	very low density lipoprotein cholesterol measurement|| esterified cholesterol measurement	GCST005461	very low density lipoprotein cholesterol measurement|| esterified cholesterol measurement	
Cholesterol ester levels in medium VLDL	very low density lipoprotein cholesterol measurement|| esterified cholesterol measurement	GCST005465	very low density lipoprotein cholesterol measurement|| esterified cholesterol measurement	
Phospholipid levels in large VLDL	very low density lipoprotein cholesterol measurement|| phospholipid measurement	GCST005454	very low density lipoprotein cholesterol measurement|| phospholipid measurement	
Phospholipid levels in medium VLDL	very low density lipoprotein cholesterol measurement|| phospholipid measurement	GCST005463	very low density lipoprotein cholesterol measurement|| phospholipid measurement	
Phospholipid levels in small VLDL	very low density lipoprotein cholesterol measurement|| phospholipid measurement	GCST005469	very low density lipoprotein cholesterol measurement|| phospholipid measurement	
Phospholipid levels in very large VLDL	very low density lipoprotein cholesterol measurement|| phospholipid measurement	GCST005451	very low density lipoprotein cholesterol measurement|| phospholipid measurement	
Phospholipid levels in very small VLDL	very low density lipoprotein cholesterol measurement|| phospholipid measurement	GCST005474	very low density lipoprotein cholesterol measurement|| phospholipid measurement	
Response to anti-VEGF treatment in neovascular age-related macular degeneration (visual acuity)	visual acuity measurement|| wet macular degeneration|| response to anti-vascular endothelial growth factor drug	GCST006808	visual acuity measurement|| response to anti-vascular endothelial growth factor drug	wet macular degeneration
Accelerated cognitive decline after conversion of mild cognitive impairment to Alzheimer's disease (Alzhiemer's diagnosis trajectory interaction)	cognitive impairment|| Alzheimer's disease|| cognitive decline measurement	GCST004253	cognitive impairment|| Alzheimer's disease|| cognitive decline measurement	
ACPA-negative rheumatoid arthritis (smoking interaction)	rheumatoid arthritis|| smoking status measurement|| ACPA-negative rheumatoid arthritis	GCST006807	rheumatoid arthritis|| smoking status measurement|| ACPA-negative rheumatoid arthritis	
ACPA-positive rheumatoid arthritis (smoking interaction)	rheumatoid arthritis|| smoking status measurement|| ACPA-positive rheumatoid arthritis	GCST006410	rheumatoid arthritis|| smoking status measurement|| ACPA-positive rheumatoid arthritis	
Acute urticaria and angioedema (non-steroidal anti-inflammatory drug-induced)	urticaria|| response to non-steroidal anti-inflammatory|| angioedema	GCST002263	urticaria|| response to non-steroidal anti-inflammatory|| angioedema	
Acylcarnitine levels	acylcarnitine measurement|| blood metabolite measurement	GCST002961	acylcarnitine measurement|| blood metabolite measurement	
Adult onset asthma (smoking interaction)	smoking behavior|| adult onset asthma	GCST004220	smoking behavior|| adult onset asthma	
Advanced age-related macular degeneration	atrophic macular degeneration|| age-related macular degeneration|| wet macular degeneration	GCST003219	atrophic macular degeneration|| age-related macular degeneration|| wet macular degeneration	
Advanced glycation end-product levels	advanced glycation end-product measurement|| type II diabetes mellitus	GCST003457	advanced glycation end-product measurement|| type II diabetes mellitus	
Adverse response to chemotherapy (neutropenia/leucopenia) (5-fluorouracil)	response to 5' fluorouracil|| response to antineoplastic agent	GCST001997	response to 5' fluorouracil|| response to antineoplastic agent	
Adverse response to chemotherapy (neutropenia/leucopenia) (all anthracycline-based drugs)	response to antineoplastic agent|| response to anthracycline-based chemotherapy	GCST002008	response to antineoplastic agent|| response to anthracycline-based chemotherapy	
Adverse response to chemotherapy (neutropenia/leucopenia) (all antimetabolite drugs)	response to antineoplastic agent|| response to antimetabolite	GCST002005	response to antineoplastic agent|| response to antimetabolite	
Adverse response to chemotherapy (neutropenia/leucopenia) (all antimicrotubule drugs)	response to antineoplastic agent|| response to antimicrotubule agent	GCST002001	response to antineoplastic agent|| response to antimicrotubule agent	
Adverse response to chemotherapy (neutropenia/leucopenia) (all platinum-based drugs)	response to platinum based chemotherapy|| response to antineoplastic agent	GCST001998	response to platinum based chemotherapy|| response to antineoplastic agent	
Adverse response to chemotherapy (neutropenia/leucopenia) (all topoisomerase inhibitors)	response to topoisomerase inhibitor|| response to antineoplastic agent	GCST001994	response to topoisomerase inhibitor|| response to antineoplastic agent	
Adverse response to chemotherapy (neutropenia/leucopenia) (camptothecin)	response to camptothecin|| response to antineoplastic agent	GCST001993	response to camptothecin|| response to antineoplastic agent	
Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	response to carboplatin|| response to antineoplastic agent	GCST002004	response to carboplatin|| response to antineoplastic agent	
Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin)	response to cisplatin|| response to antineoplastic agent	GCST002007	response to cisplatin|| response to antineoplastic agent	
Adverse response to chemotherapy (neutropenia/leucopenia) (cyclophosphamide)	response to cyclophosphamide|| response to antineoplastic agent	GCST002002	response to cyclophosphamide|| response to antineoplastic agent	
Adverse response to chemotherapy (neutropenia/leucopenia) (docetaxel)	response to docetaxel|| response to antineoplastic agent	GCST001995	response to docetaxel|| response to antineoplastic agent	
Adverse response to chemotherapy (neutropenia/leucopenia) (doxorubicin)	response to antineoplastic agent|| response to doxorubicin	GCST002009	response to antineoplastic agent|| response to doxorubicin	
Adverse response to chemotherapy (neutropenia/leucopenia) (epirubicin)	response to epirubicin|| response to antineoplastic agent	GCST001996	response to epirubicin|| response to antineoplastic agent	
Adverse response to chemotherapy (neutropenia/leucopenia) (etoposide)	response to etoposide|| response to antineoplastic agent	GCST002000	response to etoposide|| response to antineoplastic agent	
Adverse response to chemotherapy (neutropenia/leucopenia) (gemcitabine)	response to gemcitabine|| response to antineoplastic agent	GCST002003	response to gemcitabine|| response to antineoplastic agent	
Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel + carboplatin)	response to carboplatin|| response to paclitaxel|| response to antineoplastic agent	GCST002006	response to carboplatin|| response to paclitaxel|| response to antineoplastic agent	
Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel)	response to paclitaxel|| response to antineoplastic agent	GCST001999	response to paclitaxel|| response to antineoplastic agent	
Affective disorder and suicide attempts	attempted suicide|| mood disorder	GCST006420	attempted suicide|| mood disorder	
Age of smoking initiation	age at onset|| smoking initiation	GCST002394	age at onset|| smoking initiation	
Age-related disease endophenotypes	total cholesterol measurement|| diastolic blood pressure|| triglyceride measurement|| systolic blood pressure|| hematocrit|| ventricular rate measurement|| glucose measurement|| body mass index|| high density lipoprotein cholesterol measurement	GCST004046	total cholesterol measurement|| diastolic blood pressure|| triglyceride measurement|| systolic blood pressure|| hematocrit|| ventricular rate measurement|| glucose measurement|| body mass index|| high density lipoprotein cholesterol measurement	
Age-related diseases and mortality	cancer|| heart failure|| diabetes mellitus|| stroke|| coronary heart disease|| atrial fibrillation|| mortality	GCST004044	cancer|| heart failure|| diabetes mellitus|| stroke|| coronary heart disease|| atrial fibrillation|| mortality	
"Age-related diseases, mortality and associated endophenotypes"	total cholesterol measurement|| hematocrit|| stroke|| ventricular rate measurement|| coronary heart disease|| body mass index|| atrial fibrillation|| high density lipoprotein cholesterol measurement|| cancer|| diastolic blood pressure|| triglyceride measurement|| systolic blood pressure|| heart failure|| diabetes mellitus|| glucose measurement|| mortality	GCST004045	total cholesterol measurement|| hematocrit|| stroke|| ventricular rate measurement|| coronary heart disease|| body mass index|| atrial fibrillation|| high density lipoprotein cholesterol measurement|| cancer|| diastolic blood pressure|| triglyceride measurement|| systolic blood pressure|| heart failure|| diabetes mellitus|| glucose measurement|| mortality	
Age-related macular degeneration	glaucoma|| age-related macular degeneration	GCST001899	glaucoma|| age-related macular degeneration	
Age-related macular degeneration (CNV vs. GA)	atrophic macular degeneration|| wet macular degeneration	GCST001577	atrophic macular degeneration|| wet macular degeneration	
Age-related macular degeneration (smoking status interaction)	smoking status measurement|| age-related macular degeneration	GCST001990	smoking status measurement|| age-related macular degeneration	
Aggressive periodontitis (sex interaction)	sex interaction measurement|| aggressive periodontitis	GCST002635	sex interaction measurement|| aggressive periodontitis	
Aggressive prostate cancer	cancer aggressiveness measurement|| prostate carcinoma	GCST003585	cancer aggressiveness measurement|| prostate carcinoma	
Aging (time to death)	longevity|| aging	GCST001167	longevity|| aging	
Aging traits	age at menopause|| aging|| exercise test|| age at death	GCST000096	age at menopause|| aging|| exercise test|| age at death	
Alcohol consumption (drinkers vs non-drinkers)	alcohol consumption measurement|| alcohol drinking	GCST004404	alcohol consumption measurement|| alcohol drinking	
Alcohol consumption (drinks per week)	alcohol consumption measurement|| alcohol drinking	GCST004405	alcohol consumption measurement|| alcohol drinking	
Alcohol dependence or chronic alcoholic pancreatitis or alcohol-related liver cirrhosis	alcoholic liver cirrhosis|| alcohol dependence|| alcoholic pancreatitis	GCST004757	alcoholic liver cirrhosis|| alcohol dependence|| alcoholic pancreatitis	
Alcohol misuse (trauma interaction)	stressful life event measurement|| alcohol dependence measurement	GCST004225	stressful life event measurement|| alcohol dependence measurement	
Alzheimer's disease (APOE e4 interaction)	Alzheimer's disease|| APOE carrier status	GCST002814	Alzheimer's disease|| APOE carrier status	
Alzheimer's disease or family history of Alzheimer's disease	Alzheimer's disease|| family history of Alzheimer’s disease	GCST005922	Alzheimer's disease|| family history of Alzheimer’s disease	
Alzheimer's disease or small vessel stroke	Alzheimer's disease|| small vessel stroke	GCST003423	Alzheimer's disease|| small vessel stroke	
Alzheimer's disease or type 2 diabetes (pleiotropy)	Alzheimer's disease|| type II diabetes mellitus	GCST004880	Alzheimer's disease|| type II diabetes mellitus	
Amino acid levels	blood metabolite measurement|| amino acid measurement	GCST002966	blood metabolite measurement|| amino acid measurement	
Amyotrophic lateral sclerosis and immune-mediated diseases (pleiotropy)	rheumatoid arthritis|| type I diabetes mellitus|| psoriasis|| amyotrophic lateral sclerosis|| celiac disease|| ulcerative colitis|| Crohn's disease	GCST005321	rheumatoid arthritis|| type I diabetes mellitus|| psoriasis|| amyotrophic lateral sclerosis|| celiac disease|| ulcerative colitis|| Crohn's disease	
Amyotrophic lateral sclerosis or frontotemporal dementia	amyotrophic lateral sclerosis|| Frontotemporal dementia	GCST002510	amyotrophic lateral sclerosis|| Frontotemporal dementia	
Amyotrophic lateral sclerosis or schizophrenia (pleiotropy)	schizophrenia|| amyotrophic lateral sclerosis	GCST004252	schizophrenia|| amyotrophic lateral sclerosis	
Androgen levels	dihydrotestosterone measurement|| testosterone measurement	GCST001653	dihydrotestosterone measurement|| testosterone measurement	
Anorexia nervosa or obsessive-compulsive disorder	anorexia nervosa|| obsessive-compulsive disorder	GCST006576	anorexia nervosa|| obsessive-compulsive disorder	
Anti-thyroid drug induced agranulocytosis	drug-induced agranulocytosis|| response to anti-thyroid drug	GCST003527	drug-induced agranulocytosis|| response to anti-thyroid drug	
Antiepileptic drug-induced maculopapular exanthema	maculopapular eruption|| response to anticonvulsant	GCST005197	maculopapular eruption|| response to anticonvulsant	
Antipsychotic drug-induced weight gain (time interaction)	longitudinal BMI measurement|| antipsychotic drug related weight gain	GCST003108	longitudinal BMI measurement|| antipsychotic drug related weight gain	
Antithyroid drug-induced agranulocytosis	drug-induced agranulocytosis|| response to thioamide	GCST003580	drug-induced agranulocytosis|| response to thioamide	
Anxiety and major depressive disorder	unipolar depression|| anxiety	GCST002200	unipolar depression|| anxiety	
Asthma (sex interaction)	sex interaction measurement|| asthma	GCST002445	sex interaction measurement|| asthma	
Asthma and hay fever	seasonal allergic rhinitis|| asthma	GCST002322	seasonal allergic rhinitis|| asthma	
Asthma or atopy (farm exposure interaction)	farm exposure measurement|| asthma	GCST000934	farm exposure measurement|| asthma	
Asthma or chronic obstructive pulmonary disease	chronic obstructive pulmonary disease|| asthma	GCST002519	chronic obstructive pulmonary disease|| asthma	
Asymmetrical dimethylarginine levels	asymmetrical dimethylarginine measurement|| serum dimethylarginine measurement	GCST002241	asymmetrical dimethylarginine measurement|| serum dimethylarginine measurement	
Atopic march	childhood onset asthma|| atopic eczema|| atopic march	GCST003180	childhood onset asthma|| atopic eczema|| atopic march	
Attention deficit hyperactivity disorder (sex interaction)	attention deficit hyperactivity disorder|| sex interaction measurement	GCST005361	attention deficit hyperactivity disorder|| sex interaction measurement	
Attention deficit hyperactivity disorder and conduct disorder	attention deficit hyperactivity disorder|| conduct disorder	GCST000253	attention deficit hyperactivity disorder|| conduct disorder	
Attention deficit hyperactivity disorder and obsessive compulsive disorder	obsessive-compulsive disorder|| attention deficit hyperactivity disorder	GCST004223	obsessive-compulsive disorder|| attention deficit hyperactivity disorder	
Attention deficit hyperactivity disorder or educational attainment (years of education) (pleiotropy)	attention deficit hyperactivity disorder|| self reported educational attainment	GCST006216	attention deficit hyperactivity disorder|| self reported educational attainment	
Attention deficit hyperactivity disorder symptoms (maternal expressed emotions interaction)	attention deficit hyperactivity disorder|| parental emotion expression measurmement	GCST000247	attention deficit hyperactivity disorder|| parental emotion expression measurmement	
Autism spectrum disorder or schizophrenia	schizophrenia|| autism spectrum disorder	GCST004521	schizophrenia|| autism spectrum disorder	
Autism spectrum disorder-related traits	autism spectrum disorder|| autism|| autism spectrum disorder symptom	GCST002639	autism spectrum disorder|| autism|| autism spectrum disorder symptom	
"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)"	attention deficit hyperactivity disorder|| unipolar depression|| schizophrenia|| autism spectrum disorder|| bipolar disorder	GCST001877	attention deficit hyperactivity disorder|| unipolar depression|| schizophrenia|| autism spectrum disorder|| bipolar disorder	
Autoimmune thyroid diseases (Graves disease or Hashimoto's thyroiditis)	autoimmune thyroid disease|| Hashimoto's thyroiditis|| Graves disease	GCST005524	autoimmune thyroid disease|| Hashimoto's thyroiditis|| Graves disease	
Axial length or spherical error (univariate decomposition analysis)	axial length measurement|| refractive error measurement	GCST006864	axial length measurement|| refractive error measurement	
"B-cell malignancies (chronic lymphocytic leukemia, Hodgkin lymphoma or multiple myeloma) (pleiotropy)"	Hodgkins lymphoma|| multiple myeloma|| chronic lymphocytic leukemia	GCST004099	Hodgkins lymphoma|| multiple myeloma|| chronic lymphocytic leukemia	
Barrett's esophagus  or Esophageal adenocarcinoma	esophageal adenocarcinoma|| Barrett's esophagus	GCST003740	esophageal adenocarcinoma|| Barrett's esophagus	
Barrett's esophagus x BMI interaction	Barrett's esophagus|| body mass index	GCST006529	Barrett's esophagus|| body mass index	
Barrett's esophagus x gastroesophageal reflux disease interaction	Barrett's esophagus|| gastroesophageal reflux disease	GCST006526	Barrett's esophagus|| gastroesophageal reflux disease	
Barrett's esophagus x pack-years of smoking exposure interaction	pack-years measurement|| Barrett's esophagus	GCST006528	pack-years measurement|| Barrett's esophagus	
Barrett's esophagus x smoking interaction	smoking status measurement|| Barrett's esophagus	GCST006527	smoking status measurement|| Barrett's esophagus	
Behavioral disturbance or psychiatric symptoms and prion disease	behavioral abnormality|| prion disease	GCST002866	behavioral abnormality|| prion disease	
Behavioural disinhibition (generation interaction)	nicotine use|| generational effect measurement|| illegal drug consumption|| non-substance related disinhibited behaviour|| alcohol drinking|| alcohol dependence	GCST002131	nicotine use|| generational effect measurement|| illegal drug consumption|| non-substance related disinhibited behaviour|| alcohol drinking|| alcohol dependence	
Benign prostatic hyperplasia and/or lower urinary tract symptoms	lower urinary tract symptom|| benign prostatic hyperplasia	GCST004638	lower urinary tract symptom|| benign prostatic hyperplasia	
Binge eating behaviour and bipolar disorder	binge eating|| bipolar disorder	GCST005386	binge eating|| bipolar disorder	
Binge eating behaviour and bipolar disorder	binge eating|| bipolar disorder	GCST002419	binge eating|| bipolar disorder	
Biochemical measures	serum albumin measurement|| total cholesterol measurement|| triglyceride measurement|| low density lipoprotein cholesterol measurement|| fibrinogen measurement|| uric acid measurement|| high density lipoprotein cholesterol measurement	GCST000328	serum albumin measurement|| total cholesterol measurement|| triglyceride measurement|| low density lipoprotein cholesterol measurement|| fibrinogen measurement|| uric acid measurement|| high density lipoprotein cholesterol measurement	
Biomedical quantitative traits	diastolic blood pressure|| systolic blood pressure|| bone density|| heart rate|| waist-hip ratio|| body mass index	GCST000381	diastolic blood pressure|| systolic blood pressure|| bone density|| heart rate|| waist-hip ratio|| body mass index	
Bipolar disorder (body mass index interaction)	bipolar disorder|| body mass index	GCST002306	bipolar disorder|| body mass index	
Bipolar disorder (inflammation and infection response interaction)	HSV1 seropositivity|| bipolar disorder|| cytomegalovirus seropositivity	GCST002815	HSV1 seropositivity|| bipolar disorder|| cytomegalovirus seropositivity	
Bipolar disorder and eating disorder	eating disorder|| bipolar disorder	GCST003135	eating disorder|| bipolar disorder	
Bipolar disorder and schizophrenia	schizophrenia|| bipolar disorder	GCST001567	schizophrenia|| bipolar disorder	
Bipolar disorder lithium response (categorical) or schizophrenia	schizophrenia|| bipolar disorder|| response to lithium ion	GCST005082	schizophrenia|| bipolar disorder|| response to lithium ion	
Bipolar disorder lithium response (continuous) or schizophrenia	schizophrenia|| bipolar disorder|| response to lithium ion	GCST005081	schizophrenia|| bipolar disorder|| response to lithium ion	
Bipolar disorder or attention deficit hyperactivity disorder	attention deficit hyperactivity disorder|| bipolar disorder	GCST004001	attention deficit hyperactivity disorder|| bipolar disorder	
Bipolar disorder or major depressive disorder	unipolar depression|| bipolar disorder	GCST000641	unipolar depression|| bipolar disorder	
Blood metabolite levels	urate measurement|| mannose measurement|| blood metabolite measurement|| X12063 measurement	GCST002872	urate measurement|| mannose measurement|| blood metabolite measurement|| X12063 measurement	
Blood pressure	diastolic blood pressure|| systolic blood pressure	GCST004705	diastolic blood pressure|| systolic blood pressure	
Blood pressure (age interaction)	blood pressure|| age at assessment	GCST002495	blood pressure|| age at assessment	
Blood pressure (anthropometric measures interaction)	anthropometric measurement|| diastolic blood pressure|| systolic blood pressure	GCST002471	anthropometric measurement|| diastolic blood pressure|| systolic blood pressure	
Blood pressure (response to antihypertensive medication)	blood pressure|| response to antihypertensive drug	GCST002262	blood pressure|| response to antihypertensive drug	
Blood pressure (smoking interaction)	pack-years measurement|| smoking behavior|| smoking status measurement|| diastolic blood pressure|| systolic blood pressure|| blood pressure|| smoking behaviour measurement|| cigarettes per day measurement	GCST002587	pack-years measurement|| smoking behavior|| smoking status measurement|| diastolic blood pressure|| systolic blood pressure|| blood pressure|| smoking behaviour measurement|| cigarettes per day measurement	
Blood pressure measurement (cold pressor test)	blood pressure|| response to cold pressor test	GCST002247	blood pressure|| response to cold pressor test	
Blood pressure measurement (high sodium and potassium intervention)	blood pressure|| response to high sodium diet|| response to dietary potassium supplementation	GCST002252	blood pressure|| response to high sodium diet|| response to dietary potassium supplementation	
Blood pressure measurement (high sodium intervention)	blood pressure|| response to high sodium diet	GCST002249	blood pressure|| response to high sodium diet	
Blood pressure measurement (low sodium intervention)	blood pressure|| response to low sodium diet	GCST002250	blood pressure|| response to low sodium diet	
Blood pressure traits (multi-trait analysis)	pulse pressure measurement|| diastolic blood pressure|| systolic blood pressure|| hypertension	GCST004388	pulse pressure measurement|| diastolic blood pressure|| systolic blood pressure|| hypertension	
BMI (adjusted for smoking behaviour)	smoking behavior|| body mass index	GCST004495	smoking behavior|| body mass index	
BMI (smoking interaction)	smoking behavior|| body mass index	GCST004496	smoking behavior|| body mass index	
BMI x dairy intake interaction (1df interaction test)	energy intake|| body mass index	GCST006173	energy intake|| body mass index	
Body mass index	physical activity measurement|| body mass index	GCST004557	physical activity measurement|| body mass index	
Body mass index  (smoking years interaction)	smoking behaviour measurement|| body mass index	GCST004581	smoking behaviour measurement|| body mass index	
Body mass index (alcohol intake interaction)	alcohol consumption measurement|| body mass index	GCST001753	alcohol consumption measurement|| body mass index	
Body mass index (dietary energy interaction)	diet measurement|| body mass index	GCST004587	diet measurement|| body mass index	
Body mass index (ever vs never smoking interaction)	smoking behaviour measurement|| body mass index	GCST004586	smoking behaviour measurement|| body mass index	
Body mass index (joint analysis main effects and physical activity interaction)	physical activity measurement|| body mass index	GCST004558	physical activity measurement|| body mass index	
Body mass index (joint analysis main effects and smoking interaction)	smoking behavior|| body mass index	GCST004497	smoking behavior|| body mass index	
Body mass index (physical activity interaction)	physical activity measurement|| body mass index	GCST004568	physical activity measurement|| body mass index	
Body mass index (recreational physical activity interaction)	physical activity measurement|| body mass index	GCST004580	physical activity measurement|| body mass index	
Body mass index (sex interaction)	sex interaction measurement|| body mass index	GCST000930	sex interaction measurement|| body mass index	
Body mass index and cholesterol (psychopharmacological treatment)	total cholesterol measurement|| response to drug|| body mass index	GCST001440	total cholesterol measurement|| response to drug|| body mass index	
Body mass index and fat mass	adipose tissue measurement|| body mass index	GCST000443	adipose tissue measurement|| body mass index	
Body mass index and waist-hip ratio (pleiotropy)	waist-hip ratio|| body mass index	GCST006430	waist-hip ratio|| body mass index	
Body mass index x age interaction	body mass index|| age at assessment	GCST005954	body mass index|| age at assessment	
Body mass index x sex interaction	sex interaction measurement|| body mass index	GCST005949	sex interaction measurement|| body mass index	
Body mass index x sex x age interaction	sex interaction measurement|| body mass index|| age at assessment	GCST005955	sex interaction measurement|| body mass index|| age at assessment	
Body mass index x sex x age interaction (4df test)	sex interaction measurement|| body mass index|| age at assessment	GCST005950	sex interaction measurement|| body mass index|| age at assessment	
Bone mineral density (hip) and age at menarche	hip bone mineral density|| age at menarche	GCST003102	hip bone mineral density|| age at menarche	
Bone mineral density (sex interaction)	sex interaction measurement|| bone density	GCST001566	sex interaction measurement|| bone density	
Bone mineral density (spine) and age at menarche	age at menarche|| spine bone mineral density	GCST003101	age at menarche|| spine bone mineral density	
Brain structure (hippocampal volume)	brain measurement|| hippocampal volume	GCST000615	brain measurement|| hippocampal volume	
Breast cancer (menopausal hormone therapy interaction)	breast carcinoma|| hormone replacement therapy	GCST002265	breast carcinoma|| hormone replacement therapy	
Breast cancer (menopausal hormone therapy interaction)	breast carcinoma|| hormone replacement therapy	GCST001869	breast carcinoma|| hormone replacement therapy	
Breast cancer and/or colorectal cancer	colorectal cancer|| breast carcinoma	GCST006035	colorectal cancer|| breast carcinoma	
Breast milk fatty acid composition (infant genotype effect)	fatty acid measurement|| fetal genotype effect measurement|| breast milk measurement	GCST005587	fatty acid measurement|| fetal genotype effect measurement|| breast milk measurement	
Breast milk fatty acid composition (maternal genotype effect)	fatty acid measurement|| breast milk measurement|| parental genotype effect measurement	GCST005586	fatty acid measurement|| breast milk measurement|| parental genotype effect measurement	
Burning and freckling	freckles|| sunburn	GCST000196	freckles|| sunburn	
C-reactive protein (red blood cell fatty acid level interaction)	fatty acid measurement|| C-reactive protein measurement	GCST004815	fatty acid measurement|| C-reactive protein measurement	
C-reactive protein and white blood cell count	leukocyte count|| C-reactive protein measurement	GCST001605	leukocyte count|| C-reactive protein measurement	
C-reactive protein levels or HDL-cholesterol levels (pleiotropy)	C-reactive protein measurement|| high density lipoprotein cholesterol measurement	GCST003680	C-reactive protein measurement|| high density lipoprotein cholesterol measurement	
C-reactive protein levels or LDL-cholesterol levels (pleiotropy)	low density lipoprotein cholesterol measurement|| C-reactive protein measurement	GCST003679	low density lipoprotein cholesterol measurement|| C-reactive protein measurement	
C-reactive protein levels or total cholesterol levels (pleiotropy)	total cholesterol measurement|| C-reactive protein measurement	GCST003678	total cholesterol measurement|| C-reactive protein measurement	
C-reactive protein levels or triglyceride levels (pleiotropy)	triglyceride measurement|| C-reactive protein measurement	GCST003681	triglyceride measurement|| C-reactive protein measurement	
Calcific aortic valve stenosis	aortic stenosis|| aortic valve calcification	GCST005785	aortic stenosis|| aortic valve calcification	
Cancer	cancer|| lung carcinoma|| estrogen-receptor negative breast cancer|| colorectal cancer|| ovarian endometrioid carcinoma|| prostate carcinoma|| ovarian serous carcinoma|| breast carcinoma|| ovarian carcinoma|| lung adenocarcinoma|| squamous cell lung carcinoma	GCST003587	cancer|| lung carcinoma|| estrogen-receptor negative breast cancer|| colorectal cancer|| ovarian endometrioid carcinoma|| prostate carcinoma|| ovarian serous carcinoma|| breast carcinoma|| ovarian carcinoma|| lung adenocarcinoma|| squamous cell lung carcinoma	
Cancer (pleiotropy)	cancer|| lung carcinoma|| estrogen-receptor negative breast cancer|| colorectal cancer|| ovarian endometrioid carcinoma|| prostate carcinoma|| ovarian serous carcinoma|| breast carcinoma|| ovarian carcinoma|| lung adenocarcinoma|| squamous cell lung carcinoma	GCST003588	cancer|| lung carcinoma|| estrogen-receptor negative breast cancer|| colorectal cancer|| ovarian endometrioid carcinoma|| prostate carcinoma|| ovarian serous carcinoma|| breast carcinoma|| ovarian carcinoma|| lung adenocarcinoma|| squamous cell lung carcinoma	
Carbamazepine-induced maculopapular exanthema	maculopapular eruption|| response to carbamazepine	GCST005198	maculopapular eruption|| response to carbamazepine	
Cardiac muscle measurement	cardiovascular measurement|| left ventricular hypertrophy	GCST000936	cardiovascular measurement|| left ventricular hypertrophy	
Cardiovascular disease risk factors	aspartate aminotransferase measurement|| butyrylcholinesterase measurement|| triglyceride measurement|| ferritin measurement|| serum gamma-glutamyl transferase measurement|| low density lipoprotein cholesterol measurement|| C-reactive protein measurement|| uric acid measurement|| high density lipoprotein cholesterol measurement	GCST001247	aspartate aminotransferase measurement|| butyrylcholinesterase measurement|| triglyceride measurement|| ferritin measurement|| serum gamma-glutamyl transferase measurement|| low density lipoprotein cholesterol measurement|| C-reactive protein measurement|| uric acid measurement|| high density lipoprotein cholesterol measurement	
Cardiovascular risk factors	waist circumference|| triglyceride measurement|| low density lipoprotein cholesterol measurement|| cardiovascular disease|| high density lipoprotein cholesterol measurement	GCST004704	waist circumference|| triglyceride measurement|| low density lipoprotein cholesterol measurement|| cardiovascular disease|| high density lipoprotein cholesterol measurement	
Cardiovascular risk factors (age interaction)	waist circumference|| triglyceride measurement|| low density lipoprotein cholesterol measurement|| cardiovascular disease|| high density lipoprotein cholesterol measurement|| age at assessment	GCST000789	waist circumference|| triglyceride measurement|| low density lipoprotein cholesterol measurement|| cardiovascular disease|| high density lipoprotein cholesterol measurement|| age at assessment	
Carotenoid and tocopherol levels	carotenoid measurement|| tocopherol measurement	GCST000324	carotenoid measurement|| tocopherol measurement	
Carotid artery intima media thickness (sex interaction)	sex interaction measurement|| carotid artery intima media thickness	GCST002856	sex interaction measurement|| carotid artery intima media thickness	
Carotid plaque burden (smoking interaction)	smoking behaviour measurement|| carotid plaque build	GCST002482	smoking behaviour measurement|| carotid plaque build	
Caudate activity during disappointment	caudate nucleus measurement|| response to disappointment|| functional brain measurement	GCST004969	caudate nucleus measurement|| response to disappointment|| functional brain measurement	
Caudate activity during reward	caudate nucleus measurement|| functional brain measurement|| response to reward	GCST004970	caudate nucleus measurement|| functional brain measurement|| response to reward	
Cellular adhesion molecule (red blood cell fatty acid level interaction)	fatty acid measurement|| cellular adhesion molecule measurement	GCST004820	fatty acid measurement|| cellular adhesion molecule measurement	
Cerebrospinal fluid AB1-42 levels	beta-amyloid 1-42 measurement|| cerebrospinal fluid biomarker measurement	GCST003072	beta-amyloid 1-42 measurement|| cerebrospinal fluid biomarker measurement	
Cerebrospinal fluid levels of Alzheimer's disease-related proteins	matrix metalloproteinase measurement|| angiotensin-converting enzyme measurement|| Alzheimer's disease|| CCL4 measurement|| interleukin-6 measurement|| Alzheimer's disease biomarker measurement|| CCL2 measurement	GCST002665	matrix metalloproteinase measurement|| angiotensin-converting enzyme measurement|| Alzheimer's disease|| CCL4 measurement|| interleukin-6 measurement|| Alzheimer's disease biomarker measurement|| CCL2 measurement	
Cerebrospinal fluid α-synuclein levels	cerebrospinal fluid biomarker measurement|| alpha synuclein measurement	GCST006279	cerebrospinal fluid biomarker measurement|| alpha synuclein measurement	
Cerebrospinal P-tau181p levels	p-tau measurement|| cerebrospinal fluid biomarker measurement	GCST003071	p-tau measurement|| cerebrospinal fluid biomarker measurement	
Cerebrospinal T-tau levels	cerebrospinal fluid biomarker measurement|| t-tau measurement	GCST003070	cerebrospinal fluid biomarker measurement|| t-tau measurement	
Cerivastatin-induced rhabdomyolysis	response to statin|| rhabdomyolysis	GCST001002	response to statin|| rhabdomyolysis	
Childhood onset asthma (traffic air pollution exposure interaction)	childhood onset asthma|| traffic air pollution measurement	GCST003975	childhood onset asthma|| traffic air pollution measurement	
Childhood onset systemic lupus erythematosus	age at onset|| systemic lupus erythematosus	GCST006260	age at onset|| systemic lupus erythematosus	
Cholesterol and Triglycerides	triglyceride measurement|| high density lipoprotein cholesterol measurement	GCST001704	triglyceride measurement|| high density lipoprotein cholesterol measurement	
Chronic alcoholic pancreatitis or alcohol-related cirrhosis	alcoholic liver cirrhosis|| alcoholic pancreatitis	GCST004755	alcoholic liver cirrhosis|| alcoholic pancreatitis	
Chronic bronchitis and chronic obstructive pulmonary disease	chronic obstructive pulmonary disease|| chronic bronchitis	GCST002625	chronic obstructive pulmonary disease|| chronic bronchitis	
"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)"	ankylosing spondylitis|| psoriasis|| ulcerative colitis|| Crohn's disease|| sclerosing cholangitis	GCST005537	ankylosing spondylitis|| psoriasis|| ulcerative colitis|| Crohn's disease|| sclerosing cholangitis	
Chronic kidney disease	cystatin C measurement|| chronic kidney disease|| serum creatinine measurement	GCST000649	cystatin C measurement|| chronic kidney disease|| serum creatinine measurement	
Chronic kidney disease and serum creatinine levels	chronic kidney disease|| serum creatinine measurement	GCST000742	chronic kidney disease|| serum creatinine measurement	
Chronic obstructive pulmonary disease-related biomarkers	tumor necrosis factor-alpha measurement|| interleukin-6 measurement|| chronic obstructive pulmonary disease|| interleukin-8 measurement|| fibrinogen measurement|| C-reactive protein measurement|| CC16 measurement|| surfactant protein D measurement	GCST001737	tumor necrosis factor-alpha measurement|| interleukin-6 measurement|| chronic obstructive pulmonary disease|| interleukin-8 measurement|| fibrinogen measurement|| C-reactive protein measurement|| CC16 measurement|| surfactant protein D measurement	
Chronic venous disease	chronic venous insufficiency|| Varicose veins	GCST004343	chronic venous insufficiency|| Varicose veins	
Chylomicron and largest VLDL particle concentration	chylomicron measurement|| very low density lipoprotein cholesterol measurement	GCST005510	chylomicron measurement|| very low density lipoprotein cholesterol measurement	
Cingulate cortical amyloid beta load	amyloid-beta measurement|| cingulate cortex measurement	GCST003113	amyloid-beta measurement|| cingulate cortex measurement	
Circulating chromogranin peptide levels	CHGB cleavage product measurement|| CHGA cleavage product measurement	GCST004038	CHGB cleavage product measurement|| CHGA cleavage product measurement	
Cisplatin-induced ototoxicity	ototoxicity|| response to cisplatin	GCST003898	ototoxicity|| response to cisplatin	
Cleft lip with or without cleft palate	cleft palate|| cleft lip	GCST004050	cleft palate|| cleft lip	
Cleft lip with or without cleft palate (maternal periconceptional alcohol intake interaction)	cleft lip|| alcohol exposure measurement	GCST005653	cleft lip|| alcohol exposure measurement	
Cleft lip with or without cleft palate (maternal periconceptional cigarette smoking interaction)	tobacco smoke exposure measurement|| cleft lip	GCST005654	tobacco smoke exposure measurement|| cleft lip	
Cleft lip with or without cleft palate (maternal periconceptional vitamin use interaction)	vitamin supplement exposure measurement|| cleft lip	GCST005652	vitamin supplement exposure measurement|| cleft lip	
Cleft plate (environmental tobacco smoke interaction)	cleft palate|| environmental tobacco smoke exposure measurement	GCST002348	cleft palate|| environmental tobacco smoke exposure measurement	
Clinical laboratory measurements	alkaline phosphatase measurement|| calcium measurement|| hemoglobin measurement|| clinical laboratory measurement|| mean corpuscular hemoglobin|| glucose measurement|| erythrocyte measurement|| bilirubin measurement	GCST003540	alkaline phosphatase measurement|| calcium measurement|| hemoglobin measurement|| clinical laboratory measurement|| mean corpuscular hemoglobin|| glucose measurement|| erythrocyte measurement|| bilirubin measurement	
Clozapine-induced agranulocytosis	drug-induced agranulocytosis|| response to clozapine	GCST002595	drug-induced agranulocytosis|| response to clozapine	
Clozapine-induced cytotoxicity	cytotoxicity measurement|| response to clozapine	GCST002777	cytotoxicity measurement|| response to clozapine	
Cluster headache	smoking status measurement|| cluster headache	GCST003900	smoking status measurement|| cluster headache	
Coffee consumption	coffee consumption|| cups of coffee per day measurement	GCST003621	coffee consumption|| cups of coffee per day measurement	
Coffee consumption (cups per day)	coffee consumption|| cups of coffee per day measurement	GCST002650	coffee consumption|| cups of coffee per day measurement	
Cognitive ability (MTAG)	intelligence|| self reported educational attainment	GCST005141	intelligence|| self reported educational attainment	
Cognitive impairment (brain beta-amyloid deposition interaction)	cognitive impairment|| cerebral amyloid deposition measurement	GCST003399	cognitive impairment|| cerebral amyloid deposition measurement	
Cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) with severe mucosal involvement	Stevens-Johnson syndrome|| toxic epidermal necrolysis|| response to cold medicine	GCST002779	Stevens-Johnson syndrome|| toxic epidermal necrolysis|| response to cold medicine	
Cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) with severe ocular complications	Stevens-Johnson syndrome|| toxic epidermal necrolysis|| response to cold medicine	GCST004072	Stevens-Johnson syndrome|| toxic epidermal necrolysis|| response to cold medicine	
Colorectal cancer (alcohol consumption interaction)	colorectal cancer|| alcohol consumption measurement	GCST003873	colorectal cancer|| alcohol consumption measurement	
Colorectal cancer (aspirin and/or NSAID use interaction)	drug use measurement|| aspirin use measurement|| NSAID use measurement|| colorectal cancer	GCST002816	drug use measurement|| aspirin use measurement|| NSAID use measurement|| colorectal cancer	
Colorectal cancer (calcium intake interaction)	calcium intake measurement|| colorectal cancer	GCST002596	calcium intake measurement|| colorectal cancer	
Colorectal cancer (diet interaction)	colorectal cancer|| diet measurement	GCST002415	colorectal cancer|| diet measurement	
Colorectal cancer (environment interaction)	smoking status measurement|| colorectal cancer|| alcohol consumption measurement|| overweight body mass index status	GCST001731	smoking status measurement|| colorectal cancer|| alcohol consumption measurement|| overweight body mass index status	
Colorectal cancer (menopausal hormone therapy interaction)	colorectal cancer|| hormone replacement therapy	GCST003385	colorectal cancer|| hormone replacement therapy	
Colorectal cancer (oestrogen hormone therapy interaction)	colorectal cancer|| hormone replacement therapy	GCST003387	colorectal cancer|| hormone replacement therapy	
Colorectal cancer (oestrogen-progestogen hormone therapy interaction)	colorectal cancer|| hormone replacement therapy	GCST003386	colorectal cancer|| hormone replacement therapy	
Colorectal cancer (smoking interaction)	smoking status measurement|| colorectal cancer	GCST003874	smoking status measurement|| colorectal cancer	
Colorectal or endometrial cancer	colorectal cancer|| endometrial neoplasm	GCST003209	colorectal cancer|| endometrial neoplasm	
Colorectal or endometrial cancer	colorectal cancer|| endometrial neoplasm	GCST003208	colorectal cancer|| endometrial neoplasm	
Common traits (Other)	sensory perception of taste|| functional laterality|| hair morphology|| circadian rhythm|| personality|| braces|| sensory perception of smell|| Attached earlobe|| Astigmatism|| Sneeze	GCST000706	sensory perception of taste|| functional laterality|| hair morphology|| circadian rhythm|| personality|| braces|| sensory perception of smell|| Attached earlobe|| Astigmatism|| Sneeze	
Complement C3 and C4 levels	complement C4 measurement|| complement C3 measurement	GCST001679	complement C4 measurement|| complement C3 measurement	
Comprehensive strength and appendicular lean mass	comprehensive strength index|| muscle measurement	GCST001656	comprehensive strength index|| muscle measurement	
Conduct disorder (maternal expressed emotions interaction)	parental emotion expression measurmement|| conduct disorder	GCST000245	parental emotion expression measurmement|| conduct disorder	
Congenital left-sided heart lesions (maternal effect)	congenital left-sided heart lesions|| parental genotype effect measurement	GCST002574	congenital left-sided heart lesions|| parental genotype effect measurement	
Coronary artery calcification (smoking interaction)	smoking status measurement|| coronary artery calcification	GCST002213	smoking status measurement|| coronary artery calcification	
Coronary artery disease and/or body mass index (pleiotropy)	body mass index|| coronary artery disease	GCST004838	body mass index|| coronary artery disease	
Coronary artery disease or ischemic stroke	stroke|| coronary heart disease	GCST002287	stroke|| coronary heart disease	
Coronary artery disease or large artery stroke	large artery stroke|| coronary heart disease	GCST002290	large artery stroke|| coronary heart disease	
Coronary artery disease-related phenotypes	coronary heart disease|| angiographic measurement	GCST002659	coronary heart disease|| angiographic measurement	
Coronary atherosclerosis (increased number of diseased vessels) (traffic exposure interaction)	coronary atheroscleroris measurement|| traffic air pollution measurement	GCST004224	coronary atheroscleroris measurement|| traffic air pollution measurement	
Coronary heart disease event reduction (statin therapy interaction)	response to statin|| coronary heart disease	GCST001545	response to statin|| coronary heart disease	
Coronary heart disease events during statin therapy	response to statin|| cardiovascular event measurement	GCST006217	response to statin|| cardiovascular event measurement	
Corrected insulin response adjusted for insulin sensitivity index	insulin sensitivity measurement|| insulin response measurement	GCST005216	insulin sensitivity measurement|| insulin response measurement	
Corticobasal degeneration and immune-mediated diseases (pleiotropy)	Corticobasal degeneration|| rheumatoid arthritis|| type I diabetes mellitus|| psoriasis|| celiac disease|| ulcerative colitis|| Crohn's disease	GCST005322	Corticobasal degeneration|| rheumatoid arthritis|| type I diabetes mellitus|| psoriasis|| celiac disease|| ulcerative colitis|| Crohn's disease	
Corticosteroid-induced adrenal suppression (peak cortisol < 350 nmol/L)	adrenal suppression measurement|| response to corticosteroid	GCST005927	adrenal suppression measurement|| response to corticosteroid	
Corticosteroid-induced adrenal suppression (peak cortisol < 500 nmol/L)	adrenal suppression measurement|| response to corticosteroid	GCST005924	adrenal suppression measurement|| response to corticosteroid	
Crohn's disease and celiac disease	celiac disease|| Crohn's disease	GCST000955	celiac disease|| Crohn's disease	
Crohn's disease and psoriasis	psoriasis|| Crohn's disease	GCST001473	psoriasis|| Crohn's disease	
Crohn's disease and sarcoidosis (combined)	Sarcoidosis|| Crohn's disease	GCST000212	Sarcoidosis|| Crohn's disease	
Crohn's disease-related phenotypes	stricture|| ileocolitis|| erythema nodosum|| perianal Crohn's disease|| Crohn's disease|| mild disease course|| complicated disease course	GCST002729	stricture|| ileocolitis|| erythema nodosum|| perianal Crohn's disease|| Crohn's disease|| mild disease course|| complicated disease course	
Cutaneous psoriasis	cutaneous psoriasis measurement|| psoriasis	GCST003269	cutaneous psoriasis measurement|| psoriasis	
Cystic fibrosis-related diabetes	Cystic fibrosis|| type II diabetes mellitus	GCST002025	Cystic fibrosis|| type II diabetes mellitus	
Cytokine and corticosteroid-stimulated IL-6 production	interleukin-6 measurement|| response to corticosteroid|| response to cytokine	GCST002858	interleukin-6 measurement|| response to corticosteroid|| response to cytokine	
Cytokine-stimulated IL-6 production	interleukin-6 measurement|| response to cytokine	GCST002859	interleukin-6 measurement|| response to cytokine	
Delta-5 desaturase activity response to n3-polyunsaturated fat supplement	delta-5 desaturase measurement|| response to polyunsaturated fatty acid supplementation	GCST005668	delta-5 desaturase measurement|| response to polyunsaturated fatty acid supplementation	
Delta-6 desaturase activity response to n3-polyunsaturated fat supplement	delta-6 desaturase measurement|| response to polyunsaturated fatty acid supplementation	GCST005669	delta-6 desaturase measurement|| response to polyunsaturated fatty acid supplementation	
Dementia and core Alzheimer's disease neuropathologic changes	dementia|| Alzheimer's disease neuropathologic change	GCST002593	dementia|| Alzheimer's disease neuropathologic change	
Depressed affect	unipolar depression|| mood disorder	GCST006475	unipolar depression|| mood disorder	
Depression	unipolar depression|| depressive symptom measurement	GCST003769	unipolar depression|| depressive symptom measurement	
Depressive symptom measurement or major depressive disorder	unipolar depression|| depressive symptom measurement	GCST004024	unipolar depression|| depressive symptom measurement	
Depressive symptoms (SSRI exposure interaction)	drug use measurement|| depressive symptom measurement|| SSRI use measurement	GCST002755	drug use measurement|| depressive symptom measurement|| SSRI use measurement	
Depressive symptoms (stressful life events interaction)	depressive symptom measurement|| stressful life event measurement	GCST003835	depressive symptom measurement|| stressful life event measurement	
Dermatomyositis or juvenile dermatomyositis	dermatomyositis|| juvenile dermatomyositis	GCST006053	dermatomyositis|| juvenile dermatomyositis	
Developmental language disorder (linguistic errors)	linguistic error measurement|| specific language impairment	GCST003397	linguistic error measurement|| specific language impairment	
Developmental language disorder (syntactic complexity)	syntactic complexity measurement|| specific language impairment	GCST003398	syntactic complexity measurement|| specific language impairment	
Diabetes related insulin traits	insulin sensitivity measurement|| A1C measurement|| insulin resistance|| fasting blood insulin measurement	GCST000077	insulin sensitivity measurement|| A1C measurement|| insulin resistance|| fasting blood insulin measurement	
Diastolic blood pressure (alcohol consumption interaction)	diastolic blood pressure|| alcohol drinking	GCST002309	diastolic blood pressure|| alcohol drinking	
Diastolic blood pressure (cigarette smoking interaction)	smoking status measurement|| diastolic blood pressure	GCST006187	smoking status measurement|| diastolic blood pressure	
Diastolic blood pressure (cigarette smoking interaction)	diastolic blood pressure|| smoking behaviour measurement	GCST003366	diastolic blood pressure|| smoking behaviour measurement	
Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test)	diastolic blood pressure|| alcohol consumption measurement	GCST006169	diastolic blood pressure|| alcohol consumption measurement	
Diastolic blood pressure x alcohol consumption interaction (2df test)	diastolic blood pressure|| alcohol drinking	GCST006166	diastolic blood pressure|| alcohol drinking	
Diastolic blood pressure x smoking status (current vs non-current) interaction (1df test)	smoking status measurement|| diastolic blood pressure	GCST006194	smoking status measurement|| diastolic blood pressure	
Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test)	smoking status measurement|| diastolic blood pressure	GCST006193	smoking status measurement|| diastolic blood pressure	
Diastolic blood pressure x smoking status (ever vs never) interaction (1df test)	smoking status measurement|| diastolic blood pressure	GCST006191	smoking status measurement|| diastolic blood pressure	
Diastolic blood pressure x smoking status (ever vs never) interaction (2df test)	smoking status measurement|| diastolic blood pressure	GCST006190	smoking status measurement|| diastolic blood pressure	
Diastolic blood pressure x sodium interaction (1df test)	sodium measurement|| diastolic blood pressure	GCST006112	sodium measurement|| diastolic blood pressure	
Diastolic blood pressure x sodium interaction (2df test)	sodium measurement|| diastolic blood pressure	GCST006111	sodium measurement|| diastolic blood pressure	
Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined)	esophageal adenocarcinoma|| digestive system disease|| Barrett's esophagus	GCST002231	esophageal adenocarcinoma|| digestive system disease|| Barrett's esophagus	
Diisocyanate-induced asthma	response to diisocyanate|| asthma	GCST002875	response to diisocyanate|| asthma	
Drug-induced liver injury	response to flupirtine|| drug-induced liver injury	GCST003426	response to flupirtine|| drug-induced liver injury	
Drug-induced liver injury (anti-tuberculosis drugs)	response to anti-tuberculosis drug|| drug-induced liver injury	GCST004084	response to anti-tuberculosis drug|| drug-induced liver injury	
Drug-induced liver injury (diclofenac)	response to diclofenac|| drug-induced liver injury	GCST004083	response to diclofenac|| drug-induced liver injury	
Drug-induced liver injury (fluoroquinolones)	response to fluoroquinolones|| drug-induced liver injury	GCST004085	response to fluoroquinolones|| drug-induced liver injury	
Drug-induced liver injury (nitrofurantoin)	response to nitrofurantoin|| drug-induced liver injury	GCST004082	response to nitrofurantoin|| drug-induced liver injury	
Drug-induced liver injury (nonsteroidal anti-inflammatory drugs)	response to non-steroidal anti-inflammatory|| drug-induced liver injury	GCST004087	response to non-steroidal anti-inflammatory|| drug-induced liver injury	
Drug-induced liver injury (statins)	response to statin|| drug-induced liver injury	GCST004080	response to statin|| drug-induced liver injury	
Drug-induced liver injury (terbinafine)	drug-induced liver injury|| response to terbinafine	GCST004078	drug-induced liver injury|| response to terbinafine	
Drug-induced Stevens-Johnson syndrome or toxic epidermal necrolysis (SJS/TEN)	Stevens-Johnson syndrome|| toxic epidermal necrolysis	GCST001181	Stevens-Johnson syndrome|| toxic epidermal necrolysis	
Drug-induced Stevens-Johnson syndrome or toxic epidermal necrolysis (SJS/TEN)	Stevens-Johnson syndrome|| toxic epidermal necrolysis	GCST000942	Stevens-Johnson syndrome|| toxic epidermal necrolysis	
Drug-induced torsades de pointes	torsades de pointes|| response to drug	GCST002269	torsades de pointes|| response to drug	
Early gestational weight gain (fetal effect)	early gestational weight gain|| fetal genotype effect measurement	GCST005032	early gestational weight gain|| fetal genotype effect measurement	
Echocardiographic traits	cardiovascular measurement|| left ventricular function|| left atrial function	GCST000110	cardiovascular measurement|| left ventricular function|| left atrial function	
Egg allergy (maternal genetic effects)	egg allergy measurement|| parental genotype effect measurement	GCST005728	egg allergy measurement|| parental genotype effect measurement	
Egg allergy (parent-of-origin effect)	egg allergy measurement|| parental genotype effect measurement	GCST005725	egg allergy measurement|| parental genotype effect measurement	
Electrocardiographic traits	QRS complex|| QRS duration|| electrocardiography|| PR interval|| heart rate|| QT interval	GCST000561	QRS complex|| QRS duration|| electrocardiography|| PR interval|| heart rate|| QT interval	
Electrodermal activity	skin conductance level|| skin conductance response frequency|| electrodermal activity measurement|| skin conductance response amplitude	GCST002706	skin conductance level|| skin conductance response frequency|| electrodermal activity measurement|| skin conductance response amplitude	
Electroencephalogram traits	theta wave measurement|| delta wave measurement|| alpha peak frequency measurement|| alpha wave measurement|| electroencephalogram measurement|| beta wave measurement	GCST002709	theta wave measurement|| delta wave measurement|| alpha peak frequency measurement|| alpha wave measurement|| electroencephalogram measurement|| beta wave measurement	
End stage renal disease x APOL1 genotype interaction	chronic kidney disease|| APOL1 risk genotype carrier status	GCST006813	chronic kidney disease|| APOL1 risk genotype carrier status	
End-stage coagulation	factor VIII measurement|| von Willebrand factor measurement|| coagulation factor measurement	GCST001798	factor VIII measurement|| von Willebrand factor measurement|| coagulation factor measurement	
Endometriosis or endometrial cancer (pleiotropy)	endometrial carcinoma|| endometriosis	GCST005906	endometrial carcinoma|| endometriosis	
Endothelial growth factor levels	endothelial growth factor measurement|| angiopoietin-2 receptor measurement|| angiopoietin-2 measurement|| hepatocyte growth factor measurement	GCST002731	endothelial growth factor measurement|| angiopoietin-2 receptor measurement|| angiopoietin-2 measurement|| hepatocyte growth factor measurement	
Entorhinal cortical thickness (Alzheimer's disease interaction)	Alzheimer's disease|| cortical thickness	GCST000889	Alzheimer's disease|| cortical thickness	
Entorhinal cortical volume (Alzheimer's disease interaction)	Alzheimer's disease|| entorhinal cortical volume	GCST000893	Alzheimer's disease|| entorhinal cortical volume	
Epilepsy (remission after treatment)	response to drug|| epilepsy	GCST002141	response to drug|| epilepsy	
Epilepsy and lamotrigine-induced maculopapular eruptions	response to lamotrigine|| maculopapular eruption|| epilepsy	GCST002949	response to lamotrigine|| maculopapular eruption|| epilepsy	
Epstein Barr virus nuclear antigen 1 IgG levels or multiple sclerosis	multiple sclerosis|| Epstein Barr virus nuclear antigen 1 IgG measurement	GCST003340	multiple sclerosis|| Epstein Barr virus nuclear antigen 1 IgG measurement	
Epstein-Barr virus immune response (EBNA-1)	antibody measurement|| Epstein-Barr virus infection	GCST001812	antibody measurement|| Epstein-Barr virus infection	
Erectile dysfunction and prostate cancer treatment	response to radiation|| prostate carcinoma|| erectile dysfunction	GCST001700	response to radiation|| prostate carcinoma|| erectile dysfunction	
Erectile dysfunction and prostate cancer treatment	response to radiation|| prostate carcinoma|| erectile dysfunction	GCST000824	response to radiation|| prostate carcinoma|| erectile dysfunction	
Esophageal adenocarcinoma x BMI interaction	esophageal adenocarcinoma|| body mass index	GCST006525	esophageal adenocarcinoma|| body mass index	
Esophageal adenocarcinoma x gastroesophageal reflux disease interaction	esophageal adenocarcinoma|| gastroesophageal reflux disease	GCST006531	esophageal adenocarcinoma|| gastroesophageal reflux disease	
Esophageal adenocarcinoma x pack-years of smoking exposure interaction	esophageal adenocarcinoma|| pack-years measurement	GCST006532	esophageal adenocarcinoma|| pack-years measurement	
Esophageal adenocarcinoma x smoking interaction	esophageal adenocarcinoma|| smoking status measurement	GCST006530	esophageal adenocarcinoma|| smoking status measurement	
Esophageal cancer (squamous cell)	squamous cell carcinoma|| esophageal carcinoma	GCST001674	squamous cell carcinoma|| esophageal carcinoma	
Esophageal cancer and gastric cancer	esophageal carcinoma|| gastric carcinoma	GCST000777	esophageal carcinoma|| gastric carcinoma	
Exhaled carbon monoxide levels	smoking behavior|| carbon monoxide exhalation measurement	GCST002584	smoking behavior|| carbon monoxide exhalation measurement	
"Facial morphology (factor 13, vertical position of alar curvature relative to upper lip)"	nose morphology measurement|| mouth morphology measurement	GCST004317	nose morphology measurement|| mouth morphology measurement	
Familial lung adenocarcinoma	lung adenocarcinoma|| family history of lung cancer	GCST006087	lung adenocarcinoma|| family history of lung cancer	
Familial lung cancer	lung carcinoma|| family history of lung cancer	GCST006086	lung carcinoma|| family history of lung cancer	
Familial squamous cell lung carcinoma	squamous cell lung carcinoma|| family history of lung cancer	GCST006088	squamous cell lung carcinoma|| family history of lung cancer	
Fast beta electroencephalogram	alcohol dependence measurement|| electroencephalogram measurement	GCST003902	alcohol dependence measurement|| electroencephalogram measurement	
Fasting blood glucose (BMI interaction)	body mass index|| fasting blood glucose measurement	GCST001527	body mass index|| fasting blood glucose measurement	
Fasting blood insulin (BMI interaction)	body mass index|| fasting blood insulin measurement	GCST001526	body mass index|| fasting blood insulin measurement	
Fasting insulin (dietary factor interaction)	diet measurement|| fasting blood insulin measurement	GCST002248	diet measurement|| fasting blood insulin measurement	
Femoral neck bone mineral density or breast cancer (pleiotropy)	breast carcinoma|| femoral neck bone mineral density	GCST004836	breast carcinoma|| femoral neck bone mineral density	
Femoral neck bone mineral density or plasma lipids (pleiotropy)	lipid measurement|| femoral neck bone mineral density	GCST005317	lipid measurement|| femoral neck bone mineral density	
Femoral neck bone mineral density or type 2 diabetes (pleiotropy)	type II diabetes mellitus|| femoral neck bone mineral density	GCST006861	type II diabetes mellitus|| femoral neck bone mineral density	
"Fibrinogen levels (smoking status, alcohol consumption or body mass index interaction)"	smoking status measurement|| alcohol drinking|| fibrinogen measurement|| body mass index	GCST002734	smoking status measurement|| alcohol drinking|| fibrinogen measurement|| body mass index	
Folate pathway vitamin levels	vitamin B measurement|| vitamin B12 measurement|| vitamin B6 measurement	GCST000358	vitamin B measurement|| vitamin B12 measurement|| vitamin B6 measurement	
Food addiction	eating behaviour|| food addiction measurement	GCST003489	eating behaviour|| food addiction measurement	
Food allergy (maternal genetic effects)	food allergy measurement|| parental genotype effect measurement	GCST005724	food allergy measurement|| parental genotype effect measurement	
Food allergy (parent-of-origin effect)	food allergy measurement|| parental genotype effect measurement	GCST005721	food allergy measurement|| parental genotype effect measurement	
Food antigen IgG levels	serum IgG measurement|| response to dietary antigen	GCST002518	serum IgG measurement|| response to dietary antigen	
Forced expiratory volume in 1 second (environmental tobacco smoke interaction)	forced expiratory volume|| environmental tobacco smoke exposure measurement	GCST004800	forced expiratory volume|| environmental tobacco smoke exposure measurement	
Forced expiratory volume in 1 second (occupational environmental exposures interaction)	response to biological dust exposure|| response to gases and fumes exposure|| forced expiratory volume|| response to mineral dust exposure	GCST002955	response to biological dust exposure|| response to gases and fumes exposure|| forced expiratory volume|| response to mineral dust exposure	
Free cholesterol levels in IDL	free cholesterol measurement|| intermediate density lipoprotein measurement	GCST005479	free cholesterol measurement|| intermediate density lipoprotein measurement	
Free cholesterol levels in large HDL	free cholesterol measurement|| high density lipoprotein cholesterol measurement	GCST005502	free cholesterol measurement|| high density lipoprotein cholesterol measurement	
Free cholesterol levels in large LDL	free cholesterol measurement|| low density lipoprotein cholesterol measurement	GCST005485	free cholesterol measurement|| low density lipoprotein cholesterol measurement	
Free cholesterol levels in large VLDL	free cholesterol measurement|| very low density lipoprotein cholesterol measurement	GCST005459	free cholesterol measurement|| very low density lipoprotein cholesterol measurement	
Free cholesterol levels in medium VLDL	free cholesterol measurement|| very low density lipoprotein cholesterol measurement	GCST005466	free cholesterol measurement|| very low density lipoprotein cholesterol measurement	
Free cholesterol levels in small VLDL	free cholesterol measurement|| very low density lipoprotein cholesterol measurement	GCST005471	free cholesterol measurement|| very low density lipoprotein cholesterol measurement	
Free cholesterol levels in very large HDL	free cholesterol measurement|| high density lipoprotein cholesterol measurement	GCST005496	free cholesterol measurement|| high density lipoprotein cholesterol measurement	
Frontotemporal dementia and immune-mediated diseases (pleiotropy)	rheumatoid arthritis|| psoriasis|| celiac disease|| Frontotemporal dementia|| ulcerative colitis|| Crohn's disease	GCST005319	rheumatoid arthritis|| psoriasis|| celiac disease|| Frontotemporal dementia|| ulcerative colitis|| Crohn's disease	
Gestational age at birth (child effect)	gestational age|| birth measurement	GCST003686	gestational age|| birth measurement	
Gestational age at birth (maternal effect)	gestational age|| birth measurement	GCST003688	gestational age|| birth measurement	
Gestational age at birth (maternal effect)	gestational age|| parental genotype effect measurement	GCST004899	gestational age|| parental genotype effect measurement	
Gestational age at birth (maternal effect)	gestational age|| parental genotype effect measurement	GCST004844	gestational age|| parental genotype effect measurement	
Gestational weight gain (fetal effect)	fetal genotype effect measurement|| gestational weight gain measurement	GCST005031	fetal genotype effect measurement|| gestational weight gain measurement	
GIP levels in response to oral glucose tolerance test (120 minutes)	glucose-dependent insulinotropic peptide measurement|| glucose tolerance test	GCST005166	glucose-dependent insulinotropic peptide measurement|| glucose tolerance test	
GIP levels in response to oral glucose tolerance test (fasting)	glucose-dependent insulinotropic peptide measurement|| glucose tolerance test	GCST005167	glucose-dependent insulinotropic peptide measurement|| glucose tolerance test	
Glioblastoma	central nervous system cancer|| glioblastoma multiforme	GCST004349	central nervous system cancer|| glioblastoma multiforme	
Glioblastoma (age-stratified)	age at onset|| glioblastoma multiforme	GCST006480	age at onset|| glioblastoma multiforme	
Glioma	central nervous system cancer|| glioma	GCST004347	central nervous system cancer|| glioma	
Glomerular filtration rate (creatinine)	glomerular filtration rate|| serum creatinine measurement	GCST003371	glomerular filtration rate|| serum creatinine measurement	
Glomerular filtration rate (creatinine)	glomerular filtration rate|| serum creatinine measurement	GCST003372	glomerular filtration rate|| serum creatinine measurement	
Glomerular filtration rate (creatinine)	glomerular filtration rate|| serum creatinine measurement	GCST004292	glomerular filtration rate|| serum creatinine measurement	
Glomerular filtration rate (cystatin C)	glomerular filtration rate|| cystatin C measurement	GCST003375	glomerular filtration rate|| cystatin C measurement	
Glomerular filtration rate (cystatin C)	glomerular filtration rate|| cystatin C measurement	GCST004293	glomerular filtration rate|| cystatin C measurement	
GLP-1 levels in response to oral glucose tolerance test (120 minutes)	glucagon-like peptide-1 measurement|| glucose tolerance test	GCST005165	glucagon-like peptide-1 measurement|| glucose tolerance test	
GLP-1 levels in response to oral glucose tolerance test (fasting)	glucagon-like peptide-1 measurement|| glucose tolerance test	GCST005164	glucagon-like peptide-1 measurement|| glucose tolerance test	
Glucagon levels in response to oral glucose tolerance test (120 minutes)	glucagon measurement|| glucose tolerance test	GCST005163	glucagon measurement|| glucose tolerance test	
Glucagon levels in response to oral glucose tolerance test (fasting)	glucagon measurement|| glucose tolerance test	GCST005162	glucagon measurement|| glucose tolerance test	
Glucocorticoid-induced osteonecrosis	response to glucocorticoid|| osteonecrosis	GCST003084	response to glucocorticoid|| osteonecrosis	
Glucocorticoid-induced osteonecrosis (age 10 years and older)	response to glucocorticoid|| osteonecrosis	GCST003081	response to glucocorticoid|| osteonecrosis	
Glucocorticoid-induced osteonecrosis (time dependent analysis)	response to glucocorticoid|| osteonecrosis	GCST003083	response to glucocorticoid|| osteonecrosis	
Glucocorticoid-induced osteonecrosis (time independent analysis)	response to glucocorticoid|| osteonecrosis	GCST003080	response to glucocorticoid|| osteonecrosis	
Glucose homeostasis traits	insulin metabolic clearance rate measurement|| disposition index measurement|| insulin sensitivity measurement|| glucose homeostasis measurement|| glucose effectiveness measurement|| acute insulin response measurement	GCST002726	insulin metabolic clearance rate measurement|| disposition index measurement|| insulin sensitivity measurement|| glucose homeostasis measurement|| glucose effectiveness measurement|| acute insulin response measurement	
Glycemic traits (multi-trait analysis)	fasting blood glucose measurement|| glucose tolerance test|| fasting blood insulin measurement	GCST006404	fasting blood glucose measurement|| glucose tolerance test|| fasting blood insulin measurement	
Glycemic traits (pregnancy)	C-peptide measurement|| fasting blood glucose measurement|| glucose tolerance test	GCST002110	C-peptide measurement|| fasting blood glucose measurement|| glucose tolerance test	
Glycerophospholipid levels	glycerophospholipid measurement|| blood metabolite measurement	GCST002965	glycerophospholipid measurement|| blood metabolite measurement	
Gout vs. Hyperuricemia	gout|| hyperuricemia	GCST005801	gout|| hyperuricemia	
Graft survival time in renal transplantation (donor effect)	renal transplant outcome measurement|| donor genotype effect measurement	GCST005429	renal transplant outcome measurement|| donor genotype effect measurement	
Graft survival time in renal transplantation (donor-recipient interaction)	renal transplant outcome measurement|| donor genotype effect measurement	GCST005430	renal transplant outcome measurement|| donor genotype effect measurement	
Gray matter volume (schizophrenia interaction)	schizophrenia|| grey matter volume measurement	GCST002203	schizophrenia|| grey matter volume measurement	
Gut microbiota (bacterial taxa)	gut microbiome measurement|| taxonomic microbiome measurement	GCST003875	gut microbiome measurement|| taxonomic microbiome measurement	
Hashimoto thyroiditis versus Graves' disease	autoimmune thyroid disease|| Hashimoto's thyroiditis|| Graves disease	GCST002705	autoimmune thyroid disease|| Hashimoto's thyroiditis|| Graves disease	
HDL Cholesterol - Triglycerides (HDLC-TG)	triglyceride measurement|| high density lipoprotein cholesterol measurement	GCST001005	triglyceride measurement|| high density lipoprotein cholesterol measurement	
HDL cholesterol and triglyceride levels	triglyceride measurement|| high density lipoprotein cholesterol measurement	GCST006682	triglyceride measurement|| high density lipoprotein cholesterol measurement	
HDL cholesterol and triglyceride levels (pleiotropy)	triglyceride measurement|| high density lipoprotein cholesterol measurement	GCST006669	triglyceride measurement|| high density lipoprotein cholesterol measurement	
Hearing function (0.25 kHz)	hearing threshold measurement|| hearing measurement	GCST003039	hearing threshold measurement|| hearing measurement	
Hearing function (0.5 kHz)	hearing threshold measurement|| hearing measurement	GCST003037	hearing threshold measurement|| hearing measurement	
Hearing function (1 kHz)	hearing threshold measurement|| hearing measurement	GCST003041	hearing threshold measurement|| hearing measurement	
Hearing function (2 kHz)	hearing threshold measurement|| hearing measurement	GCST003032	hearing threshold measurement|| hearing measurement	
Hearing function (4 kHz)	hearing threshold measurement|| hearing measurement	GCST003035	hearing threshold measurement|| hearing measurement	
Hearing function (8 kHz)	hearing threshold measurement|| hearing measurement	GCST003034	hearing threshold measurement|| hearing measurement	
Hearing function (high tone)	pure tone hearing measurement|| hearing measurement	GCST003040	pure tone hearing measurement|| hearing measurement	
Hearing function (low tone)	pure tone hearing measurement|| hearing measurement	GCST003036	pure tone hearing measurement|| hearing measurement	
Hearing function (medium tone)	pure tone hearing measurement|| hearing measurement	GCST003033	pure tone hearing measurement|| hearing measurement	
Heart rate response to beta blockers	response to beta blocker|| heart rate	GCST005519	response to beta blocker|| heart rate	
Heart rate response to beta blockers (atenolol add-on therapy)	response to beta blocker|| heart rate	GCST005520	response to beta blocker|| heart rate	
Heart rate response to beta blockers (atenolol monotherapy)	response to beta blocker|| heart rate	GCST005521	response to beta blocker|| heart rate	
Heavy vaginal discharge	quality of life during menstruation measurement|| vaginal discharge	GCST006639	quality of life during menstruation measurement|| vaginal discharge	
Hematological and biochemical traits	serum albumin measurement|| aspartate aminotransferase measurement|| alkaline phosphatase measurement|| hemoglobin measurement|| serum alanine aminotransferase measurement|| serum gamma-glutamyl transferase measurement|| hematocrit|| creatine kinase measurement|| protein measurement|| uric acid measurement|| high density lipoprotein cholesterol measurement|| serum creatinine measurement	GCST000583	serum albumin measurement|| aspartate aminotransferase measurement|| alkaline phosphatase measurement|| hemoglobin measurement|| serum alanine aminotransferase measurement|| serum gamma-glutamyl transferase measurement|| hematocrit|| creatine kinase measurement|| protein measurement|| uric acid measurement|| high density lipoprotein cholesterol measurement|| serum creatinine measurement	
Hematological parameters	leukocyte count|| erythrocyte count|| mean corpuscular volume|| mean corpuscular hemoglobin|| platelet count	GCST000498	leukocyte count|| erythrocyte count|| mean corpuscular volume|| mean corpuscular hemoglobin|| platelet count	
Hematology traits	hemoglobin measurement|| leukocyte count|| erythrocyte count|| hematocrit	GCST001779	hemoglobin measurement|| leukocyte count|| erythrocyte count|| hematocrit	
Hematology traits	mean corpuscular volume|| mean corpuscular hemoglobin|| platelet count	GCST000510	mean corpuscular volume|| mean corpuscular hemoglobin|| platelet count	
Hemostatic factors and hematological phenotypes	platelet aggregation|| hemoglobin measurement|| erythrocyte count|| mean corpuscular hemoglobin|| blood viscosity|| tissue plasminogen activator measurement|| plasminogen activator inhibitor 1 measurement	GCST000080	platelet aggregation|| hemoglobin measurement|| erythrocyte count|| mean corpuscular hemoglobin|| blood viscosity|| tissue plasminogen activator measurement|| plasminogen activator inhibitor 1 measurement	
Heparin-induced thrombocytopenia	response to heparin|| thrombocytopenia	GCST006144	response to heparin|| thrombocytopenia	
Heparin-induced thrombocytopenia	response to heparin|| thrombocytopenia	GCST002722	response to heparin|| thrombocytopenia	
Hepatitis B (viral clearance)	seroconversion|| hepatitis B infection	GCST003718	seroconversion|| hepatitis B infection	
Hepatitis B virus-related hepatocellular carcinoma	hepatocellular carcinoma|| hepatitis B infection	GCST005570	hepatocellular carcinoma|| hepatitis B infection	
Hepatitis C induced liver fibrosis	hepatitis C infection|| cirrhosis of liver	GCST001623	hepatitis C infection|| cirrhosis of liver	
Hereditary hemochromatosis-related traits (HFE mutation homozygotes)	hereditary hemochromatosis type 1|| transferrin measurement|| serum iron measurement	GCST002660	hereditary hemochromatosis type 1|| transferrin measurement|| serum iron measurement	
Hexose levels	blood metabolite measurement|| hexose measurement	GCST002959	blood metabolite measurement|| hexose measurement	
Hip bone mineral density and alcohol drinking	hip bone mineral density|| alcohol consumption measurement	GCST003920	hip bone mineral density|| alcohol consumption measurement	
Hip circumference (psychosocial stress interaction)	hip circumference|| psychosocial stress measurement	GCST002641	hip circumference|| psychosocial stress measurement	
Hip circumference adjusted for BMI	hip circumference|| body mass index	GCST004067	hip circumference|| body mass index	
Hip osteoarthritis or femoral neck bone mineral density	osteoarthritis|| hip|| femoral neck bone mineral density	GCST005229	osteoarthritis|| hip|| femoral neck bone mineral density	
Hip osteoarthritis or lumbar spine bone mineral density	osteoarthritis|| hip|| spine bone mineral density	GCST005226	osteoarthritis|| hip|| spine bone mineral density	
Hippocampal volume (Alzheimer's disease interaction)	Alzheimer's disease|| hippocampal volume	GCST000897	Alzheimer's disease|| hippocampal volume	
HIV-1 susceptibility	HIV-1 infection|| Susceptibility to viral and mycobacterial infections	GCST002818	HIV-1 infection|| Susceptibility to viral and mycobacterial infections	
HIV-1 susceptibility	HIV-1 infection|| Susceptibility to viral and mycobacterial infections	GCST001353	HIV-1 infection|| Susceptibility to viral and mycobacterial infections	
HIV-associated neurocognitive disorder (asymptomatic neurocogntive impairment)	HIV-associated neurocognitive disorder|| asymptomatic neurocognitive impairment	GCST004410	HIV-associated neurocognitive disorder|| asymptomatic neurocognitive impairment	
HIV-associated neurocognitive disorder (mild neurocognitive disorder or asymptomatic neurocognitive impairment)	HIV-associated neurocognitive disorder|| mild neurocognitive disorder|| asymptomatic neurocognitive impairment	GCST004411	HIV-associated neurocognitive disorder|| mild neurocognitive disorder|| asymptomatic neurocognitive impairment	
HIV-associated neurocognitive disorder (mild neurocognitive disorder)	HIV-associated neurocognitive disorder|| mild neurocognitive disorder	GCST004408	HIV-associated neurocognitive disorder|| mild neurocognitive disorder	
Homeostasis model assessment of beta-cell function (dietary factor interaction)	diet measurement|| HOMA-B	GCST002251	diet measurement|| HOMA-B	
Homeostasis model assessment of insulin resistance (dietary factor interaction)	diet measurement|| HOMA-IR	GCST002253	diet measurement|| HOMA-IR	
Hormone measurements	estradiol measurement|| sex hormone-binding globulin measurement|| testosterone measurement	GCST002195	estradiol measurement|| sex hormone-binding globulin measurement|| testosterone measurement	
Immune reponse to smallpox (secreted IFN-alpha)	response to vaccine|| cytokine measurement	GCST001538	response to vaccine|| cytokine measurement	
Immune reponse to smallpox (secreted IL-10)	response to vaccine|| cytokine measurement	GCST001534	response to vaccine|| cytokine measurement	
Immune reponse to smallpox (secreted IL-12p40)	response to vaccine|| cytokine measurement	GCST001537	response to vaccine|| cytokine measurement	
Immune reponse to smallpox (secreted IL-1beta)	response to vaccine|| cytokine measurement	GCST001533	response to vaccine|| cytokine measurement	
Immune reponse to smallpox (secreted IL-2)	response to vaccine|| cytokine measurement	GCST001535	response to vaccine|| cytokine measurement	
Immune reponse to smallpox (secreted TNF-alpha)	response to vaccine|| cytokine measurement	GCST001536	response to vaccine|| cytokine measurement	
Immune response to smallpox vaccine (IL-6)	response to vaccine|| cytokine measurement	GCST001532	response to vaccine|| cytokine measurement	
Immunoglobulin light (AL) amyloidosis (serum Ig kappa profile)	AL amyloidosis|| IgG isotype profile measurement	GCST004810	AL amyloidosis|| IgG isotype profile measurement	
Immunoglobulin light chain (AL) amyloidosis (heart and kidney involvement)	heart amyloid deposition measurement|| AL amyloidosis|| kidney amyloid deposition measurement	GCST004806	heart amyloid deposition measurement|| AL amyloidosis|| kidney amyloid deposition measurement	
Immunoglobulin light chain (AL) amyloidosis (heart involvement)	heart amyloid deposition measurement|| AL amyloidosis	GCST004805	heart amyloid deposition measurement|| AL amyloidosis	
Immunoglobulin light chain (AL) amyloidosis (kidney involvement)	AL amyloidosis|| kidney amyloid deposition measurement	GCST004812	AL amyloidosis|| kidney amyloid deposition measurement	
Immunoglobulin light chain (AL) amyloidosis (liver involvement)	AL amyloidosis|| liver amyloid deposition measurement	GCST004807	AL amyloidosis|| liver amyloid deposition measurement	
Immunoglobulin light chain (AL) amyloidosis (serum Ig lambda profile)	AL amyloidosis|| IgG isotype profile measurement	GCST004809	AL amyloidosis|| IgG isotype profile measurement	
Immunoglobulin light chain (AL) amyloidosis (serum Ig light chain only lambda based profile)	AL amyloidosis|| IgG isotype profile measurement	GCST004804	AL amyloidosis|| IgG isotype profile measurement	
Immunoglobulin light chain (AL) amyloidosis (serum Ig light chain only lambda/kappa based profile)	AL amyloidosis|| IgG isotype profile measurement	GCST004811	AL amyloidosis|| IgG isotype profile measurement	
Immunoglobulin light chain (AL) amyloidosis (serum IgG profile)	AL amyloidosis|| IgG isotype profile measurement	GCST004808	AL amyloidosis|| IgG isotype profile measurement	
Inflammatory biomarkers	interleukin-1 beta measurement|| interleukin 1 receptor antagonist measurement	GCST002255	interleukin-1 beta measurement|| interleukin 1 receptor antagonist measurement	
Inflammatory biomarkers	blood sedimentation|| interleukin-6 measurement|| C-reactive protein measurement|| CCL2 measurement	GCST001385	blood sedimentation|| interleukin-6 measurement|| C-reactive protein measurement|| CCL2 measurement	
Inflammatory bowel disease	ulcerative colitis|| Crohn's disease|| inflammatory bowel disease	GCST005837	ulcerative colitis|| Crohn's disease|| inflammatory bowel disease	
Insulin levels in response to oral glucose tolerance test (120 minutes)	insulin measurement|| glucose tolerance test	GCST005161	insulin measurement|| glucose tolerance test	
Insulin levels in response to oral glucose tolerance test (30 minutes)	insulin measurement|| glucose tolerance test	GCST005160	insulin measurement|| glucose tolerance test	
Insulin levels in response to oral glucose tolerance test (fasting)	insulin measurement|| glucose tolerance test	GCST005159	insulin measurement|| glucose tolerance test	
Intercellular adhesion molecule 1 (red blood cell fatty acid level interaction)	fatty acid measurement|| ICAM-1 measurement	GCST004818	fatty acid measurement|| ICAM-1 measurement	
Interleukin-6 (red blood cell fatty acid level interaction)	fatty acid measurement|| interleukin-6 measurement	GCST004814	fatty acid measurement|| interleukin-6 measurement	
"Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy)"	thoracic aortic aneurysm|| Abdominal Aortic Aneurysm|| brain aneurysm	GCST003683	thoracic aortic aneurysm|| Abdominal Aortic Aneurysm|| brain aneurysm	
Iron status biomarkers (ferritin levels)	iron biomarker measurement|| ferritin measurement	GCST002677	iron biomarker measurement|| ferritin measurement	
Iron status biomarkers (iron levels)	iron biomarker measurement|| serum iron measurement	GCST002679	iron biomarker measurement|| serum iron measurement	
Iron status biomarkers (transferrin levels)	iron biomarker measurement|| transferrin measurement	GCST002678	iron biomarker measurement|| transferrin measurement	
Iron status biomarkers (transferrin saturation)	iron biomarker measurement|| transferrin saturation measurement	GCST002680	iron biomarker measurement|| transferrin saturation measurement	
Ischemic stroke (cardioembolic)	Ischemic stroke|| cardiac embolism	GCST003490	Ischemic stroke|| cardiac embolism	
Ischemic stroke (cardioembolic)	Ischemic stroke|| cardiac embolism	GCST003323	Ischemic stroke|| cardiac embolism	
Ischemic stroke (cardioembolic)	Ischemic stroke|| cardiac embolism	GCST003257	Ischemic stroke|| cardiac embolism	
Ischemic stroke (large artery atherosclerosis)	Ischemic stroke|| large artery stroke	GCST003322	Ischemic stroke|| large artery stroke	
Ischemic stroke (large artery atherosclerosis)	Ischemic stroke|| large artery stroke	GCST003259	Ischemic stroke|| large artery stroke	
Ischemic stroke (small artery occlusion)	Ischemic stroke|| small artery occlusion	GCST003260	Ischemic stroke|| small artery occlusion	
Itch intensity from mosquito bite adjusted by bite size	mosquito bite reaction itch intensity measurement|| mosquito bite reaction size measurement	GCST004865	mosquito bite reaction itch intensity measurement|| mosquito bite reaction size measurement	
Itch intensity from mosquito bite adjusted by bite size	mosquito bite reaction itch intensity measurement|| mosquito bite reaction size measurement	GCST004862	mosquito bite reaction itch intensity measurement|| mosquito bite reaction size measurement	
Joint destruction and growth retardation	Kashin-Beck disease|| joint damage measurement|| height growth measurement	GCST003727	Kashin-Beck disease|| joint damage measurement|| height growth measurement	
JT interval (sulfonylurea treatment interaction)	JT interval|| response to sulfonylurea	GCST004032	JT interval|| response to sulfonylurea	
Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)	"systemic juvenile idiopathic arthritis|| polyarticular juvenile idiopathic arthritis, rheumatoid factor negative|| oligoarticular juvenile idiopathic arthritis"	GCST005528	"systemic juvenile idiopathic arthritis|| polyarticular juvenile idiopathic arthritis, rheumatoid factor negative|| oligoarticular juvenile idiopathic arthritis"	
Kidney function decline traits	chronic kidney disease|| rapid kidney function decline|| GFR change measurement	GCST002720	chronic kidney disease|| rapid kidney function decline|| GFR change measurement	
Knee osteoarthritis	osteoarthritis|| knee	GCST003820	osteoarthritis|| knee	
Knee osteoarthritis	osteoarthritis|| knee	GCST004881	osteoarthritis|| knee	
Knee osteoarthritis	osteoarthritis|| knee	GCST000629	osteoarthritis|| knee	
Knee osteoarthritis	osteoarthritis|| knee	GCST000186	osteoarthritis|| knee	
Knee osteoarthritis or femoral neck bone mineral density	osteoarthritis|| knee|| femoral neck bone mineral density	GCST005224	osteoarthritis|| knee|| femoral neck bone mineral density	
Knee osteoarthritis or lumbar spine bone mineral density	osteoarthritis|| knee|| spine bone mineral density	GCST005227	osteoarthritis|| knee|| spine bone mineral density	
Lamotrigine-induced maculopapular exanthema	response to lamotrigine|| maculopapular eruption	GCST005199	response to lamotrigine|| maculopapular eruption	
Language performance in older adults (adjusted for episodic memory)	cognitive decline measurement|| memory performance|| language measurement	GCST004372	cognitive decline measurement|| memory performance|| language measurement	
Lapatinib-induced hepatotoxicity	response to lapatinib|| drug-induced liver injury	GCST002918	response to lapatinib|| drug-induced liver injury	
Late gestational weight gain (fetal effect)	fetal genotype effect measurement|| late gestational weight gain	GCST005030	fetal genotype effect measurement|| late gestational weight gain	
Lateral ventricle volume in trauma-exposed individuals	lateral ventricle volume measurement|| response to trauma exposure	GCST005286	lateral ventricle volume measurement|| response to trauma exposure	
LDL peak particle diameter (total fat intake interaction)	LDL peak particle diameter measurement|| total fat intake measurement	GCST002989	LDL peak particle diameter measurement|| total fat intake measurement	
Lean body mass and age at menarche (combined)	body fat distribution|| age at menarche	GCST001584	body fat distribution|| age at menarche	
Left inferior lateral ventricle volume (Cerebrospinal fluid biomarker status interaction)	cerebrospinal fluid biomarker measurement|| left inferior lateral ventricle volume measurement	GCST002554	cerebrospinal fluid biomarker measurement|| left inferior lateral ventricle volume measurement	
Left superior temporal gyrus thickness (schizophrenia interaction)	schizophrenia|| left superior temporal gyrus thickness measurement	GCST003069	schizophrenia|| left superior temporal gyrus thickness measurement	
Left ventricular function change in anthracycline treatment	left ventricular function|| response to anthracycline-based chemotherapy	GCST004353	left ventricular function|| response to anthracycline-based chemotherapy	
Left ventricular QRS voltage	QRS amplitude|| S wave amplitude|| R wave amplitude	GCST003630	QRS amplitude|| S wave amplitude|| R wave amplitude	
Lewy body disease	Lewy body dementia|| Lewy body dementia measurement	GCST002591	Lewy body dementia|| Lewy body dementia measurement	
Lipid traits	total cholesterol measurement|| triglyceride measurement|| low density lipoprotein cholesterol measurement|| high density lipoprotein cholesterol measurement	GCST002321	total cholesterol measurement|| triglyceride measurement|| low density lipoprotein cholesterol measurement|| high density lipoprotein cholesterol measurement	
Lipid traits	total cholesterol measurement|| triglyceride measurement|| low density lipoprotein cholesterol measurement|| high density lipoprotein cholesterol measurement	GCST002174	total cholesterol measurement|| triglyceride measurement|| low density lipoprotein cholesterol measurement|| high density lipoprotein cholesterol measurement	
Lipid traits	triglyceride measurement|| low density lipoprotein cholesterol measurement|| high density lipoprotein cholesterol measurement	GCST002173	triglyceride measurement|| low density lipoprotein cholesterol measurement|| high density lipoprotein cholesterol measurement	
Lipid traits (pleiotropy) (HIPO component 1)	total cholesterol measurement|| triglyceride measurement|| low density lipoprotein cholesterol measurement|| high density lipoprotein cholesterol measurement	GCST006666	total cholesterol measurement|| triglyceride measurement|| low density lipoprotein cholesterol measurement|| high density lipoprotein cholesterol measurement	
Lipid traits (pleiotropy) (HIPO component 2)	total cholesterol measurement|| triglyceride measurement|| low density lipoprotein cholesterol measurement|| high density lipoprotein cholesterol measurement	GCST006667	total cholesterol measurement|| triglyceride measurement|| low density lipoprotein cholesterol measurement|| high density lipoprotein cholesterol measurement	
Lipoprotein-associated phospholipase A2 (red blood cell fatty acid level interaction)	fatty acid measurement|| lipoprotein-associated phospholipase A(2) measurement	GCST004816	fatty acid measurement|| lipoprotein-associated phospholipase A(2) measurement	
Lipoprotein(a) levels adjusted for apolipoprotein(a) isoforms	lipoprotein A measurement|| apolipoprotein A 1 measurement	GCST004399	lipoprotein A measurement|| apolipoprotein A 1 measurement	
Lobular breast cancer (menopausal hormone therapy interaction)	invasive lobular carcinoma|| hormone replacement therapy	GCST002266	invasive lobular carcinoma|| hormone replacement therapy	
lower facial morphology traits (ordinal measurement)	lip morphology measurement|| chin morphology measurement	GCST003634	lip morphology measurement|| chin morphology measurement	
lower facial morphology traits (quantitative measurement)	lip morphology measurement|| chin morphology measurement	GCST003636	lip morphology measurement|| chin morphology measurement	
Lumbar spine bone mineral density or breast cancer (pleiotropy)	breast carcinoma|| spine bone mineral density	GCST004837	breast carcinoma|| spine bone mineral density	
Lumbar spine bone mineral density or coronary artery disease (pleiotropy)	spine bone mineral density|| coronary artery disease	GCST004717	spine bone mineral density|| coronary artery disease	
Lung cancer	lung carcinoma|| squamous cell carcinoma|| lung adenocarcinoma	GCST002466	lung carcinoma|| squamous cell carcinoma|| lung adenocarcinoma	
Lung cancer (asbestos exposure interaction)	lung carcinoma|| asbestos exposure measurement	GCST003049	lung carcinoma|| asbestos exposure measurement	
Lung cancer (asbestos exposure interaction)	lung carcinoma|| asbestos exposure measurement	GCST001543	lung carcinoma|| asbestos exposure measurement	
Lung cancer (household air pollution interaction)	lung carcinoma|| household air pollution measurement	GCST002739	lung carcinoma|| household air pollution measurement	
Lung cancer (smoking interaction)	smoking status measurement|| lung carcinoma	GCST002392	smoking status measurement|| lung carcinoma	
Lung cancer and family history of lung cancer	lung carcinoma|| family history of lung cancer	GCST002753	lung carcinoma|| family history of lung cancer	
Lung cancer x radon exposure interaction (1df)	lung carcinoma|| radon exposure measurement	GCST006413	lung carcinoma|| radon exposure measurement	
Lung function (maximal voluntary ventilation)	maximal voluntary ventilation|| pulmonary function measurement	GCST005127	maximal voluntary ventilation|| pulmonary function measurement	
Major depression and alcohol dependence	unipolar depression|| alcohol dependence	GCST005022	unipolar depression|| alcohol dependence	
Major depressive disorder (stressful life events interaction)	unipolar depression|| self rated health|| stressful life event measurement	GCST003319	unipolar depression|| self rated health|| stressful life event measurement	
Male fertility	birth rate|| male fertility|| family size	GCST001540	birth rate|| male fertility|| family size	
Mammographic density (dense area)	dense area measurement|| mammographic density measurement	GCST002667	dense area measurement|| mammographic density measurement	
Mammographic density (non-dense area)	non-dense area measurement|| mammographic density measurement	GCST002668	non-dense area measurement|| mammographic density measurement	
Maternal genotype effects in autism spectrum disorder families	autism spectrum disorder|| genetic variation	GCST002368	autism spectrum disorder|| genetic variation	
Mean arterial pressure (alcohol consumption interaction)	diastolic blood pressure|| alcohol drinking	GCST002308	diastolic blood pressure|| alcohol drinking	
Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test)	mean arterial pressure|| alcohol consumption measurement	GCST006172	mean arterial pressure|| alcohol consumption measurement	
Mean arterial pressure x alcohol consumption interaction (2df test)	mean arterial pressure|| alcohol drinking	GCST006167	mean arterial pressure|| alcohol drinking	
Mean arterial pressure x sodium interaction (1df test)	sodium measurement|| mean arterial pressure	GCST006116	sodium measurement|| mean arterial pressure	
Mean arterial pressure x sodium interaction (2df test)	sodium measurement|| mean arterial pressure	GCST006114	sodium measurement|| mean arterial pressure	
Mean corpuscular hemoglobin	hemoglobin measurement|| mean corpuscular hemoglobin	GCST000587	hemoglobin measurement|| mean corpuscular hemoglobin	
Mean corpuscular hemoglobin concentration	hemoglobin measurement|| mean corpuscular hemoglobin concentration	GCST000582	hemoglobin measurement|| mean corpuscular hemoglobin concentration	
Menarche and menopause (age at onset)	age at menarche|| age at menopause	GCST001336	age at menarche|| age at menopause	
Menarche and menopause (age at onset)	age at menarche|| age at menopause	GCST000403	age at menarche|| age at menopause	
Menstruation quality of life impact (acne)	quality of life during menstruation measurement|| acne	GCST006640	quality of life during menstruation measurement|| acne	
Menstruation quality of life impact (aggressiveness)	quality of life during menstruation measurement|| aggressive behavior	GCST006641	quality of life during menstruation measurement|| aggressive behavior	
Menstruation quality of life impact (bowel movement)	quality of life during menstruation measurement|| abnormal peristalsis	GCST006643	quality of life during menstruation measurement|| abnormal peristalsis	
Menstruation quality of life impact (depression)	quality of life during menstruation measurement|| unipolar depression	GCST006644	quality of life during menstruation measurement|| unipolar depression	
Menstruation quality of life impact (dysmenorrhea)	quality of life during menstruation measurement|| dysmenorrheic pain measurement	GCST006636	quality of life during menstruation measurement|| dysmenorrheic pain measurement	
Menstruation quality of life impact (edema)	quality of life during menstruation measurement|| edema	GCST006645	quality of life during menstruation measurement|| edema	
Menstruation quality of life impact (fever)	quality of life during menstruation measurement|| fever	GCST006638	quality of life during menstruation measurement|| fever	
Menstruation quality of life impact (headache)	quality of life during menstruation measurement|| Headache	GCST006646	quality of life during menstruation measurement|| Headache	
Menstruation quality of life impact (increased appetite)	quality of life during menstruation measurement|| eating behaviour	GCST006642	quality of life during menstruation measurement|| eating behaviour	
Menstruation quality of life impact (joint pain)	quality of life during menstruation measurement|| arthralgia	GCST006647	quality of life during menstruation measurement|| arthralgia	
Menstruation quality of life impact (loss of concentration)	quality of life during menstruation measurement|| decreased attention	GCST006648	quality of life during menstruation measurement|| decreased attention	
Menstruation quality of life impact (nervousness)	nervousness|| quality of life during menstruation measurement	GCST006649	nervousness|| quality of life during menstruation measurement	
Menstruation quality of life impact (pressure in breast)	quality of life during menstruation measurement|| breast pressure measurement	GCST006650	quality of life during menstruation measurement|| breast pressure measurement	
Menstruation quality of life impact (sleepiness)	quality of life during menstruation measurement|| sleepiness	GCST006651	quality of life during menstruation measurement|| sleepiness	
Menstruation quality of life impact (stiff neck)	quality of life during menstruation measurement|| Stiff neck	GCST006652	quality of life during menstruation measurement|| Stiff neck	
Mental development (prenatal lead exposure interaction)	blood lead measurement|| mental development measurement	GCST004769	blood lead measurement|| mental development measurement	
Metabolic traits	inflammatory response|| triglyceride measurement|| insulin measurement|| glucose measurement	GCST000292	inflammatory response|| triglyceride measurement|| insulin measurement|| glucose measurement	
Metabolite levels	serum albumin measurement|| metabolite measurement|| serum alanine aminotransferase measurement|| low density lipoprotein cholesterol measurement|| fasting blood glucose measurement|| uric acid measurement	GCST001233	serum albumin measurement|| metabolite measurement|| serum alanine aminotransferase measurement|| low density lipoprotein cholesterol measurement|| fasting blood glucose measurement|| uric acid measurement	
Metabolite levels	phenylalanine measurement|| acylcarnitine measurement|| carbohydrate measurement|| tyrosine measurement|| sphingolipid measurement|| lysine measurement|| lipid measurement|| phospholipid measurement|| serotonin measurement	GCST000274	phenylalanine measurement|| acylcarnitine measurement|| carbohydrate measurement|| tyrosine measurement|| sphingolipid measurement|| lysine measurement|| lipid measurement|| phospholipid measurement|| serotonin measurement	
Metabolite levels (5-HIAA/ MHPG Ratio)	MHPG measurement|| 5-HIAA measurement	GCST001821	MHPG measurement|| 5-HIAA measurement	
Metabolite levels (HVA-5-HIAA Factor score)	HVA measurement|| 5-HIAA measurement	GCST001817	HVA measurement|| 5-HIAA measurement	
Metabolite levels (HVA/5-HIAA ratio)	HVA measurement|| 5-HIAA measurement	GCST001818	HVA measurement|| 5-HIAA measurement	
Metabolite levels (HVA/MHPG ratio)	HVA measurement|| MHPG measurement	GCST001823	HVA measurement|| MHPG measurement	
Metabolite levels (lipid measures)	lipid measurement|| blood metabolite measurement	GCST003664	lipid measurement|| blood metabolite measurement	
Metabolite levels (lipoprotein measures)	lipoprotein measurement|| blood metabolite measurement	GCST003665	lipoprotein measurement|| blood metabolite measurement	
Metabolite levels (small molecules and protein measures)	blood metabolite measurement|| protein measurement|| amino acid measurement	GCST003666	blood metabolite measurement|| protein measurement|| amino acid measurement	
middle facial morphology traits (ordinal measurement)	nose morphology measurement|| cheekbone morphology measurement	GCST003633	nose morphology measurement|| cheekbone morphology measurement	
Midgestational circulating levels of organochlorine pesticides	gestational serum measurement|| organochlorine pesticide measurement	GCST004281	gestational serum measurement|| organochlorine pesticide measurement	
Midgestational circulating levels of organochlorine pesticides (fetal genetic effect)	gestational serum measurement|| fetal genotype effect measurement|| organochlorine pesticide measurement	GCST004282	gestational serum measurement|| fetal genotype effect measurement|| organochlorine pesticide measurement	
Midgestational circulating levels of PBDEs	polybrominated biphenyl measurement|| gestational serum measurement|| polybrominated diphenyl ether measurement	GCST004285	polybrominated biphenyl measurement|| gestational serum measurement|| polybrominated diphenyl ether measurement	
Midgestational circulating levels of PBDEs (fetal genetic effect)	polybrominated biphenyl measurement|| gestational serum measurement|| fetal genotype effect measurement|| polybrominated diphenyl ether measurement	GCST004286	polybrominated biphenyl measurement|| gestational serum measurement|| fetal genotype effect measurement|| polybrominated diphenyl ether measurement	
Midgestational circulating levels of PCBs	polychlorinated biphenyls measurement|| gestational serum measurement	GCST004283	polychlorinated biphenyls measurement|| gestational serum measurement	
Midgestational circulating levels of PCBs (fetal genetic effect)	polychlorinated biphenyls measurement|| gestational serum measurement|| fetal genotype effect measurement	GCST004284	polychlorinated biphenyls measurement|| gestational serum measurement|| fetal genotype effect measurement	
Midgestational cytokine/chemokine levels (fetal genetic effect)	gestational serum measurement|| fetal genotype effect measurement|| protein measurement	GCST006623	gestational serum measurement|| fetal genotype effect measurement|| protein measurement	
Midgestational cytokine/chemokine levels (maternal genetic effect)	gestational serum measurement|| protein measurement|| parental genotype effect measurement	GCST006621	gestational serum measurement|| protein measurement|| parental genotype effect measurement	
Migraine or coronary artery disease	migraine disorder|| coronary artery disease	GCST004944	migraine disorder|| coronary artery disease	
Milk allergy (maternal genetic effects)	milk allergy measurement|| parental genotype effect measurement	GCST005722	milk allergy measurement|| parental genotype effect measurement	
Milk allergy (parent-of-origin effect)	milk allergy measurement|| parental genotype effect measurement	GCST005726	milk allergy measurement|| parental genotype effect measurement	
Modified Stumvoll Insulin Sensitivity Index (BMI interaction)	insulin sensitivity measurement|| body mass index	GCST003659	insulin sensitivity measurement|| body mass index	
Modified Stumvoll Insulin Sensitivity Index (model adjusted for BMI)	insulin sensitivity measurement|| body mass index	GCST003658	insulin sensitivity measurement|| body mass index	
Monocyte chemoattractant protein-1 (red blood cell fatty acid level interaction)	fatty acid measurement|| CCL2 measurement	GCST004821	fatty acid measurement|| CCL2 measurement	
Mood disorder and prion disease	prion disease|| mood disorder	GCST002862	prion disease|| mood disorder	
Motor development (prenatal lead exposure interaction)	motor development measurement|| blood lead measurement	GCST004768	motor development measurement|| blood lead measurement	
"Multiple cancers (lung cancer, gastric cancer, and squamous cell carcinoma)"	lung carcinoma|| squamous cell carcinoma|| gastric carcinoma	GCST001718	lung carcinoma|| squamous cell carcinoma|| gastric carcinoma	
Multiple keratinocyte cancers	squamous cell carcinoma|| mulitple keratinocyte carcinoma susceptibility measurement|| basal cell carcinoma	GCST004134	squamous cell carcinoma|| mulitple keratinocyte carcinoma susceptibility measurement|| basal cell carcinoma	
Multiple myeloma and monoclonal gammopathy	multiple myeloma|| monoclonal gammopathy	GCST002922	multiple myeloma|| monoclonal gammopathy	
Multiple sclerosis (OCB status)	multiple sclerosis|| oligoclonal band measurement	GCST001892	multiple sclerosis|| oligoclonal band measurement	
Multiple sclerosis or amyotrophic lateral sclerosis	multiple sclerosis|| amyotrophic lateral sclerosis	GCST002274	multiple sclerosis|| amyotrophic lateral sclerosis	
Neonatal cytokine/chemokine levels (fetal genetic effect)	fetal genotype effect measurement|| protein measurement	GCST006622	fetal genotype effect measurement|| protein measurement	
Neonatal cytokine/chemokine levels (maternal genetic effect)	protein measurement|| parental genotype effect measurement	GCST006625	protein measurement|| parental genotype effect measurement	
Neovascular age-related macular degeneration	age-related macular degeneration|| wet macular degeneration	GCST004737	age-related macular degeneration|| wet macular degeneration	
Neuranatomic and neurocognitive phenotypes	neuroimaging measurement|| South Texas Assessment of Neurocognition	GCST001037	neuroimaging measurement|| South Texas Assessment of Neurocognition	
Neuritic plaques or cerebral amyloid angiopathy (pleiotropy)	neuritic plaque measurement|| cerebral amyloid angiopathy	GCST005515	neuritic plaque measurement|| cerebral amyloid angiopathy	
Neuritic plaques or neurofibrillary tangles (pleiotropy)	neuritic plaque measurement|| neurofibrillary tangles measurement	GCST005516	neuritic plaque measurement|| neurofibrillary tangles measurement	
Neuritic plaques or neurofibrillary tangles or cerebral amyloid angiopathy (pleiotropy)	neuritic plaque measurement|| cerebral amyloid angiopathy|| neurofibrillary tangles measurement	GCST005514	neuritic plaque measurement|| cerebral amyloid angiopathy|| neurofibrillary tangles measurement	
Neurofibrillary tangles or cerebral amyloid angiopathy (pleiotropy)	cerebral amyloid angiopathy|| neurofibrillary tangles measurement	GCST005517	cerebral amyloid angiopathy|| neurofibrillary tangles measurement	
Neuroticism (age interaction)	neurotic disorder|| age at assessment	GCST000724	neurotic disorder|| age at assessment	
Nicotine dependence and major depression (severity of comorbidity)	nicotine dependence symptom count|| depressive symptom measurement	GCST006631	nicotine dependence symptom count|| depressive symptom measurement	
Night sleep phenotypes	sleep duration|| nighttime rest measurement|| sleep quality|| sleep latency	GCST003542	sleep duration|| nighttime rest measurement|| sleep quality|| sleep latency	
Non-alcoholic fatty liver disease histology (AST)	non-alcoholic fatty liver disease|| cirrhosis of liver	GCST000767	non-alcoholic fatty liver disease|| cirrhosis of liver	
Non-alcoholic fatty liver disease histology (lobular)	non-alcoholic fatty liver disease|| cirrhosis of liver	GCST000766	non-alcoholic fatty liver disease|| cirrhosis of liver	
Non-alcoholic fatty liver disease histology (other)	serum alanine aminotransferase measurement|| non-alcoholic fatty liver disease|| cirrhosis of liver	GCST000765	serum alanine aminotransferase measurement|| non-alcoholic fatty liver disease|| cirrhosis of liver	
Non-chemotherapy drug induced agranulocytosis	drug-induced agranulocytosis|| response to drug	GCST003526	drug-induced agranulocytosis|| response to drug	
Non-glioblastoma glioma	central nervous system cancer|| glioma	GCST004348	central nervous system cancer|| glioma	
Non-response to antidepressants and depression	unipolar depression|| mood disorder|| response to antidepressant	GCST003812	unipolar depression|| mood disorder|| response to antidepressant	
Non-response to bupropion and depression	unipolar depression|| response to bupropion|| mood disorder	GCST003804	unipolar depression|| response to bupropion|| mood disorder	
Non-response to citalopram or escitalopram and depression	unipolar depression|| response to escitalopram|| response to citalopram|| mood disorder	GCST003810	unipolar depression|| response to escitalopram|| response to citalopram|| mood disorder	
Non-response to selective serotonin reuptake inhibitors and depression	unipolar depression|| response to selective serotonin reuptake inhibitor|| mood disorder	GCST003808	unipolar depression|| response to selective serotonin reuptake inhibitor|| mood disorder	
Nonalcoholic steatohepatitis-derived hepatocellular carcinoma	hepatocellular carcinoma|| non-alcoholic steatohepatitis	GCST005309	hepatocellular carcinoma|| non-alcoholic steatohepatitis	
Nonsyndromic cleft lip with cleft palate	cleft palate|| cleft lip	GCST004166	cleft palate|| cleft lip	
Nonsyndromic cleft lip with or without cleft palate	cleft palate|| cleft lip	GCST006415	cleft palate|| cleft lip	
Nonsyndromic cleft lip with or without cleft palate	cleft palate|| cleft lip	GCST004088	cleft palate|| cleft lip	
Nonsyndromic cleft lip with or without cleft palate	cleft palate|| cleft lip	GCST002811	cleft palate|| cleft lip	
Nonsyndromic cleft lip with or without cleft palate x sex interaction (2df test)	cleft palate|| sex interaction measurement|| cleft lip	GCST006680	cleft palate|| sex interaction measurement|| cleft lip	
Number of children	female fertility|| fertility measurement	GCST002801	female fertility|| fertility measurement	
Number of children (6+ vs. 0 or 1)	female fertility|| fertility measurement	GCST002800	female fertility|| fertility measurement	
Number of pregnancies	female fertility|| fertility measurement	GCST002799	female fertility|| fertility measurement	
Obesity and osteoporosis	obesity|| osteoporosis	GCST000469	obesity|| osteoporosis	
Obesity-related traits	cortisol secretion measurement|| hormone measurement|| antioxidant measurement|| CCL2 measurement|| body mass index|| IGFBP-3 measurement|| fatty acid measurement|| tumor necrosis factor-alpha measurement|| gestational age|| energy expenditure|| sleep measurement|| metabolic rate measurement|| urinary metabolite measurement|| blood urea nitrogen measurement|| vitamin B12 measurement|| energy intake|| ICAM-1 measurement|| body height|| hip circumference|| arm span|| physical activity|| heart rate|| protein measurement|| estradiol measurement|| thyroid stimulating hormone measurement|| waist circumference|| total cholesterol measurement|| interleukin-6 measurement|| body composition measurement|| birth weight|| amino acid measurement|| C-reactive protein measurement|| HOMA-IR|| head circumference|| adiponectin measurement|| high density lipoprotein cholesterol measurement|| aspartate aminotransferase measurement|| leptin measurement|| transforming growth factor beta measurement|| systolic blood pressure|| IGFBP-1 measurement|| bone density|| body weight|| fasting blood glucose measurement|| homocysteine measurement|| folic acid measurement|| serum alanine aminotransferase measurement|| CCL5 measurement|| IGF-1 measurement|| testosterone measurement|| insulin sensitivity measurement|| diastolic blood pressure|| maximal oxygen uptake measurement|| triglyceride measurement|| low density lipoprotein cholesterol measurement|| lean body mass|| fasting blood insulin measurement	GCST001762	cortisol secretion measurement|| hormone measurement|| antioxidant measurement|| CCL2 measurement|| body mass index|| IGFBP-3 measurement|| fatty acid measurement|| tumor necrosis factor-alpha measurement|| gestational age|| energy expenditure|| sleep measurement|| metabolic rate measurement|| urinary metabolite measurement|| blood urea nitrogen measurement|| vitamin B12 measurement|| energy intake|| ICAM-1 measurement|| body height|| hip circumference|| arm span|| physical activity|| heart rate|| protein measurement|| estradiol measurement|| thyroid stimulating hormone measurement|| waist circumference|| total cholesterol measurement|| interleukin-6 measurement|| body composition measurement|| birth weight|| amino acid measurement|| C-reactive protein measurement|| HOMA-IR|| head circumference|| adiponectin measurement|| high density lipoprotein cholesterol measurement|| aspartate aminotransferase measurement|| leptin measurement|| transforming growth factor beta measurement|| systolic blood pressure|| IGFBP-1 measurement|| bone density|| body weight|| fasting blood glucose measurement|| homocysteine measurement|| folic acid measurement|| serum alanine aminotransferase measurement|| CCL5 measurement|| IGF-1 measurement|| testosterone measurement|| insulin sensitivity measurement|| diastolic blood pressure|| maximal oxygen uptake measurement|| triglyceride measurement|| low density lipoprotein cholesterol measurement|| lean body mass|| fasting blood insulin measurement	
Obesity-related traits	fat body mass|| body mass index|| obesity	GCST001288	fat body mass|| body mass index|| obesity	
Obesity-related traits	body weight|| waist-hip ratio|| body mass index	GCST000060	body weight|| waist-hip ratio|| body mass index	
Objective response to lithium treatment	bipolar disorder|| response to lithium ion	GCST003159	bipolar disorder|| response to lithium ion	
Obsessive-compulsive disorder or autism spectrum disorder	obsessive-compulsive disorder|| autism spectrum disorder	GCST004703	obsessive-compulsive disorder|| autism spectrum disorder	
Obstructive sleep apnea (average oxygen saturation during sleep)	sleep apnea measurement|| obstructive sleep apnea	GCST003673	sleep apnea measurement|| obstructive sleep apnea	
Obstructive sleep apnea trait (apnea hypopnea index)	sleep apnea measurement|| obstructive sleep apnea	GCST003674	sleep apnea measurement|| obstructive sleep apnea	
Obstructive sleep apnea trait (average respiratory event duration)	sleep apnea measurement|| obstructive sleep apnea	GCST003675	sleep apnea measurement|| obstructive sleep apnea	
Occipital cortical area (total cortical area interaction)	total cortical area measurement|| visual cortical surface area measurement	GCST001411	total cortical area measurement|| visual cortical surface area measurement	
Offspring birth weight	birth weight|| parental genotype effect measurement	GCST005314	birth weight|| parental genotype effect measurement	
Open-angle glaucoma and intra-ocular pressure	open-angle glaucoma|| intraocular pressure measurement	GCST005408	open-angle glaucoma|| intraocular pressure measurement	
Open-angle glaucoma and optic cup area	optic cup area measurement|| open-angle glaucoma	GCST005406	optic cup area measurement|| open-angle glaucoma	
Open-angle glaucoma and optic disc area	open-angle glaucoma|| optic disc area measurement	GCST005410	open-angle glaucoma|| optic disc area measurement	
Open-angle glaucoma and vertical cup-disc ratio	cup-to-disc ratio measurement|| open-angle glaucoma	GCST005409	cup-to-disc ratio measurement|| open-angle glaucoma	
Opioid requirements during laparoscopic-assisted colectomy	response to opioid|| analgesia requirement measurement	GCST005364	response to opioid|| analgesia requirement measurement	
Oral cancers (chewing tobacco related)	matrix metalloproteinase measurement|| mouth neoplasm	GCST001480	matrix metalloproteinase measurement|| mouth neoplasm	
Oral cavity and pharyngeal cancer	pharynx cancer|| oral cavity cancer	GCST003857	pharynx cancer|| oral cavity cancer	
Orofacial clefts (cleft lip vs. cleft lip and palate)	cleft palate|| Orofacial clefting syndrome|| cleft lip	GCST005079	cleft palate|| Orofacial clefting syndrome|| cleft lip	
Orofacial clefts (maternal alcohol consumption interaction)	alcohol consumption measurement|| Orofacial clefting syndrome|| cleft lip	GCST001082	alcohol consumption measurement|| Orofacial clefting syndrome|| cleft lip	
Osteoarthritis (with total hip replacement)	hip osteoarthritis symptom severity measurement|| osteoarthritis	GCST004199	hip osteoarthritis symptom severity measurement|| osteoarthritis	
Osteoarthritis of the hip (hospital diagnosed)	osteoarthritis|| hip	GCST005810	osteoarthritis|| hip	
Osteoarthritis of the hip (with total joint replacement)	osteoarthritis|| hip	GCST005572	osteoarthritis|| hip	
Osteoarthritis of the hip or knee	osteoarthritis|| hip|| osteoarthritis|| knee	GCST005573	osteoarthritis|| hip|| osteoarthritis|| knee	
Osteoarthritis of the hip or knee (hospital diagnosed)	osteoarthritis|| hip|| osteoarthritis|| knee	GCST005812	osteoarthritis|| hip|| osteoarthritis|| knee	
Osteoarthritis of the hip or knee (with total joint replacement)	osteoarthritis|| hip|| osteoarthritis|| knee	GCST005571	osteoarthritis|| hip|| osteoarthritis|| knee	
Osteoarthritis of the knee (hospital diagnosed)	osteoarthritis|| knee	GCST005813	osteoarthritis|| knee	
Osteoarthritis of the knee (with total joint replacement)	osteoarthritis|| knee	GCST005574	osteoarthritis|| knee	
Osteoarthritis or femoral neck bone mineral density	osteoarthritis|| femoral neck bone mineral density	GCST005228	osteoarthritis|| femoral neck bone mineral density	
Osteoarthritis or lumbar spine bone mineral density	osteoarthritis|| spine bone mineral density	GCST005225	osteoarthritis|| spine bone mineral density	
Osteoporosis or obesity (pleiotropy)	obesity|| osteoporosis	GCST005114	obesity|| osteoporosis	
Osteoprotegerin (red blood cell fatty acid level interaction)	fatty acid measurement|| osteoprotegerin measurement	GCST004819	fatty acid measurement|| osteoprotegerin measurement	
Other erythrocyte phenotypes	erythrocyte count|| mean corpuscular hemoglobin concentration	GCST000500	erythrocyte count|| mean corpuscular hemoglobin concentration	
P-Selectin (red blood cell fatty acid level interaction)	fatty acid measurement|| P-Selectin measurement	GCST004822	fatty acid measurement|| P-Selectin measurement	
Paclitaxel-induced cytotoxicity	cytotoxicity measurement|| response to paclitaxel	GCST002924	cytotoxicity measurement|| response to paclitaxel	
Paclitaxel-induced neuropathy	peripheral neuropathy|| response to paclitaxel	GCST002923	peripheral neuropathy|| response to paclitaxel	
Paclitaxel-induced neuropathy	brain serotonin transporter measurement|| response to paclitaxel	GCST002074	brain serotonin transporter measurement|| response to paclitaxel	
Paclitaxel-induced neuropathy	response to paclitaxel|| neuropathy	GCST001755	response to paclitaxel|| neuropathy	
Paclitaxel-induced neuropathy	response to paclitaxel|| neuropathy	GCST001624	response to paclitaxel|| neuropathy	
Pain medicine use during menstruation	drug use measurement|| quality of life during menstruation measurement	GCST006637	drug use measurement|| quality of life during menstruation measurement	
Parkinson disease and lewy body pathology	Parkinson's disease|| Lewy body measurement	GCST002778	Parkinson's disease|| Lewy body measurement	
Parkinson's disease (coffee consumption interaction)	Parkinson's disease|| coffee consumption	GCST001205	Parkinson's disease|| coffee consumption	
Parkinson's disease (pesticide exposure interaction)	Parkinson's disease|| pesticide exposure measurement	GCST003600	Parkinson's disease|| pesticide exposure measurement	
Peanut allergy (maternal genetic effects)	peanut allergy measurement|| parental genotype effect measurement	GCST005723	peanut allergy measurement|| parental genotype effect measurement	
Peanut allergy (parent-of-origin effect)	peanut allergy measurement|| parental genotype effect measurement	GCST005727	peanut allergy measurement|| parental genotype effect measurement	
Pediatric autoimmune diseases	autoimmune thyroid disease|| type I diabetes mellitus|| Common variable immunodeficiency|| chronic childhood arthritis|| ankylosing spondylitis|| psoriasis|| celiac disease|| ulcerative colitis|| Crohn's disease|| autoimmune disease|| systemic lupus erythematosus	GCST003097	autoimmune thyroid disease|| type I diabetes mellitus|| Common variable immunodeficiency|| chronic childhood arthritis|| ankylosing spondylitis|| psoriasis|| celiac disease|| ulcerative colitis|| Crohn's disease|| autoimmune disease|| systemic lupus erythematosus	
Pediatric non-alcoholic fatty liver disease activity score	non-alcoholic fatty liver disease|| cirrhosis of liver	GCST001928	non-alcoholic fatty liver disease|| cirrhosis of liver	
Percent mammographic density	mammographic density percentage|| mammographic density measurement	GCST002669	mammographic density percentage|| mammographic density measurement	
Pericardial adipose tissue adjusted for height and weight	pericardial adipose tissue measurement|| body weight|| body height	GCST006544	pericardial adipose tissue measurement|| body weight|| body height	
Pericardial adipose tissue adjusted for height and weight	pericardial adipose tissue measurement|| body weight|| body height	GCST006543	pericardial adipose tissue measurement|| body weight|| body height	
Pericardial adipose tissue adjusted for height and weight	pericardial adipose tissue measurement|| body weight|| body height	GCST003968	pericardial adipose tissue measurement|| body weight|| body height	
Periodontal disease-related phenotypes	periodontitis|| periodontal measurement	GCST003484	periodontitis|| periodontal measurement	
Peripheral arterial disease (traffic-related air pollution interaction)	peripheral arterial disease|| traffic air pollution measurement	GCST004482	peripheral arterial disease|| traffic air pollution measurement	
Phenytoin-induced maculopapular exanthema	maculopapular eruption|| response to phenytoin	GCST005200	maculopapular eruption|| response to phenytoin	
Phenytoin-induced severe cutaneous adverse reactions	severe cutaneous adverse reaction|| response to phenytoin	GCST002558	severe cutaneous adverse reaction|| response to phenytoin	
Plantar fascial disorders	Plantar Fasciitis|| Plantar Fibromatosis	GCST005558	Plantar Fasciitis|| Plantar Fibromatosis	
Platelet thrombus formation	platelet reactivity measurement|| thrombus formation measurement	GCST001501	platelet reactivity measurement|| thrombus formation measurement	
Post bronchodilator FEV1	forced expiratory volume|| response to bronchodilator	GCST003262	forced expiratory volume|| response to bronchodilator	
Post bronchodilator FEV1/FVC ratio	response to bronchodilator|| FEV/FEC ratio	GCST003264	response to bronchodilator|| FEV/FEC ratio	
Posterior cortical atrophy and Alzheimer's disease	Alzheimer's disease|| Posterior cortical atrophy	GCST003452	Alzheimer's disease|| Posterior cortical atrophy	
Postprandial triglyceride response to high fat diet meal	response to high fat food intake|| triglyceride change measurement	GCST003014	response to high fat food intake|| triglyceride change measurement	
Preterm birth (maternal effect)	premature birth|| parental genotype effect measurement	GCST004898	premature birth|| parental genotype effect measurement	
Preterm birth (maternal effect)	premature birth|| parental genotype effect measurement	GCST004841	premature birth|| parental genotype effect measurement	
Preterm birth (maternal effect) (maternal pre-pregnancy BMI interaction)	body mass index|| premature birth|| parental genotype effect measurement	GCST004842	body mass index|| premature birth|| parental genotype effect measurement	
Preterm birth (maternal effect) (maternal pre-pregnancy BMI interaction)	body mass index|| premature birth|| parental genotype effect measurement	GCST004843	body mass index|| premature birth|| parental genotype effect measurement	
"Primary sclerosing cholangitis associated immune-mediated diseases (Crohn's disease, celiac disease, psoriasis, rheumatoid arthritis, sarcoidosis, type 1 diabetes or ulcerative colitis) (pleiotropy)"	rheumatoid arthritis|| type I diabetes mellitus|| psoriasis|| Sarcoidosis|| celiac disease|| ulcerative colitis|| Crohn's disease|| sclerosing cholangitis	GCST005563	rheumatoid arthritis|| type I diabetes mellitus|| psoriasis|| Sarcoidosis|| celiac disease|| ulcerative colitis|| Crohn's disease|| sclerosing cholangitis	
Progressive supranuclear palsy and immune-mediated diseases (pleiotropy)	rheumatoid arthritis|| type I diabetes mellitus|| psoriasis|| celiac disease|| ulcerative colitis|| Crohn's disease|| Progressive supranuclear palsy	GCST005320	rheumatoid arthritis|| type I diabetes mellitus|| psoriasis|| celiac disease|| ulcerative colitis|| Crohn's disease|| Progressive supranuclear palsy	
Prostate cancer (SNP x SNP interaction)	genetic variation|| prostate carcinoma	GCST001370	genetic variation|| prostate carcinoma	
Prostate cancer aggressiveness	cancer aggressiveness measurement|| Gleason score measurement|| prostate carcinoma	GCST002886	cancer aggressiveness measurement|| Gleason score measurement|| prostate carcinoma	
Prostate cancer mortality	survival time|| metastatic prostate cancer	GCST000844	survival time|| metastatic prostate cancer	
Proteinuria and chronic kidney disease	chronic kidney disease|| Proteinuria	GCST003141	chronic kidney disease|| Proteinuria	
Psoriatic arthritis vs Cutaneous psoriasis	cutaneous psoriasis measurement|| psoriatic arthritis|| psoriasis	GCST003271	cutaneous psoriasis measurement|| psoriatic arthritis|| psoriasis	
Psychiatric diseases (pleiotropy) (HIPO component 1)	attention deficit hyperactivity disorder|| unipolar depression|| schizophrenia|| autism spectrum disorder|| bipolar disorder	GCST006668	attention deficit hyperactivity disorder|| unipolar depression|| schizophrenia|| autism spectrum disorder|| bipolar disorder	
Psychosis and Alzheimer's disease	Alzheimer's disease|| psychotic symptoms	GCST001285	Alzheimer's disease|| psychotic symptoms	
Psychotic symptoms and prion disease	prion disease|| psychotic symptoms	GCST002871	prion disease|| psychotic symptoms	
Pubertal anthropometrics	puberty|| height growth measurement	GCST001876	puberty|| height growth measurement	
Pulmonary artery enlargement and chronic obstructive pulmonary disease	pulmonary artery enlargement|| chronic obstructive pulmonary disease	GCST002798	pulmonary artery enlargement|| chronic obstructive pulmonary disease	
Pulmonary function	pulmonary function measurement|| forced expiratory volume|| FEV/FEC ratio|| vital capacity	GCST002113	pulmonary function measurement|| forced expiratory volume|| FEV/FEC ratio|| vital capacity	
Pulmonary function (smoking interaction)	pulmonary function measurement|| smoking behaviour measurement	GCST001784	pulmonary function measurement|| smoking behaviour measurement	
Pulmonary function decline	forced expiratory volume|| FEV/FEC ratio	GCST001444	forced expiratory volume|| FEV/FEC ratio	
Pulse pressure (alcohol consumption interaction)	pulse pressure measurement|| alcohol drinking	GCST002310	pulse pressure measurement|| alcohol drinking	
Pulse pressure (dietary potassium intake interaction)	pulse pressure measurement|| dietary potassium intake measurement	GCST005201	pulse pressure measurement|| dietary potassium intake measurement	
Pulse pressure x alcohol consumption (light vs heavy) interaction (2df test)	pulse pressure measurement|| alcohol consumption measurement	GCST006171	pulse pressure measurement|| alcohol consumption measurement	
Pulse pressure x alcohol consumption interaction (2df test)	pulse pressure measurement|| alcohol drinking	GCST006168	pulse pressure measurement|| alcohol drinking	
Pulse pressure x sodium interaction (1df test)	pulse pressure measurement|| sodium measurement	GCST006117	pulse pressure measurement|| sodium measurement	
Pulse pressure x sodium interaction (2df test)	pulse pressure measurement|| sodium measurement	GCST006118	pulse pressure measurement|| sodium measurement	
Putamen activity during reward	functional brain measurement|| putamen measurement|| response to reward	GCST004971	functional brain measurement|| putamen measurement|| response to reward	
Putamen actvity during disappointment	response to disappointment|| functional brain measurement|| putamen measurement	GCST004972	response to disappointment|| functional brain measurement|| putamen measurement	
QRS complex (12-leadsum)	QRS amplitude|| QRS complex	GCST003872	QRS amplitude|| QRS complex	
QRS complex (Cornell)	QRS amplitude|| QRS complex	GCST003871	QRS amplitude|| QRS complex	
QRS complex (Sokolow-Lyon)	QRS amplitude|| QRS complex	GCST003870	QRS amplitude|| QRS complex	
QRS duration	QRS complex|| QRS duration	GCST003844	QRS complex|| QRS duration	
QRS interval (sulfonylurea treatment interaction)	QRS duration|| response to sulfonylurea	GCST004033	QRS duration|| response to sulfonylurea	
QT interval (ambient particulate matter interaction)	QT interval|| particulate matter air pollution measurement	GCST004642	QT interval|| particulate matter air pollution measurement	
QT interval (sulfonylurea treatment interaction)	response to sulfonylurea|| QT interval	GCST004031	response to sulfonylurea|| QT interval	
QT interval (tricyclic/tetracyclic antidepressant use interaction)	response to tetracyclic antidepressant|| QT interval|| response to tricyclic antidepressant	GCST004010	response to tetracyclic antidepressant|| QT interval|| response to tricyclic antidepressant	
Quantitative traits	waist circumference|| total cholesterol measurement|| body fat distribution|| C-reactive protein measurement|| body mass index|| high density lipoprotein cholesterol measurement|| body height|| diastolic blood pressure|| triglyceride measurement|| systolic blood pressure|| low density lipoprotein cholesterol measurement|| body weight|| thyroid stimulating hormone measurement	GCST000337	waist circumference|| total cholesterol measurement|| body fat distribution|| C-reactive protein measurement|| body mass index|| high density lipoprotein cholesterol measurement|| body height|| diastolic blood pressure|| triglyceride measurement|| systolic blood pressure|| low density lipoprotein cholesterol measurement|| body weight|| thyroid stimulating hormone measurement	
Rate of change of FEV1 (time interaction)	FEV change measurement|| forced expiratory volume	GCST002517	FEV change measurement|| forced expiratory volume	
Ratio of apolipoprotein A1 to apolipoprotein B	apolipoprotein A 1 measurement|| apolipoprotein B measurement	GCST005443	apolipoprotein A 1 measurement|| apolipoprotein B measurement	
Reading disability and language impairment	language impairment|| dyslexia	GCST002175	language impairment|| dyslexia	
Reading disability or specific language impairment (pleiotropy)	specific language impairment|| dyslexia	GCST004401	specific language impairment|| dyslexia	
Reading disability or specific language impairment adjusted for intelligence quotient (pleiotropy)	intelligence|| specific language impairment|| dyslexia	GCST004402	intelligence|| specific language impairment|| dyslexia	
Reading or mathematical ability	reading|| mathematical ability	GCST002522	reading|| mathematical ability	
Red blood cell fatty acid levels	arachidonic acid measurement|| fatty acid measurement|| linolenic acid measurement|| oleic acid measurement|| docosapentaenoic acid measurement|| linoleic acid measurement	GCST002712	arachidonic acid measurement|| fatty acid measurement|| linolenic acid measurement|| oleic acid measurement|| docosapentaenoic acid measurement|| linoleic acid measurement	
Red blood cell traits	mean corpuscular volume|| mean corpuscular hemoglobin	GCST002109	mean corpuscular volume|| mean corpuscular hemoglobin	
Red blood cell traits	hemoglobin measurement|| erythrocyte count|| mean corpuscular hemoglobin concentration|| mean corpuscular volume|| hematocrit|| mean corpuscular hemoglobin|| red blood cell distribution width	GCST001873	hemoglobin measurement|| erythrocyte count|| mean corpuscular hemoglobin concentration|| mean corpuscular volume|| hematocrit|| mean corpuscular hemoglobin|| red blood cell distribution width	
Red blood cell traits	erythrocyte count|| mean corpuscular hemoglobin concentration|| mean corpuscular volume|| mean corpuscular hemoglobin	GCST000814	erythrocyte count|| mean corpuscular hemoglobin concentration|| mean corpuscular volume|| mean corpuscular hemoglobin	
Renal function and chronic kidney disease	renal system measurement|| chronic kidney disease	GCST000397	renal system measurement|| chronic kidney disease	
Renal function-related traits (BUN)	renal system measurement|| blood urea nitrogen measurement	GCST001610	renal system measurement|| blood urea nitrogen measurement	
Renal function-related traits (urea)	renal system measurement|| uric acid measurement	GCST001608	renal system measurement|| uric acid measurement	
Reporting of stressful life event	self rated health|| stressful life event measurement	GCST001774	self rated health|| stressful life event measurement	
Residual cognition	cognition|| aging	GCST004291	cognition|| aging	
Response to antidepressants and depression	unipolar depression|| mood disorder|| response to antidepressant	GCST003813	unipolar depression|| mood disorder|| response to antidepressant	
Response to bleomycin (chromatid breaks)	response to bleomycin|| chromatid break measurement|| response to antibiotic	GCST000882	response to bleomycin|| chromatid break measurement|| response to antibiotic	
Response to bupropion and depression	unipolar depression|| response to bupropion|| mood disorder	GCST003806	unipolar depression|| response to bupropion|| mood disorder	
Response to citalopram or escitalopram and depression	unipolar depression|| response to escitalopram|| response to citalopram|| mood disorder	GCST003811	unipolar depression|| response to escitalopram|| response to citalopram|| mood disorder	
Response to clopidogrel therapy	platelet reactivity measurement|| response to clopidogrel	GCST004266	platelet reactivity measurement|| response to clopidogrel	
Response to exercise (triglyceride level interaction)	triglyceride change measurement|| response to exercise	GCST003207	triglyceride change measurement|| response to exercise	
Response to fenofibrate (HDL cholesterol levels)	HDL cholesterol change measurement|| response to fenofibrate	GCST003485	HDL cholesterol change measurement|| response to fenofibrate	
Response to fenofibrate (LDL cholesterol levels)	LDL cholesterol change measurement|| response to fenofibrate	GCST003486	LDL cholesterol change measurement|| response to fenofibrate	
Response to fenofibrate (total cholesterol levels)	total cholesterol change measurement|| response to fenofibrate	GCST003487	total cholesterol change measurement|| response to fenofibrate	
Response to fenofibrate (triglyceride levels)	triglyceride change measurement|| response to fenofibrate	GCST003488	triglyceride change measurement|| response to fenofibrate	
Response to Homoharringtonine (cytotoxicity)	response to homoharringtonine|| cytotoxicity measurement	GCST002749	response to homoharringtonine|| cytotoxicity measurement	
Response to metformin (IC50)	cytotoxicity measurement|| response to metformin	GCST003791	cytotoxicity measurement|| response to metformin	
Response to selective serotonin reuptake inhibitors and depression	unipolar depression|| response to selective serotonin reuptake inhibitor|| mood disorder	GCST003809	unipolar depression|| response to selective serotonin reuptake inhibitor|| mood disorder	
Response to simvastatin treatment (PCSK9 protein level change)	response to simvastatin|| PCSK9 protein measurement	GCST002642	response to simvastatin|| PCSK9 protein measurement	
Response to statin therapy (LDL cholesterol subfractions)	response to statin|| low density lipoprotein cholesterol measurement	GCST002865	response to statin|| low density lipoprotein cholesterol measurement	
Response to statins (HDL cholesterol change)	HDL cholesterol change measurement|| response to statin	GCST003617	HDL cholesterol change measurement|| response to statin	
Response to statins (LDL cholesterol change)	response to statin|| low density lipoprotein cholesterol measurement	GCST002675	response to statin|| low density lipoprotein cholesterol measurement	
Response to statins (LDL cholesterol change)	response to statin|| LDL cholesterol change measurement	GCST001408	response to statin|| LDL cholesterol change measurement	
Response to thiazide diuretic treatment (hypokalemia)	response to hydrochlorothiazide|| hypokalemia	GCST002600	response to hydrochlorothiazide|| hypokalemia	
Response to treatment for acute lymphoblastic leukemia	acute lymphoblastic leukemia|| response to antineoplastic agent	GCST000323	acute lymphoblastic leukemia|| response to antineoplastic agent	
Response to ximelagatran treatment (increased serum alanine aminotransferase levels)	serum alanine aminotransferase measurement|| response to ximelagatran	GCST000034	serum alanine aminotransferase measurement|| response to ximelagatran	
Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)	rheumatoid arthritis|| anti-citrullinated protein antibody seropositivity|| rheumatoid factor seropositivity measurement	GCST004174	rheumatoid arthritis|| anti-citrullinated protein antibody seropositivity|| rheumatoid factor seropositivity measurement	
Ribavirin-induced anemia	anemia|| response to ribavirin	GCST000729	anemia|| response to ribavirin	
Risky sexual behaviors (alcohol dependence interaction)	behavioural disinhibition measurement|| alcohol dependence|| risky sexual behaviour measurement	GCST003860	behavioural disinhibition measurement|| alcohol dependence|| risky sexual behaviour measurement	
Risky sexual behaviors (alcohol dependence interaction)	alcohol dependence|| risky sexual behaviour measurement	GCST004956	alcohol dependence|| risky sexual behaviour measurement	
RR interval (tricyclic/tetracyclic antidepressant use interaction)	RR interval|| response to tetracyclic antidepressant|| response to tricyclic antidepressant	GCST004011	RR interval|| response to tetracyclic antidepressant|| response to tricyclic antidepressant	
Rubella-specific interferon-gamma secretion	interferon gamma measurement|| response to vaccine	GCST005177	interferon gamma measurement|| response to vaccine	
Rubella-specific interleukin-6 secretion	interleukin-6 measurement|| response to vaccine	GCST005176	interleukin-6 measurement|| response to vaccine	
Sasang constitutional medicine type (So-Eum)	So-Eum|| Sasang constitutional medicine type	GCST002854	So-Eum|| Sasang constitutional medicine type	
Sasang constitutional medicine type (So-Yang)	So-Yang|| Sasang constitutional medicine type	GCST002852	So-Yang|| Sasang constitutional medicine type	
Sasang constitutional medicine type (Tae-Eum)	Tae-Eum|| Sasang constitutional medicine type	GCST002853	Tae-Eum|| Sasang constitutional medicine type	
Sasang constitutional medicine type (Tae-Yang)	Tae-Yang|| Sasang constitutional medicine type	GCST002851	Tae-Yang|| Sasang constitutional medicine type	
Schizophrenia (cytomegalovirus infection interaction)	schizophrenia|| cytomegalovirus infection	GCST001833	schizophrenia|| cytomegalovirus infection	
Schizophrenia (inflammation and infection response interaction)	schizophrenia|| HSV1 seropositivity|| Toxoplasma gondii seropositivity|| cytomegalovirus seropositivity	GCST002812	schizophrenia|| HSV1 seropositivity|| Toxoplasma gondii seropositivity|| cytomegalovirus seropositivity	
Schizophrenia or bipolar disorder	schizophrenia|| bipolar disorder	GCST002295	schizophrenia|| bipolar disorder	
Schizophrenia or cigarettes per day (pleiotropy)	schizophrenia|| cigarettes per day measurement	GCST005266	schizophrenia|| cigarettes per day measurement	
Schizophrenia or general cognitive function (pleiotropy)	schizophrenia|| cognitive function measurement	GCST004975	schizophrenia|| cognitive function measurement	
Schizophrenia or lung cancer (pleiotropy)	lung carcinoma|| schizophrenia	GCST005267	lung carcinoma|| schizophrenia	
Schizophrenia or reaction time (pleiotropy)	schizophrenia|| reaction time measurement	GCST004974	schizophrenia|| reaction time measurement	
Schizophrenia or verbal-numerical reasoning (pleiotropy)	schizophrenia|| verbal-numerical reasoning measurement	GCST004973	schizophrenia|| verbal-numerical reasoning measurement	
"Schizophrenia, bipolar disorder and depression (combined)"	unipolar depression|| mental or behavioural disorder|| bipolar disorder	GCST000774	unipolar depression|| mental or behavioural disorder|| bipolar disorder	
"Schizophrenia, schizoaffective disorder or bipolar disorder"	schizophrenia|| bipolar disorder|| schizoaffective disorder	GCST002254	schizophrenia|| bipolar disorder|| schizoaffective disorder	
Sciatica caused by lumbar disc herniation (treated with microdiscectomy)	lumbar disc herniation|| Sciatica|| LDH-related sciatica symptom severity measurement	GCST004098	lumbar disc herniation|| Sciatica|| LDH-related sciatica symptom severity measurement	
Sclerosing cholangitis and ulcerative colitis (combined)	ulcerative colitis|| sclerosing cholangitis	GCST001615	ulcerative colitis|| sclerosing cholangitis	
Sleep traits (multi-trait analysis)	sleep duration|| circadian rhythm|| excessive daytime sleepiness measurement|| insomnia measurement	GCST003982	sleep duration|| circadian rhythm|| excessive daytime sleepiness measurement|| insomnia measurement	
Smoking interaction in lung adenocarcinoma (1df test)	smoking behavior|| lung adenocarcinoma	GCST005909	smoking behavior|| lung adenocarcinoma	
Smoking interaction in non-small cell lung cancer (1df test)	smoking behavior|| non-small cell lung carcinoma	GCST005910	smoking behavior|| non-small cell lung carcinoma	
Smoking interaction in squamous cell lung cancer (1df test)	smoking behavior|| squamous cell lung carcinoma	GCST005911	smoking behavior|| squamous cell lung carcinoma	
Social science traits (pleiotropy) (HIPO component 1)	neuroticism measurement|| wellbeing measurement|| depressive symptom measurement	GCST006665	neuroticism measurement|| wellbeing measurement|| depressive symptom measurement	
Sotalol-induced IKr potassium channel inhibition  (T wave peak and end interval change)	response to sotalol|| TpTe measurement	GCST005134	response to sotalol|| TpTe measurement	
Sotalol-induced IKr potassium channel inhibition  (ventricular repolarization duration change)	response to sotalol|| ventricular repolarisation duration measurement	GCST005140	response to sotalol|| ventricular repolarisation duration measurement	
Sotalol-induced IKr potassium channel inhibition (T wave maximal amplitude change)	response to sotalol|| T wave amplitude	GCST005135	response to sotalol|| T wave amplitude	
Sotalol-induced IKr potassium channel inhibition (T wave morphology notching)	response to sotalol|| T wave morphology measurement	GCST005137	response to sotalol|| T wave morphology measurement	
Sotalol-induced IKr potassium channel inhibition (ventricular repolarization changes PC1)	response to sotalol|| T wave amplitude|| TpTe measurement|| ventricular repolarisation duration measurement	GCST005139	response to sotalol|| T wave amplitude|| TpTe measurement|| ventricular repolarisation duration measurement	
Sotalol-induced IKr potassium channel inhibition (ventricular repolarization changes PC2)	response to sotalol|| T wave amplitude|| TpTe measurement|| ventricular repolarisation duration measurement	GCST005136	response to sotalol|| T wave amplitude|| TpTe measurement|| ventricular repolarisation duration measurement	
Sotalol-induced IKr potassium channel inhibition (ventricular repolarization changes PC3)	response to sotalol|| T wave amplitude|| TpTe measurement|| ventricular repolarisation duration measurement	GCST005138	response to sotalol|| T wave amplitude|| TpTe measurement|| ventricular repolarisation duration measurement	
Spherical equivalent (joint analysis main effects and education interaction)	self reported educational attainment|| refractive error measurement	GCST003455	self reported educational attainment|| refractive error measurement	
Sphingolipid levels	sphingolipid measurement|| blood metabolite measurement	GCST002964	sphingolipid measurement|| blood metabolite measurement	
Spine bone mineral density and alcohol drinking	alcohol consumption measurement|| spine bone mineral density	GCST003919	alcohol consumption measurement|| spine bone mineral density	
Spontaneous preterm birth (maternal effect)	spontaneous preterm birth|| parental genotype effect measurement	GCST004845	spontaneous preterm birth|| parental genotype effect measurement	
Spontaneous preterm birth (preterm birth)	birth measurement|| spontaneous preterm birth	GCST002751	birth measurement|| spontaneous preterm birth	
Spontaneous preterm birth (preterm delivery)	delivery measurement|| spontaneous preterm birth	GCST002752	delivery measurement|| spontaneous preterm birth	
Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS-TEN)	Stevens-Johnson syndrome|| toxic epidermal necrolysis	GCST001239	Stevens-Johnson syndrome|| toxic epidermal necrolysis	
Subcutaneous adipose tissue (sex interaction)	subcutaneous adipose tissue measurement|| sex interaction measurement	GCST005092	subcutaneous adipose tissue measurement|| sex interaction measurement	
Suicide risk	mental or behavioural disorder|| attempted suicide	GCST000854	mental or behavioural disorder|| attempted suicide	
Sulfasalazine-induced agranulocytosis	drug-induced agranulocytosis|| response to sulfasalazine	GCST004781	drug-induced agranulocytosis|| response to sulfasalazine	
Susceptibility to persistent hepatitis B virus infection	hepatitis B infection|| Susceptibility to viral and mycobacterial infections	GCST003615	hepatitis B infection|| Susceptibility to viral and mycobacterial infections	
Systemic lupus erythematosus and Systemic sclerosis	systemic scleroderma|| systemic lupus erythematosus	GCST002069	systemic scleroderma|| systemic lupus erythematosus	
Systemic lupus erythematosus or rheumatoid arthritis	rheumatoid arthritis|| systemic lupus erythematosus	GCST003620	rheumatoid arthritis|| systemic lupus erythematosus	
Systolic blood pressure (alcohol consumption interaction)	systolic blood pressure|| alcohol drinking	GCST002307	systolic blood pressure|| alcohol drinking	
Systolic blood pressure (cigarette smoking interaction)	smoking status measurement|| systolic blood pressure	GCST006188	smoking status measurement|| systolic blood pressure	
Systolic blood pressure (cigarette smoking interaction)	systolic blood pressure|| smoking behaviour measurement	GCST003365	systolic blood pressure|| smoking behaviour measurement	
Systolic blood pressure (dietary potassium intake interaction)	systolic blood pressure|| dietary potassium intake measurement	GCST005204	systolic blood pressure|| dietary potassium intake measurement	
Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test)	systolic blood pressure|| alcohol consumption measurement	GCST006170	systolic blood pressure|| alcohol consumption measurement	
Systolic blood pressure x alcohol consumption interaction (2df test)	systolic blood pressure|| alcohol drinking	GCST006434	systolic blood pressure|| alcohol drinking	
Systolic blood pressure x smoking status (current vs non-current) interaction (1df test)	smoking status measurement|| systolic blood pressure	GCST006186	smoking status measurement|| systolic blood pressure	
Systolic blood pressure x smoking status (current vs non-current) interaction (2df test)	smoking status measurement|| systolic blood pressure	GCST006195	smoking status measurement|| systolic blood pressure	
Systolic blood pressure x smoking status (ever vs never) interaction (1df test)	smoking status measurement|| systolic blood pressure	GCST006189	smoking status measurement|| systolic blood pressure	
Systolic blood pressure x smoking status (ever vs never) interaction (2df test)	smoking status measurement|| systolic blood pressure	GCST006192	smoking status measurement|| systolic blood pressure	
Systolic blood pressure x sodium interaction (1df test)	sodium measurement|| systolic blood pressure	GCST006115	sodium measurement|| systolic blood pressure	
Systolic blood pressure x sodium interaction (2df test)	sodium measurement|| systolic blood pressure	GCST006113	sodium measurement|| systolic blood pressure	
TB-LM or TBLH-BMD (pleiotropy)	bone density|| lean body mass	GCST004771	bone density|| lean body mass	
Total ventricular volume (Alzheimer's disease interaction)	Alzheimer's disease|| brain volume measurement	GCST000892	Alzheimer's disease|| brain volume measurement	
Tourette's syndrome or obsessive-compulsive disorder	obsessive-compulsive disorder|| Tourette syndrome	GCST002682	obsessive-compulsive disorder|| Tourette syndrome	
Triptolide cytotoxicity	response to triptolide|| cytotoxicity measurement	GCST003008	response to triptolide|| cytotoxicity measurement	
Tumor necrosis factor receptor II (red blood cell fatty acid level interaction)	fatty acid measurement|| tumor necrosis factor receptor II measurement	GCST004817	fatty acid measurement|| tumor necrosis factor receptor II measurement	
Type 1 diabetes and autoimmune thyroid diseases	autoimmune thyroid disease|| type I diabetes mellitus	GCST002876	autoimmune thyroid disease|| type I diabetes mellitus	
Type 1 diabetes autoantibodies	type I diabetes mellitus|| autoantibody measurement	GCST001479	type I diabetes mellitus|| autoantibody measurement	
Type 2 diabetes (dietary heme iron intake interaction)	type II diabetes mellitus|| dietary heme iron intake measurement	GCST001843	type II diabetes mellitus|| dietary heme iron intake measurement	
Ulcerative colitis or Crohn's disease	ulcerative colitis|| Crohn's disease	GCST001118	ulcerative colitis|| Crohn's disease	
Urate levels (BMI interaction)	urate measurement|| body mass index	GCST002827	urate measurement|| body mass index	
Urate levels (BMI interaction)	urate measurement|| body mass index	GCST002826	urate measurement|| body mass index	
Uveitis (juvenile idiopathic arthritis-associated)	chronic childhood arthritis|| uveitis	GCST006127	chronic childhood arthritis|| uveitis	
Vaginal discharge (metrorrhagia)	metrorrhagia|| vaginal discharge	GCST006657	metrorrhagia|| vaginal discharge	
Vascular brain injury	vascular brain injury measurement|| vascular brain injury	GCST002590	vascular brain injury measurement|| vascular brain injury	
Ventricular ectopy or supraventricular ectopy (pleiotropy)	premature cardiac contractions|| supraventricular ectopy|| ventricular ectopy	GCST005935	premature cardiac contractions|| supraventricular ectopy|| ventricular ectopy	
Visceral adipose tissue (sex interaction)	visceral adipose tissue measurement|| sex interaction measurement	GCST005086	visceral adipose tissue measurement|| sex interaction measurement	
Visceral adipose tissue adjusted for BMI	visceral adipose tissue measurement|| body mass index	GCST006533	visceral adipose tissue measurement|| body mass index	
Visceral adipose tissue adjusted for BMI	visceral adipose tissue measurement|| body mass index	GCST006534	visceral adipose tissue measurement|| body mass index	
Visceral adipose tissue adjusted for BMI	visceral adipose tissue measurement|| body mass index	GCST003967	visceral adipose tissue measurement|| body mass index	
Visceral adipose tissue adjusted for BMI	visceral adipose tissue measurement|| body mass index	GCST001523	visceral adipose tissue measurement|| body mass index	
Visceral adipose tissue adjusted for BMI (sex interaction)	visceral adipose tissue measurement|| sex interaction measurement	GCST005088	visceral adipose tissue measurement|| sex interaction measurement	
Visceral adipose tissue/subcutaneous adipose tissue ratio (sex interaction)	sex interaction measurement|| visceral:subcutaneous adipose tissue ratio	GCST005090	sex interaction measurement|| visceral:subcutaneous adipose tissue ratio	
Visceral adipose tissue/subcutaneous adipose tissue ratio adjusted for BMI	body mass index|| visceral:subcutaneous adipose tissue ratio	GCST006554	body mass index|| visceral:subcutaneous adipose tissue ratio	
Visceral adipose tissue/subcutaneous adipose tissue ratio adjusted for BMI	body mass index|| visceral:subcutaneous adipose tissue ratio	GCST006553	body mass index|| visceral:subcutaneous adipose tissue ratio	
Vitamin D levels (dietary vitamin D intake interaction)	vitamin D measurement|| vitamin D dietary intake measurement	GCST005366	vitamin D measurement|| vitamin D dietary intake measurement	
Waist circumference (sex interaction)	waist circumference|| sex interaction measurement	GCST000931	waist circumference|| sex interaction measurement	
Waist circumference adjusted for BMI (adjusted for smoking behaviour)	smoking behavior|| BMI-adjusted waist circumference	GCST004500	smoking behavior|| BMI-adjusted waist circumference	
Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction)	BMI-adjusted waist circumference|| physical activity measurement	GCST004563	BMI-adjusted waist circumference|| physical activity measurement	
Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction)	smoking behavior|| BMI-adjusted waist circumference	GCST004501	smoking behavior|| BMI-adjusted waist circumference	
Waist circumference adjusted for BMI (physical activity interaction)	BMI-adjusted waist circumference|| physical activity measurement	GCST004561	BMI-adjusted waist circumference|| physical activity measurement	
Waist circumference adjusted for BMI (smoking interaction)	smoking behavior|| BMI-adjusted waist circumference	GCST004502	smoking behavior|| BMI-adjusted waist circumference	
Waist-to-hip circumference ratio (alcohol intake interaction)	alcohol consumption measurement|| waist-hip ratio	GCST004579	alcohol consumption measurement|| waist-hip ratio	
Waist-to-hip circumference ratio (dietary energy interaction)	diet measurement|| waist-hip ratio	GCST004582	diet measurement|| waist-hip ratio	
Waist-to-hip circumference ratio (ever vs never smoking interaction)	smoking behaviour measurement|| waist-hip ratio	GCST001754	smoking behaviour measurement|| waist-hip ratio	
Waist-to-hip circumference ratio (recreational physical activity interaction)	physical activity measurement|| waist-hip ratio	GCST004583	physical activity measurement|| waist-hip ratio	
Waist-to-hip circumference ratio (smoking years interaction)	smoking behaviour measurement|| waist-hip ratio	GCST004584	smoking behaviour measurement|| waist-hip ratio	
Waist-to-hip ratio (sex interaction)	sex interaction measurement|| waist-hip ratio	GCST000928	sex interaction measurement|| waist-hip ratio	
Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour)	smoking behavior|| BMI-adjusted waist-hip ratio	GCST004505	smoking behavior|| BMI-adjusted waist-hip ratio	
Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction)	BMI-adjusted waist-hip ratio|| physical activity measurement	GCST004567	BMI-adjusted waist-hip ratio|| physical activity measurement	
Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction)	smoking behavior|| BMI-adjusted waist-hip ratio	GCST004507	smoking behavior|| BMI-adjusted waist-hip ratio	
Waist-to-hip ratio adjusted for BMI (physical activity interaction)	BMI-adjusted waist-hip ratio|| physical activity measurement	GCST004566	BMI-adjusted waist-hip ratio|| physical activity measurement	
Waist-to-hip ratio adjusted for BMI (smoking interaction)	smoking behavior|| BMI-adjusted waist-hip ratio	GCST004506	smoking behavior|| BMI-adjusted waist-hip ratio	
Waist-to-hip ratio adjusted for BMI x age interaction	BMI-adjusted waist-hip ratio|| age at assessment	GCST005961	BMI-adjusted waist-hip ratio|| age at assessment	
Waist-to-hip ratio adjusted for BMI x sex interaction	BMI-adjusted waist-hip ratio|| sex interaction measurement	GCST005959	BMI-adjusted waist-hip ratio|| sex interaction measurement	
Waist-to-hip ratio adjusted for BMI x sex x age interaction	BMI-adjusted waist-hip ratio|| sex interaction measurement|| age at assessment	GCST005960	BMI-adjusted waist-hip ratio|| sex interaction measurement|| age at assessment	
Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)	BMI-adjusted waist-hip ratio|| sex interaction measurement|| age at assessment	GCST005962	BMI-adjusted waist-hip ratio|| sex interaction measurement|| age at assessment	
Waist-to-hip ratio adjusted for body mass index	BMI-adjusted waist-hip ratio|| physical activity measurement	GCST004576	BMI-adjusted waist-hip ratio|| physical activity measurement	
White matter integrity (bipolar disorder risk interaction)	white matter integrity|| bipolar disorder	GCST001764	white matter integrity|| bipolar disorder	
Whole body bone mineral density and alcohol drinking	alcohol consumption measurement|| bone density	GCST003921	alcohol consumption measurement|| bone density	
Whole-brain volume (Alzheimer's disease interaction)	Alzheimer's disease|| whole-brain volume	GCST000895	Alzheimer's disease|| whole-brain volume	
Resistance to antipsychotic treatment in schizophrenia	schizophrenia|| response to antispychotic drug	GCST004375	response to antispychotic drug	schizophrenia